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Cells frequently incur genetic damage during their life times. To counter these, 
eukaryotic cells have evolved surveillance mechanisms, known as checkpoint controls, 
to detect such damages.  
When activated, the checkpoint pathways transiently halt progression through 
the division cycle. This allows cells to repair the DNA damage by either homologous 
recombination (HR) or non-homologous end joining (NHEJ). Once the DNA damage 
is repaired, the  cell cycle can resume. Such corrective measures are critical to the 
maintenance of genomic stability through successive cell divisions.  
Cells defective in checkpoint controls accumulate chromosomal aberrations 
which may eventually lead to uncontrolled division or, in extreme cases, even cell 
death. Checkpoint pathways are frequently found to be defective in human tumors. 
However, in some instances when repair responses cannot be mounted, the cells 
escape the DNA damage imposed arrest and progress to mitosis with damaged DNA. 
This behavior, which is detrimental to chromosome stability, is known as ‘adaptation’. 
This phenomenon was first observed in the budding yeast Saccharomyces cerevisiae 
(the organism used in this study) [1-3], subsequently, adaptation was also found to 
occur in Xenopus [4], and in human cells [5]. Although Polo kinase (Cdc5 in yeast) is 
known to be required for adaptation [3], its exact role remains to be elucidated.  
In the first part of this study, we have investigated the role of Cdc5 polo kinase 
in the adaptive response. We have developed a new method to quantify adaptation in 
a cell population and have found that ectopic expression of Cdc5 accelerates the 
adaptation response. This is consistent with our observation that the level of Cdc5 
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increases as cells prepare to undergo adaptation. High level of Cdc5 activity also 
suppresses the adaptation defect in cells deficient in Sae2, Ptc2, Ptc3 or Ckb1. We 
have shown that the requirement of Cdc5 for adaptation is not because of its role in 
mitotic progression as is generally believed. Instead, Cdc5 activity is necessary for 
extinguishing the checkpoint and to turn off the checkpoint by inhibiting the 
recruitment of checkpoint response protein Ddc2 to an unrepaired double-strand-
break (DSB). In addition, our model suggests that the prolonged period of G2/M 
arrest imposed before adaptation, could provide sufficient time for cells to accumulate 
enough Cdc5 activity needed to overcome the initial inhibition imposed by DNA 
damage-activated Rad53. Collectively, our results strongly suggest that Cdc5 polo 
kinase regulates upstream signaling events in the checkpoint pathway during the 
adaptive response. 
In the second part, a mathematical approach was taken to analyze the gene 
expression response due to oscillatory transcription factors (TFs). Oscillatory TFs 
have been reported in many diverse biological processes such as the: circadian clock 
[6, 7], somite segmentation during development [8], DNA damage response [9-12], 
inflammation [13-15], cell cycle [16, 17] and yeast glucose metabolism [18] (see 
Table 1). The resultant oscillatory gene expression appears to have specific functions. 
For instance, different oscillating dynamics of NF-B activates specific sets of genes 
[13], and p53 exhibits oscillatory profiles depending on the extent of DNA damage [9, 
19, 20]. The effects elicited by oscillating TFs have been demonstrated, but are not 
well understood. 
Our findings stem from the estimated trends of gene expression responses we 
have modeled. It appears that the various effects caused by oscillatory TFs are 
intrinsic to the system. As an example (as shown in Figure 24), we have demonstrated 
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a Hill kinetic system which involves oscillating gene expression and exhibits 
differential regulation of different target genes, suggesting that an oscillating TF could 
up-regulate a set of genes while others could be down-regulated or remain unchanged. 
These changes would not be possible for non-varying TFs without involving other 
entities. Therefore, oscillatory behaviour provides the TFs with additional degree of 
dynamics and.renders specificity to their responses. In the context of DNA damage in 
mammalian cells, an attractive possibility is that p53 may possess similar molecular 
properties that allow it to selectively up-regulate apoptotic genes upon severe DNA 
damage. Taken together, our analyses of the mathematical gene-expression models 
uncover a plausible mechanism to differentially regulate genes - an interesting 
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Chapter 1 Introduction 
 
1.1 Part 1 
Faithful chromosome duplication and maintenance are essential for the survival of all 
cells. Cell cycle checkpoints are surveillance mechanisms that participate in the 
coordinated execution of the cell cycle events and thus protect the genome integrity. 
One such mechanism, the DNA damage checkpoint, inhibits cell cycle progression in 
response to DNA damage and causes cells to arrest in G2/M until the offending 
lesions are repaired. 
A failure to repair DNA damage prolongs the G2/M arrest. However, cells 
eventually escape the checkpoint arrest and progress through mitosis with damaged 
chromosomes [1-3]. This cellular behavior has been termed ‘adaptation’. First 
identified in the budding yeast Saccharomyces cerevisiae, studies have shown that 
adaptation is a reproducible and non-random process [1-3, 21] (also verified in this 
work), and is under genetic control. As the DNA damage checkpoint pathway and its 
components are conserved in eukaryotes (see Table 1), it is not surprising that 
adaptation has been also been reported in Xenopus [4] and in human cells [5]. In a 
teleological sense, ‘adaptation’ appears to be an anomalous cellular behavior with a 
high possibility of further chromosome damage which may eventually threaten the 
fitness and/or survival of the cell. However, keeping with a general belief in the 
‘evolutionary dictum’ that cellular processes are selected for an eventual advantage to 
the organism, it has been suggested that adaptation provides cells with an opportunity 
to attempt repair in the subsequent cycle.  
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Polo-like kinase has been implicated in checkpoint adaptation; but its function 
has not been elucidated. The first part of this study aims to address the role of polo 
kinase during the adaptive response. Since yeast cells are amenable to genetic 
manipulation, and cell cycle regulation is highly conserved between eukaryotes, we 
have used budding yeast as an experimental system for our studies. Before embarking 
on a discussion of DNA damage checkpoint control and events associated with it, it is 
useful to begin with a brief description of the general regulatory landscape of the cell 
cycle in which the DNA damage response pathways are embedded.  
 
1.1.1 Cell cycle in brief 
Every living organism, whether uni- or multicellular, depends on the division process 
for successful transmission of genetic information that is critical for survival. The cell 
division process comprises a series of highly regulated molecular events, collectively 
known as the “cell cycle”. The cell cycle is divided into 4 major phases (G1, S, G2 
and M) based on chromosomal events. DNA replication occurs in S-phase (Synthesis 
phase), whereas the duplicated chromosomes are equally partitioned in M-phase 
(Mitotic phase). G1 and G2 are two gap phases which prepare the cell for the 
subsequent phases. 
Cdks (cyclin-dependent kinases) and their regulatory subunits, cyclins, are 
among the major drivers of progression through the cell cycle. In the budding yeast, 
Cdc28 (Cdk1) is the major Cdk that regulates various aspects of the division cycle 
[22]. It associates with different cyclins to catalyze various events in different phases 
of the cell cycle. Cdc28, when associated with G1 cyclins (Cln1, Cln2 and Cln3), 
helps cells undergo START, a stage in late G1 after which cells become irreversibly 
committed to one cycle of division [23]. This is also the time when the daughter cell 
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emerges as a small bud from the surface of the parental cell. In the budding yeast, the 
parental and progeny cells are referred to as mother and daughter respectively. The 
bud continues to grow throughout the division cycle to reach almost the same size as 
the mother cell by the end of the cycle, while the mother cell grows minimally. 
Traversing through START is also a prerequisite for the duplication of centrosomes, 
the microtubule organizing center (MTOC, also referred to as spindle pole bodies), 
that play a central role in the assembly of a mitotic spindle in late S phase [24]. Soon 
after traversing START, Cdc28-Clb5, Clb6 kinase complex promotes initiation of S 
phase during which DNA is replicated [25-28]. G2 phase is remarkably short in 
budding yeast. By some estimates, it occupies only 3 mins in a 90-120 mins long 
division cycle.  
The onset of M phase (also referred to as simply ‘mitosis’) is catalyzed by a 
kinase complex formed by association of Cdc28 with the mitotic cyclins (Clb1, Clb2, 
Clb3, Clb4). Cdc28-Clb2 kinase contributes a major part of the total Cdc28 mitotic 
activity [29-31]. At the time of entry into mitosis, the inter-SPB bridge is broken and 
cells assemble a mitotic spindle. In addition, kinetochore-microtubules emanating 
from the SPBs establish connection to the chromosomes such that one kinetochore is 
connected to one SPB while the other is connected to the opposite SPB (bi-
orientation). Unlike vertebrate cells, budding yeast cells undergo closed mitosis in 
which the onset of mitosis is not accompanied by breakdown of the nuclear envelope 
[32].  
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1.1.1.1 Chromosome segregation 
The duplicated chromosomes or sister chromatids are partitioned equally during 
transition from metaphase to anaphase. Until the onset of anaphase, sister chromatids 
are held together by a protein complex known as cohesins. The cohesin complex in 
the budding yeast is composed of four subunits: Smc1, Smc3, Scc1 and Scc3 [33]. 
The cohesin subunits are assembled in a roughly ‘ring-shaped’ structure that encircle 
the sister chromatids along the entire length of the chromosomes. Segregation of sister 
chromatids into progeny cells requires dissolution of the cohesion that holds them 
together. The dissolution of cohesion is accomplished by proteolytic cleavage of 
cohesin subunit Scc1 by separase, a caspase-like protease encoded by ESP1 gene [34, 
35]. However, cohesin cleavage is controlled by an inhibitory protein called securin 
(encoded by PDS1 gene) which is physically associated with the separase. Inhibition 
of separase by securin ensures that cohesins are not cleaved until the onset of 
anaphase. Anaphase is triggered by proteolytic destruction of securin by a multi-
subunit ubiquitin ligase known as the anaphase-promoting complex (APC) [36, 37]. 
Once the chromosomes have established a bipolar attachment to the mitotic spindle, 
APC is activated by its association with Cdc20, an evolutionarily conserved protein 
[38, 39]. Proteolytic destruction of securin by APCCdc20 sets the separase free, which 
in turn dissolves sister-chromatid cohesion and allows progressive separation of 
chromosomes into the mother and daughter compartments by the mitotic spindle. 
When cells incur ‘injuries’ to its chromosomes or the mitotic spindle the checkpoint 
controls disable the chromosome segregation-machinery until the damages are 
repaired (see below). 
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1.1.1.2 Mitotic Exit 
In telophase, nuclei containing one set of chromosomes each are positioned closer to 
the cell cortex with a long spindle stretching between them. The final exit from M 
phase into the G1 phase of the subsequent cycle is the next major transition cells 
undertake. The most conspicuous event associated with the exit from M phase is the 
rapid proteolytic destruction of the mitotic cyclins [40-42], which dramatically 
reduces the mitotic kinase activity. This allows cells to enter G1, trigger the onset of 
cytokinesis and induce the expression of G1 specific transcripts [43, 44]. Cyclin 
proteolysis is regulated by a signal transduction pathway known as the mitotic exit 
network (MEN) involving a small GTPase Tem1, four Ser/Thr kinases namely Cdc15, 
Cdc5 polo kinase, Dbf2 and Dbf20, Cdc14 phosphatase and the APC [45, 46]. It has 
been shown that the APC can be activated by Cdc20 or its homologue Cdh1 
(APCCdc20 and APCCdh1, respectively) and that both complexes participate in the 
destruction of mitotic cyclins [45, 47, 48]. Both APC complexes collaborate to 
destroy Clb1 and Clb2 cyclins in a biphasic manner [45, 47, 48]. The first wave of 
cyclin destruction, mediated by APCCdc20, begins at the onset of anaphase and reduces 
the cyclin abundance to ~50% by the time cells reach telophase. This is necessary for 
the activation of APCCdh1 which is inhibited via phosphorylation by mitotic kinase. 
Reduction in mitotic kinase activity by APCCdc20 paves the way for the activation of 
APCCdh1 by Cdc14 phosphatase which is released from the nucleolus under the 
influence of the MEN. Activated APCCdh1 mediates further destruction of mitotic 
cyclins, thus allowing cells’ timely exit from mitosis. Another auxiliary pathway 
called FEAR (Fourteen Early Anaphase Release) has been proposed to participate in 
efficient proteolysis of mitotic cyclins [49]. It involves a number of proteins including 
Cdc5 polo kinase, Slk19, Spo12 and Esp1; however, the exact functional relationship 
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amongst them is not clear. Unlike MEN, FEAR pathway is not essential for cyclin 
proteolysis [49, 50]. It has been suggested that while FEAR pathway initiates cyclin 
proteolysis, MEN maintains it until the mitotic kinase activity becomes sufficiently 
low to trigger the final exit from mitosis [49, 51]. Hence, proteolytic destruction plays 
a critical role in the progression of the division cycle. 
 
1.1.1.3 Regulation of Cdk1 activity in budding yeast 
Cdk1 (Cdc28) activity is regulated at multiple levels. Regulation of cyclin 
transcription may be considered as the first level of regulation. During a normal cell 
cycle, expression of Cln and Clb cyclins occurs in a sequential fashion so that Cdk1 is 
activated by the appropriate group of cyclins at the right stages of the cell division 
cycle. The mitotic kinase complex Cdc28/Clb is also regulated post-translationally. 
The association of Cdc28 and Clb1/2 is inherently unstable; it is stabilized by 
phosphorylation of a highly conserved Thr167 residue of Cdc28 by Cak (Cdk 
activating kinase) [52, 53]. Another important modification occurs close to the ATP 
binding domain at the evolutionarily conserved Tyr19 residue. While phosphorylation 
of Tyr19 by tyrosine kinase Swe1 (orthologue of fission yeast and human wee1) 
inactivates the Cdc28 kinase, dephosphorylation of this residue by Mih1 (homologous 
to fission yeast and human Cdc25) activates the kinase at the onset of mitosis. Unlike 
in the case of the fission yeast, SWE1 and MIH1 in the budding yeast are nonessential 
genes suggesting that other mechanisms regulating the timely activation of Cdc28 
may be present. Tyr19 is also the target of regulation by both the replication 
checkpoint [54-56] and the DNA damage checkpoint [57]. Cdk inhibitors constitute 
an additional layer of regulation of the master kinase Cdc28. Sic1, an inhibitor of 
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Cdc28/Clb kinase, acts at two different stages of the cell cycle: in late G1 where it 
inhibits the S phase kinase Cdc28-Clb5/Clb6 and regulates the timing of S phase 
initiation and, in late telophase when it participates in the inactivation of mitotic 
kinase to aid the final exit from mitosis. 
1.1.1.4 Cell cycle regulation by checkpoint pathways 
To ensure proper functioning of the cell cycle, the cells employ checkpoints that 
monitor various cellular events [58]. Four major checkpoints are now known in the 
budding yeast: morphogenetic checkpoint, DNA replication checkpoint, DNA damage 
checkpoint (DDC) and spindle assembly checkpoint (SAC). The morphogenetic 
checkpoint monitors conditions that affect proper bud formation [59]. It responds to a 
defect in bud emergence and delays the initiation of nuclear division. The replication 
checkpoint is triggered if DNA synthesis is disrupted, while the DDC responds to any 
insult to the DNA such as modification of nitrogenous bases or breakage of the 
phosphodiester backbone (please note that this study will focus on the DDC response 
triggered by double strand breaks). Any perturbation in the mitotic spindle or a defect 
in the kinetochore-microtubule attachment, leading to a defect in bi-orientation, is 
monitored by the spindle assembly checkpoint. In this study, our interest is primarily 
focused on the DNA damage checkpoint. 
 
1.1.2 DNA damage checkpoint (DDC) 
As expected, the DNA damage checkpoint pathway and its components are well-
conserved across eukaryotes (see Table 1). The checkpoint components can be 
broadly classified into three types: sensors, mediators/transducers and effectors [60]. 
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In response to DSB(s) (Double Strand Breaks), the sensors trigger a signaling cascade 
mediated via transducers; this leads to effector-mediated cell cycle arrest (reviewed in 
[61]) and subsequent DNA repair, either via homologous recombination or non-
homologous end joining (NHEJ). If the damage is repaired, cells proceed through the 
cell cycle via a recovery process. However, if the damage persists, cells escape from 
the checkpoint arrest after a prolonged period through a process known as 
“adaptation”. Cdc5, a polo-like kinase, is reported to be essential for adaptation. The 
following sections summarize the information gleaned from the recent relevant 
literature. 
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Role Sc Sp Dm Vertebrates Type 
Sensor Ddc1 Rad9  RAD9 PCNA-like 
Sensor Rad17 Rad1  RAD1 PCNA-like 
Sensor Mec3 Hus1  HUS1 PCNA-like 
Sensor Rad24 Rad17  RAD17 RFC1-like 
DNA synthesis/sensor RFC2-5 RFC3  RFC2-5 RFC component 
DNA synthesis/sensor RFA   RPA ssDNA-binding 
synthesis/sensor    BRCA1 BRCT-domain 
Mediator    TOBP1 BRCT-domain 
Mediator    MDC1 BRCT-domain 
Mediator Rad9 Crb2/Rhp9   BRCT-domain 
Mediator Dpb11 Cut5   BRCT-domain 
Sensor/transducer Mec1 Rad3 Mei-41 ATR PI3K-like 
Sensor/transducer Ddc2 Rad26 Mus304 ATRIP ATR-binding 
Sensor/transducer Tel1 Tel1 ATM ATM PI3K-like 
Transducer Chk1 Chk1 Grapes Chk1 Kinase 
Transducer Rad53 Cds1 Chk2 Chk2 Kinase 
Multiple Mre11 Rad32 Mre11 MRE11 Nuclease 
Multiple Rad50 Rad50 Rad50 RAD50  
Multiple Xrs2 nbs1 Nbs1 NBS1  
Effector   Dp53 p53 Transcription factor 
Effector   String Cdc25A-C Phosphatase 
Effector Pds1 Cut2  Securin APC-inhibitor 
Effector Cdc28 Cdc2 Cdk1 Cdk1 Kinase 
Polo kinase Cdc5 Plo1 Polo, Plk4/Sak Plk1-4  
 
Table 1. DNA damage checkpoint proteins 
DNA damage checkpoint proteins [62] found in Saccharomyces cerevisiae (Sc), 
Schizosaccharomyces pombe (Sp), Drosophila melanogaster (Dm) and vertebrates. 
Proteins can be classified into 3 groups: Sensors, Mediator/Transducer, and Effectors. 
The response pathway is well conserved, since most proteins have homologues / 
orthologues in other species with similar pathway structure. 
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1.1.2.1 DNA damage response 
In both yeast and mammalian cells, MRX (Mre11–Rad50–Xrs2 in yeast, / Mre11–
Rad50–NBS1 in mammalian) complex is among the first to be recruited to the site of 
DSB in the DNA, and binds directly to either blunt or minimally processed DNA ends 
(Figure 1) [63-65]. This is independent of DNA resection or Mec1 [63-65]. 
Subsequently, this complex recruits Tel1 kinase which phosphorylates histone H2A. 
The endonuclease MRX,  Sae2, exonuclease Exo1 and helicase Sgs1 are involved in 
5'-3' resection of the DNA ends [66, 67]. The efficency of resection is affected by the 
cell cycle phases [63]. As DNA is resected, MRX, Sae2 and Tel1 dissociate from the 
DSB site. However, MRX dissociation is inhibited in sae2 cells [68]. The newly 
formed single stranded DNA (ssDNA) with 3’ overhang attracts RPA (Replication 
Protein A) heterotrimer consisting of Rfa1,Rfa2, Rfa3. Subsequently, the bound RPA 
is joined by the two key transducers: Mec1-Ddc2 heterodimer (ATR/ATRIP in 
mammals) and 9-1-1 clamp (Rad9/Rad1/Hus1 in mammals, Ddc1/Rad17/Mec3 in S. 
cerevisiae). The 9-1-1 complex is loaded onto the RPA coated ssDNA by Rad24–
RFC clamp loader [69]. In the absence of RPA, 9-1-1 can be loaded onto DNA with 
either a 3’- or 5’-junction [70]. However, if the DNA is coated with RPA, loading of 
9-1-1 complex onto the 3’-junction of the DNA is prevented. As for Mec1-Ddc2, its 
binding to RPA appears to be intrinsic in that the recruitment of Mec1-Ddc2 complex 
depends on a conserved checkpoint protein recruitment domain (CRD) in Ddc2 [71, 
72]. Initial studies [73, 74] reported that 9-1-1 (Ddc1/Rad17/Mec3 in yeast) and 
Mec1-Ddc2 can bind to the damage sites independently. However later investigations 
showed that the formation of Ddc2 foci are inhibited in mec3 cells (in which 9-1-1 
would be dysfunctional without one of its subunits). These cells arrested in G1 but not 
those in S/G2 phase [75]. Moreover, inefficient loading of 9-1-1 in rad24 cells 
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prevents Mec1 foci formation [76]. Nevertheless, either complex alone is not 
sufficient to activate the checkpoint [75-78]. An in vitro study [78] demonstrated that 
Ddc1 can bind to and activate Mec1-Ddc2, which would be necessary to initiate the 
activation of downstream checkpoint cascades. 
In yeast, Mec1 is the primary checkpoint signaling molecule [79]. One of its 
key functions is to phosphorylate effector kinases, Rad53 (Chk2 in mammals) and 
Chk1, via the adaptor protein Rad9 [80]. Following this, phosphorylated Rad53 
achieves full activation by trans-autophosphorylation. The activated kinases Rad53 
and Chk1 are together responsible for a number of downstream responses. These 
include DNA damage-induced transcriptional regulation, increase in the dNTP pool 
for DNA repair and inhibition of the progression to mitosis [81]. 





Figure 1. Proteins involved in DNA damage responses due to a DSB.
 (a) MRX complex (Mre11, Rad50, and Xrs2; red) are the first checkpoint proteins to 
bind to the DSB ends. The MRX recruits Tel1 (dark yellow) which create a region of 
phosphorylated histone H2A (-H2AX, red spot on nucleosome). Sae2 (blue wedge) 
regulates the nuclease activity of the MRX complex. 
(b) DNA resection at a DSB is carried out by MRX and Exo1 (black). Resected 
ssDNA with 3'-end ssDNA recruits RPA heterotrimer (white). The bound Rad24 
(orange) with Rfc2-5 (dark orange) loads the 9-1-1 clamp (magenta). In addition, 
RPA-coated ssDNA attracts the Mec1-Ddc2 heterodimer (green and light blue), 
which activates the downstream cascade. 
(c) Activation of the checkpoint cascade. Rad9 (purple) is recruited by the modified 
histones including -H2AX. Next, the Mec1-phosphorylated Rad9 recruits Rad53 
(avocado) for phosphorylation (red dot) by Mec1, probably facilitated by the 9-1-1 
clamp. Rad9 and phosphorylated Rad53 then dissociate and multimerize to allow 
further trans-autophosphorylation, and achieve full activation of Rad53. Chk1 is 
activated by Mec1 and Rad9 in a similar way.  
Reprinted, with permission, from the Annual Review of Genetics, Volume 40 © 2006 
by Annual Reviews <http://www.annualreviews.org> [61] 
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1.1.2.2 DNA checkpoint induced cell cycle arrest 
In the budding yeast, activation of the DDC leads to a cell cycle arrest. Once DNA 
damage is detected, the checkpoint signal is transduced via the Mec1 kinase. Mec1 in 
turn activates two kinases, Rad53 and Chk1 that act in parallel pathways resulting in a 
cell cycle arrest. Pds1 or securin (the downstream target of Chk1) is an inhibitor of 
anaphase initiation. Its degradation is a prerequisite for mitotic progression. In a 
normal cell cycle, Pds1 binds to and inhibits the activity of the separase Esp1 during 
metaphase thus delaying chromosome segregation [82]. To initiate anaphase, active 
APCCdc20 complex ubiquitylates Pds1 thereby promoting its degradation. Pds1 
degradation releases the Esp1 separase which is now free to cleave cohesins [34]. 
Once the cohesins are cleaved. the spindle elongates and separation of the sister 
chromatids ensues. 
In S. cerevisiae, DDC blocks the metaphase to anaphase transition and hence 
exit from mitosis [83]. Cells are arrested at metaphase through the action of Rad53 
and Chk1 kinases. The activated Rad53 inhibits the Pds1-APCCdc20 interaction while 
Chk1-dependent phosphorylation of Pds1 prevents Pds1 ubiquitylation and 
degradation by APCCdc20 [84].  
As mentioned earlier, in the budding yeast, two signal transduction cascades, 
namely the mitotic exit network (MEN) and FEAR control mitotic exit by regulating 
the localization of the phosphatase Cdc14. Members of the MEN pathway comprise 
the protein kinases Cdc5, Cdc15, and Dbf2; a GTPase, Tem1; a phosphatase, Cdc14; 
and Mob1 (a Dbf2 binding protein). Of these, Tem1 is crucial in regulating the MEN 
pathway. Prior to anaphase, the spindle pole body (SPB)-localized Tem1 remains 
inactive by virtue of its association with Bfa1-Bub2, a GAP complex. Upon migration 
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of one of the SPBs into the daughter cell, SPB-associated Tem1 comes into close 
proximity with its activator Lte1 which is localized to the bud cortex of the daughter 
cell, leading to the activation of the MEN pathway. At the same time, Cdc5 
phosphorylates Bfa1, thus releasing Tem1 from its inhibition by Bfa1-Bub2. The 
FEAR pathway, on the other hand, consists of the Polo kinase Cdc5, the separase 
Esp1, the kinetochore-associated protein Slk19, and Spo12. While the MEN pathway 
secures the release of Cdc14 phosphatase in telophase, the FEAR network contributes 
to Cdc14 release from the nucleolus during early anaphase. The FEAR-dependent 
Cdc14 release promotes activation of the MEN pathway by dephosphorylating Cdc15. 
However, during the DNA damage checkpoint arrest, Rad53-mediated 
phosphorylation of Bfa1 promotes its binding to Tem1 which results in the inhibition 
of Tem1 activity. Activated Chk1 kinase also inhibits the FEAR pathway-dependent 
Cdc14 release [85, 86]. 
 
1.1.3 DNA repair 
The DNA repair systems aim to restore DNA to its native state by repairing the 
offending lesions. In eukaryotic cells, DSBs are repaired by two principal pathways: 
homologous recombination (HR) and non-homologous end-joining (NHEJ). DNA 
repair by homologous recombination results in a precise repair of DNA lesions and 
requires the presence of a homologous template (reviewed in [87]). The template can 
exist in the form of a homologous chromosome or a sister chromatid [87]., NHEJ-
mediated repair, on the other hand, can occur in the absence of homologous sequences. 
Here, DNA-break ends are ligated, but the end products may contain insertions or 
deletions. Hence the DNA junctions can vary in their sequence composition. While 
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NHEJ appears to be the dominant mode of repair in mammalian cells, the 
predominant form of repair in yeast is HR [88-90]. This is especially so when the 
homologous template is available in G2 phase or when the yeast is in the diploid state. 
When HR is not a viable option, e.g. when haploid yeast cells are in the G1 phase, 
NHEJ appears to be the pathway of choice. The following sections describe in greater 
detail the molecular processes involved in HR and NHEJ. 
 
1.1.3.1 Homologous recombination (HR) 
Genetic analyses of the processes involved in DNA double-strand break repair, as 
well as mitotic and meiotic recombination in the budding yeast, have resulted in the 
identification of several genes known collectively as the RAD52 epistasis group, 
including Rad50-57, 59, Mre11 and Xrs2 [91-93]. Amongst these, RAD51 is the most 
prominent. It has structural homology to E. coli RecA and T4 UvsX proteins and is 
highly conserved among eukaryotes. Rad51 behaves like RecA in homologous DNA 
pairing and strand exchange.  
In response to DNA damage and subsequent generation of ssDNA, the RAD52 
epistasis group mediates replacement of RPA with Rad51 [94]. Like RecA, Rad51 
also forms a right-handed helical filament on ssDNA in which the DNA is held in an 
extended state. The Rad51-ssDNA nucleoprotein filament (also known as the 
presynaptic filament) contains a binding site for dsDNA and searches for an 
undamaged homologous sequence. The incoming duplex is integrated into the 
presynaptic filament and tested for homology. The duplex is held briefly within the 
secondary binding site of the filament, and if homology is not found, the duplex is 
released. This process of binding and release continues until homologous DNA is 
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found. The complementary strand in the duplex molecule is continuously taken up 
into the presynaptic filament to base pair with the initiating ssDNA, resulting in the 
extension of the initial DNA joint. This process is termed "DNA strand exchange" or 
"DNA branch migration". The extent of DNA branch migration is determined by the 
length of the presynaptic filament. The homologous DNA is used as a template to 
synthesize new DNA, and forms a D loop structure [95]. The DNA structures are 
processed by synthesis-dependent strand annealing (SDSA) or via a double Holliday 
junction. Once resolved, the remaining ssDNA gaps are filled-in and ligated by DNA 
polymerase and DNA ligase, respectively. 
 
1.1.3.2 Non-homologous end joining (NHEJ) 
DNA double-strand breaks (DSB) can be repaired via direct ligation of DSB ends 
through non-homologous end joining (NHEJ). DNA-dependent protein kinase (DNA-
PK), comprising the DNA end binding Ku70/Ku80 heterodimer, the kinase catalytic 
subunit DNA-PKcs and the DNA ligase IV/XRCC4 complex (the yeast equivalents 
are Dnl4 and Lif1) are essential components of NHEJ. During NHEJ, DNA ends are 
brought together by end-bridging factors. Yku70/Yku80 (Ku70/Ku80 in mammals) 
heterodimers are the first components to recognize and to bind broken DNA ends [96]. 
In yeast, the Mre11/Rad50/Xrs2 complex associates with DNA-bound Yku70/Yku80 
to form an end-bridging complex which holds the broken DNA ends together [97]. 
However, most DNA double-strand breaks have terminal structures which 
could not be directly ligated. Hence, the DNA break ends are processed by DNA 
polymerases and nucleases to generate ligatable termini. Studies in S. cerevisiae have 
indicated a role for the DNA polymerase Pol4 and the DNA structure-specific 
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endonuclease Rad27 in the processing of these DNA ends leading to end joining by 
Dnl4/Lif1 which had been recruited to the break-site [98-100]. Rad27 interacts with 
both Pol4 and Dnl4/Lif1 [101] and these proteins coordinately process and ligate 
DNA molecules with incompatible 5' ends. The Nej1 protein interacts with Lif1 and 
enhances the ligase activity of the Dnl4/Lif1 complex for efficient NHEJ [102]. 
 
1.1.4 Recovery and adaptation 
When yeast cells are subject to a single DSB, the DNA damage checkpoint is 
activated, and the cells arrest at G2/M phase. Once the DNA damage is repaired, the 
DDC signal is turned off, and the cell resumes its cell cycle progression. This process 
is known as ‘recovery’. Contrary to the conventional models, if the damage is not 
repaired, cells are not permanently arrested in G2. Instead, they arrest for a relative 
long period but eventually escape from the cell cycle arrest and enter M phase. This 
phenomenon was first observed in the budding yeast [1, 3], and subsequently also 
reported to occur in human cells [5].  
 
1.1.4.1 Budding yeast 
As mentioned earlier, after a prolonged period of arrest spanning 10-12 hrs, yeast 
cells begin to escape from the arrest and undergo rebudding [2] despite the presence 
of persistent DNA damage. This phenomenon is known as adaptation. The broken 
chromosome is inherited for many cell divisions until it is lost.. Adaptable yeast cells 
exhibit higher viability after exposure to DNA-damaging agents [103], but they are 
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also more prone to genomic instability such as translocations and break-induced 
replication. 
Thus far, several adaptation defective mutants have been identified; they are 
cdc5-ad, ckb1, ckb2, yku70, rad51, tid1, sae2, srs2 and PP2C phosphatase 
(ptc2 /ptc3) [3, 68, 104-107]. These mutants fail to adapt and show persistently 
phosphorylated checkpoint kinase Rad53 [21], underscoring the requirement for the 
turning-off of the checkpoint prior to adaptation. Consistent with this notion, Ddc2 
foci (presence of these foci can be taken as an indication of checkpoint activation), 
but not Ddc1 foci, disappear during the course of adaptation [74]. 
Amongst these mutants, cdc5-ad, yku70, and tid1 mutants exhibit a stronger 
phenotype yet they are normal as far as recovery is concerned [61, 106]. cdc5-ad cells 
contain a point mutation in Cdc5 resulting in the substitution of amino acid residue 
251 from Lysine (L) to Tryptophan (W). It is deemed to be a “gain-of-function” 
mutation with a defective mitotic exit phenotype [108]. Forced inactivation of the 
checkpoint by shifting mec1-td (temperature sensitive degron) mutants to restrictive 
temperature can suppress cdc5-ad [21] adaptation defects. Intriguingly, cells with 
rfa1-t11 (a mutation in RPA) are checkpoint defective, and are able to suppress both 
yku70 and tid1 mutant phenotypes, but not that of cdc5-ad [21]. On the other hand, 
Yku70 is known to bind to the DNA ends at the break site to inhibit resection, thus 
allowing NHEJ to occur. Deletion of YKU70 leads to an increase in the extent of 
resection which probably leads to a stronger checkpoint signal, thus inhibiting 
adaptation [2].  
While cdc5-ad, yku70, and tid1 are defective only in adaptation, ptc2 
/ptc3, sae2 and srs2 mutants are unable to recover or adapt. Dephosphorylation of 
checkpoint proteins is clearly essential for adaptation and recovery. Studies have 
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shown that PP2C phosphatases, Ptc2 and Ptc3, can mediate the inactivation of Rad53 
via dephosphorylation. [107]. The inactivation requires CKII (which includes the 
Ckb1 and Ckb2 subunits), since CKII phosphorylation of Ptc2 facilitates its 
interaction with FHA1 domain of Rad53, and subsequently the dephosphorylation of 
Rad53. In contrast, Sae2 regulates the most upstream of the DDC pathway. Lack of 
Sae2 in cells causes MRX to remain associated with DNA. This suggests that MRX 
constitutively triggers the checkpoint, thus preventing recovery [79]. Since Srs2 
helicase could remove Rad51 from ssDNA, it is proposed that in srs2 cells, Rad51 
remains associated with DNA and maintains the checkpoint activation through an 
unknown mechanism. Interestingly, the phenotypic response in adaptation and 
recovery is not restricted to S cerevisiae. The following section describes similar 
behavior reported in other eukaryotes. 
 
1.1.4.2 Other eukaryotes 
In Xenopus, egg extracts adapt after a prolonged interphase arrest due to aphidicolin-
induced DNA replication checkpoint and enter mitosis with unreplicated DNA [4]. In 
the presence of aphidicolin, Claspin (checkpoint mediating protein) is phosphorylated. 
This phosphorylation creates a docking site for Plx1 (the Xenopus homologue of 
polo-like kinase) and hence ensinuates phosphorylation of Claspin by Plx1. Claspin 
phosphorylation leads to dissociation of Claspin from the chromatin. Due to a lack of 
Claspin-facilitated Chk1 phosphorylation by ATR [4], Chk1 is subsequently 
inactivated. A similar relationship between Plk1 (human homologue of polo-like 
kinase) and Chk1 was also demonstrated in human cells. During checkpoint recovery 
after HU or adriamycin-induced DNA damage, Plk1 mediates the phosphorylation of 
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Claspin, which facilitates its recognition by the -TrCP-SCF ubiquitin ligase and 
subsequently ubiquitin-dependent degradation. As a result, Chk1 is inactivated [109-
111]. In addition, it is reported that Plk1-mediated degradation of Wee1 is essential 
for recovery from a DNA damage-induced arrest but not for mitotic entry during a 
normal cell cycle [112]. Phosphorylation of Wee1 by Plk1 leads to Wee1 degradation, 
and also to less inhibition on Cdk1/cyclin B complex [112]. 
Adaptation to DNA damage checkpoint has also been reported recently in 
human cells [5]. Following ionizing radiation-induced damage, human osteosarcoma 
cells divided with unrepaired DNA breaks as indicated by the presence of -H2AX 
foci [5]. While excessive amounts of Chk1 or deficiency in Plk1 delays the exit from 
the G2 checkpoint arrest, suppression of Chk1 activity can accelerate the exit. 
 
1.1.5 Polo-like kinase, Cdc5 
Earlier studies have shown that polo-like kinase Cdc5 is essential for adaptation[3]. 
Therefore, it is of interest to review the current knowledge pertaining to Cdc5 and its 
functions, in order to set the context for our investigations into its role in adaptation in 
the subsequent chapters,  
Polo-like kinases are evolutionarily conserved proteins which belong to a 
subfamily of Ser/Thr protein kinases. Each polo kinase contains a N-terminal kinase 
domain and at least one polo box domain (PBD) in the C-terminal non-catalytic 
region. There are four polo kinases in mammalian cells (Plk1, Plk2, Plk3, Plk4), three 
in Xenopus laevis and Caenorhabditis elegans, two in Drosophila melanogaster; but 
only one in other species like Schizosaccharomyces pombe and Saccharomyces 
cerevisiae(Plo1 and Cdc5 respectively) (reviewed in [113]). 
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In the budding yeast, Polo-like kinase Cdc5 is well known for its multiple 
roles in mitosis [114]. During mitosis, Cdc5 regulates transcription of mitotic genes 
through its phosphorylation of Ndd1, a subunit of the Mcm1-Fkh2-Ndd1 transcription 
factor [115]. In anaphase, an essential role of Cdc5 is to promote chromosome 
condensation by phosphorylating the subunits of condensin and hence stimulating the 
latter’s DNA supercoiling activity [116]. In addition, phosphorylation by Cdc5 
stimulates the cohesins’ efficient cleavage and removal by separase [117]. Cdc5 has 
also been implicated strongly in APC/C regulation and in degradation of cyclin B 
during anaphase [118, 119]. As a member of the FEAR pathway, Cdc5 mediates the 
release of Cdc14 phosphatase in early anaphase through direct phosphorylation of the 
latter [120, 121]. Furthermore, to promote mitotic exit, Cdc5 phosphorylates Bfa1, the 
negative regulator of the MEN pathway [85]. During cytokinesis, Cdc5 controls Rho1 
activation and contractile actin ring (CAR) assembly [122]. Interestingly, despite all 
these involvements during mitosis, cdc5 mutant cells can still transit through 
metaphase and anaphase, but are unable to exit mitosis eventually arresting with a 
large bud, a long spindle and a divided nucleus. This suggests that the regulation of 
mitotic exit may be the sole essential function of Cdc5 kinase in mitotic cycle of 
budding yeast. 
Besides mitosis, Cdc5 is also implicated in DNA damage checkpoint and 
meiosis. During meiosis, it is required for resolution of Holliday junctions, exit from 
pachytene and chromosome segregation [123-125]. As a mediator of mitosis, Cdc5 is 
phosphorylated and thus inhibited by Rad53 when the DDC is activated [83, 126]. 
However, its role during adaptation remains largely unknown.  
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In this thesis, we explore the role of Cdc5 in the adaptive response to DNA damage. 
Chapter 2 details, both the experimental and computational methods employed during 
the course of these investigations. Experimental results from the study on adaptation 
are presented and discussed in Chapters 3 and 4.  
1.2 Part II 
Studies on DNA damage and cancer have reported that the extent of p53oscillation (a 
tumor suppressor) increased with DNA damage [9]. Further literature searches 
pertaining to transcription factors (TFs) revealed the existence of oscillating gene 
expression in a myriad of biological processes. In fact, the two widely studied 
transcription factors (TFs), NF-B and p53 showed oscillating expression patterns. 
Different oscillatory profiles of NF-B lead to the expression of different genes [13-
15], and p53 oscillatory behavior is distinctly different in cancerous cells when 
compared to that in normal cells [19].  
The causal relationship between oscillating TFs and different gene expression 
response is known but not well understood. In the second part of this study, we 
employed mathematical models (i) to represent gene expression triggered by an 
oscillating TF and (ii) to elucidate molecular properties that could influence this 
response. Although the analytical solutions to the general model will not be restricted 
by specific parameter values, we have used specific values to facilitate the analysis. 
As gene expression is the center piece of molecular biology, any insights gleaned 
from this analysis would certainly be helpful. 
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1.2.1 Gene Expression 
The expression level of most genes is regulated by specific transcription factors (TFs) 
that bind to certain DNA sequence motifs found in the promoter and enhancer regions 
of genes. Through interactions with components of the transcription machinery, TFs 
promote access to DNA and facilitate the recruitment of RNA polymerase to the start 
site for the commencement of transcription [127]. The fact that more than 5% of our 
genes encode TFs and that many signal transduction pathways frequently end with the 
activation of TFs underscores the significance of TFs in cell physiology [127-129]. 
 
1.2.2 Oscillating Transcriptional Factors 
A wide repertoire of diverse TFs has been observed to display oscillatory dynamics 
such that their intracellular levels vary periodically over time. In particular, TF 
oscillations occur during key biological processes such as day/night or circadian cycle, 
somite segmentation in embryogenesis, spermatogenesis, cell cycle and yeast glucose 
metabolism (summarized in Table 2). On the other hand, response to DNA damage 
(p53), serum (Stat3 and Smad1/5/8), or receptor ligands (NF-B) could also induce 
TF oscillations (Table 4). Interestingly, oscillatory TFs of the latter are each involved 
in one or more auto-regulatory transcriptional feedback loops wherein their 
transcriptional activities are inhibited by the respective target gene products. Such 
feedback loops have been proposed as a mechanistic basis for TF oscillations [130]. 
At the molecular level, the dynamic occupancy of an oscillatory TF on its 
target gene promoters tracks its oscillation profile. For instance, both NF-B and  
RNA Pol II recruited by it bind to the promoters of target genes (MIP-2, IB and IP-
10) in close synchrony with NF-B oscillation profiles [13, 131, 132]. The close 
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tracing between total and promoter-bound NF-B is due to rapid turnover of 
promoter-bound NF-B by proteasomal degradation, which is a general cellular 
mechanism to regulate transcription initiation in response to differing TF levels [127, 
133-137]. That is, if a signal is prolonged, a newly activated TF will replace the 
degraded TF, whereas if the signal stops, the degraded TF is not replaced and 
transcription halts. 
 
1.2.3 Genome widespread oscillating transcription  
Depending on the biological processes, external stimuli and cell types, between tens 
to thousands of transcripts exhibit oscillatory dynamics (Column 4 of Table 2). The 
oscillatory TFs listed in Table 2 regulate between tens to hundreds of genes (Column 
5 of Table 2). However, only a proportion of the oscillatory transcripts are under the 
TFs’ direct control. The remaining transcripts are downstream targets of TF cascades 
in which the topmost TF is oscillatory. In a TF cascade, a TF induces gene expression 
of another TF, and so forth (for examples, see Column 5 of Table 2). Indeed, among 
the oscillatory transcripts, many of them encode TFs. TF cascades are also prevalent 
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(Table 2 - continued from previous page) 
Oscillation period (column 2) refers to the time interval between successive maxima 
or minima of the transcript’s intracellular concentration. An oscillatory transcription 
factor (TF) does not necessarily induce oscillatory expression of its target gene 
transcripts (column 3). In a TF cascade (last column), TF at the upper level expresses 
TF at the immediate lower level, and so forth. 
Species E Periods 
Bacillus subtilis Periodic synthesis of OCT-ase, ACT-ase, 
DHQ-ase and histidase. 
1h 
Pseudomonas aeruginosa Periodic synthesis of creatine dehydrogenase; 
Oscillation in amidase activity. 
2h; 
40min 
E. coli Periodic synthesis of beta-galactosidase; 






Long-period oscillation in respiration 4h 
Saccharomyces cerevisiae Periodic synthesis of glutamate 
dehydrogenase; 
Periodic synthesis of alpha-glucosidase. 
6.5h; 
1.5h 
Chinese hamster cells Periodic activity of lactate dehydrogenase, 
aldolase and G6P dehydrogenase. 
3 – 4h 
Rat, in vivo Oscillation in haem biosynthesis 10h 
Sea-urchin embryo Cyclic protein synthesis 0.5 – 1h 
Table 3. Summary of reported oscillations in protein synthesis. 
Oscillation period of protein synthesis ranges from 40min to 6.5hr [245]. These 








NF-B 100min[14] TNF[[13-15], VP16[14], 
LPS[15], RANK-
L[15] 
5970[168] Targets 200 – 300 genes 
that including TFs [139, 
169, 170] 
p53 4 – 7hrs 
[9-12] 
DNA damage 51[19, 171] Targets more than 100 
gene including TFs [171, 
172] 
Stat3 2hr[173] Serum[173], IL-6[173] 
Smad 1/5/8 2hr [173] Serum[173], BM4[173] 
Target cell proliferation and cell 
survival genes [174-177] 
Table 4. Summary of reported oscillatory gene expressions induced under 
specific stimuli. 
See caption of Table 2 for definition of column description. Note that the oscillatory 
TFs listed in Column 1 are each involved in a negative-feedback loop wherein the TF 
quantity or transcriptional activity is inhibited by its target gene. 
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1.2.4 Various examples of oscillating transcription  
The following sections aim to discuss the roles and significance of oscillating 
transcription. 
1.2.4.1 NF-B 
NF-B is a family of transcription factors regulating myriads of genes including those 
involved in cell division, apoptotic, stress response and inflammation [138, 139]. 
Upon stimulation, NF-B protein oscillation is induced. In addition, studies have 
shown that the profile of oscillation depends on the type and length of stimuli [14]. 
For instance, continuous TNF stimulation leads to sustained (damping slowly) NF-
B oscillations with a period of ~100 min for >20 hrs, whereas treatment with 
topoisomerase II inhibitor etoposide (VP16) showed damped oscillations with a lower 
amplitude [14]. 
Furthermore, different oscillatory profiles could lead to differential gene 
expression. Short stimulation of NF-B activates genes such as IP-10 while RANTES 
induction required prolonged activation [13]. This highlights the significance of 
oscillation in signal transduction. 
 
1.2.4.2 p53 response to DNA damage. 
p53 is a well researched tumor suppressor which acts as a TF that targets 122 genes 
(Table 4). Activated DNA damage checkpoint leads to damped oscillations in the 
levels of p53 and its inhibitor, Mdm2 [9]. The oscillation period could range from 4 to 
Chapter 1 Introduction 
28 
7 hrs, but the phenomenon could last for as long as three days. It appears that the 
number of peaks depends on the extent of DNA damage [9]. 
A recent study had proposed that p53 oscillation could facilitate apoptosis in 
cells [20]. Consistently, it was reported that the oscillatory response of p53 in 
fibroblast cells from Bloom’s syndrome patients was markedly different from normal 
cells [19]. This implies a correlation between oscillation and phenotypic response. 
 
1.2.4.3 Circadian 
Circadian clock is a conserved biological oscillator tracking the day/night cycle of 
Earth. In mammals, the circadian rhythm is controlled by a master clock in 
suprachiasmatic nuclei (SCN) of the hypthalamus [178, 179]. 16 known genes 
comprises this control network in mammals [180], including two TFs. Interestingly, 
there are about 400 to ~10000 genes that displayed circadian oscillations found in 
mouse tissues [140], even though only a small subset of these genes are direct targets 
of the core oscillator.  
Evidently, oscillations could propagate from the core control. However, not all 
of its targets would exhibit similar dynamics. A study showed that only 28 of the 644 
oscillating circadian transcripts are common to both mouse SCN and liver cells [6]. 
Likewise, another study reported that out of 933 circadian transcripts, only 52 are 
common to both mouse heart and liver [7]. This suggests that the core clock can limit 
the propagation of its oscillatory dynamics to specific gene and cell types. 








Figure 2. Transcription factor network of SBF and MBF 
“The network illustrates the regulation of transcription factors and promoters of other 
transcription factor genes. Bold arrows indicate an interaction that has been verified 
by PCR assay [152]; green boxes correspond to genes that have a cell cycle 
periodicity of expression.” 
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1.2.4.4 Cell cycle 
Genetic network analyses in yeast have revealed the presence of prevalent 
transcriptional cascades [128]. For instance, SBF (Swi4-Swi6 cell cycle box binding 
factor) and MBF (MluI binding factor) are two transcriptional regulators of G1/S that 
bind to promoters of 235 genes [181]; these include 12 TFs which control another 33 
TFs. Through these TF cascades, SBF and MBF control expression of hundreds of 
genes. Although the expression profiles of SBF and MBF oscillate, expression of 
several of their downstream targets do not show cell cycle periodicity (Figure 2), 
implying some form of oscillation silencing [152]. Serial cascades of TFs were found 
to be responsible for CDK-independent periodic gene expression during cell cycle 
progression. Such a ‘ring network’ is also a positive feedback loop, resulting in an 
amplification of molecular signals. Naturally, a form of oscillation propagation 
control is in place. 
 
Our computational work is presented in Chapter 5 with some supplementary results 
documented in the Appendices. In Chapter 5, we formulate the mathematical models 
(Section 5.2.1) and, the  solutions derived from these models are presented in Section 
5.2.2. In Section 5.2.3, we estimated the trends of the gene expression response and 
the summary is tabulated in Table 10. Section 5.2.4 documents the possible effects of 
oscillating TFs on differential gene expression and their implications are discussed in 
Section 5.3. Finally, in Chapter 6, we present our general conclusions and 
perspectives stemming from this part of the work. 
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Chapter 2 Materials and Methods 
 
2.1 Yeast strains and culture conditions 
All Saccharomyces cerevisiae strains are derivatives of JKM139 (non-repairable) or 
tGI354 (repairable) and listed in Table 5. (Please refer to Section 3.1 for an 
introduction to the strains JKM139 and tGI354.) A combination of standard molecular 
biology and molecular genetic techniques such as gene transplacement, gene 
disruption, PCR-based tagging of endogenous genes and tetrad dissection were used 
to construct plasmids and strains with various genotypes. PCR and Southern blot 
analysis were performed to confirm gene disruptions and transplacements. Deletion of 
various genes (CKB1, SAE2, PTC3, ARG4) that were replaced by a KANMX cassette 
were done by gene transplacement using PCR amplified deletion cassettes of the 
relevant strains from Saccharomyces Genome Deletion Project [182]. Strains with 
proteins tagged with yeCitrine or yeVenus were constructed using one-step tagging 
protocol as described in earlier studies [183, 184]. 
Yeast cells were grown in YEP medium (1.1% yeast extract, 2.2% peptone 
and 50mg/l adenine) supplemented with 2% raffinose/ 0.5% glucose, 2% glucose or 
2% galactose/2% raffinose depending on the objectives of the experiments. Since 
deletion of CDC5 is lethal, cdc5 cells were kept alive with a methionine-repressible 
MET-CDC5 construct. cdc5 MET-CDC5 cells were grown in methionine free 
synthetic media (0.67% yeast nitrogen base from Difco, amino acid drop out mix) 
with 2% raffinose/ 0.5% glucose, 2% glucose or 2% galactose/2% raffinose. Yeast 
cells were grown in a water bath at 24oC with constant shaking for good aeration at 
200rpm. Temperature sensitive mutants were cultured at the permissive temperature 
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of 24oC, but filtered and transferred to restrictive temperature at 30oC to impose 
telophase arrest. To induce HO endonuclease, 2% galactose was added to the glucose-
free-medium, which is normally supplemented with 2% raffinose.. 
Strain Genotype Source 
JKM139 / 
US4877 
MATa ho hml::ADE1 hmr::ADE1 ade1-110 leu2-3,112 lys5 




ho hml::ADE1 MATa-inc hmr::ADE1 ade1 leu2-3,112 lys5 
trp1::hisG ura3-52 ade3::GAL::HO arg5,6::HPH::MATa 
[106] 
US5338 ho hml::ADE1 MATa-inc hmr::ADE1 ade1 leu2-3,112 lys5 
trp1::hisG ura3-52 ade3::GAL::HO arg5,6::HPH::MATa bar1 
this study 
US5339 MATa ho hml::ADE1 hmr::ADE1 ade1-110 leu2-3,112 lys5 
trp1::hisG ura3-52 ade3::GAL10::HO bar1 
this study 
US5750 MATa ho hml::ADE1 hmr::ADE1 ade1-110 leu2-3,112 lys5 
trp1::hisG ura3-52 ade3::GAL10::HO bar1 slk19::LEU2 
cdc15-2 
this study 
US5776 ho hml::ADE1 MATa-inc hmr::ADE1 ade1 leu2-3,112 lys5 
trp1::hisG ura3-52 ade3::GAL::HO arg5,6::HPH::MATa bar1 
slk19::LEU2 cdc15-2 
this study 
US5828 MATa ho hml::ADE1 hmr::ADE1 ade1-110 leu2-3,112 lys5 
trp1::hisG ura3-52 ade3::GAL10::HO bar1 slk19::LEU2 
cdc15-2 GAL-myc6-CDC5::TRP1 
this study 
US5880 MATa ho hml::ADE1 hmr::ADE1 ade1-110 leu2-3,112 lys5 
trp1::hisG ura3-52 ade3::GAL10::HO bar1 slk19::LEU2 
cdc15-2 RAD53-HA2::URA3 
this study 
US5881 ho hml::ADE1 MATa-inc hmr::ADE1 ade1 leu2-3,112 lys5 
trp1::hisG ura3-52 ade3::GAL::HO arg5,6::HPH::MATa bar1 
slk19::LEU2 cdc15-2 RAD53-HA2::URA3 
this study 
US5866 MATa bar1	 ho	 hml	::ADE1 hmr	::ADE1 
arg5,6	::HPH::MATa-inc ade1-100 leu2,3-112 lys5 trp::hisG 
ade3::GAL::HO cdc15-2 slk19	::URA3 
 MET-CDC5-LEU2 cdc5	::TRP1 
this study 
US5868 MATa ho hml::ADE1 hmr::ADE1 ade1-110 leu2-3,112 lys5 
trp1::hisG ura3-52 ade3::GAL10::HO cdc5::TRP1 MET3-
CDC5-LEU2 
this study 
US5885 MATa ho hml::ADE1 hmr::ADE1 ade1-110 leu2-3,112 lys5 
trp1::hisG ura3-52 ade3::GAL10::HO bar1 slk19::LEU2 
cdc15-2 RAD53-HA2::URA3 ckb1::KANMX 
this study 
US5909 MATa ho hml::ADE1 hmr::ADE1 ade1-110 leu2-3,112 lys5 
trp1::hisG ura3-52 ade3::GAL10::HO cdc5::TRP1 MET3-
CDC5-LEU2 RAD53-HA2::URA3 
this study 
US5998 MATa ho hml::ADE1 hmr::ADE1 ade1-110 leu2-3,112 lys5 
trp1::hisG ura3-52 ade3::GAL10::HO bar1 slk19::LEU2 
cdc15-2 RAD53-HA2::URA3 sae2::KANMX 
this study 
US5999 MATa ho hml::ADE1 hmr::ADE1 ade1-110 leu2-3,112 lys5 
trp1::hisG ura3-52 ade3::GAL10::HO bar1 slk19::LEU2 
cdc15-2 GAL-myc6-CDC5::TRP1 RAD53-HA2::URA3 
this study 
US6072 MATa ho hml::ADE1 hmr::ADE1 ade1-110 leu2-3,112 lys5 
trp1::hisG ura3-52 ade3::GAL10::HO bar1 slk19::LEU2 
cdc15-2 RAD53-HA2::URA3 ckb1::KANMX GAL-myc6-
CDC5::TRP1 
this study 
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US6106 MATa ho hml::ADE1 hmr::ADE1 ade1-110 leu2-3,112 lys5 
trp1::hisG ura3-52 ade3::GAL10::HO bar1 slk19::LEU2 
cdc15-2 RAD53-HA2::URA3 sae2::KANMX GAL-myc6-
CDC5::TRP1 
this study 
US6215 MATa ho hml::ADE1 hmr::ADE1 ade1-110 leu2-3,112 lys5 
trp1::hisG ura3-52 ade3::GAL10::HO bar1 slk19::LEU2 
cdc15-2 RAD53-HA2::URA3 ptc2 ptc3::KANMX 
this study 
US6266 MATa ho hml::ADE1 hmr::ADE1 ade1-110 leu2-3,112 lys5 
trp1::hisG ura3-52 ade3::GAL10::HO bar1 slk19::LEU2 
cdc15-2 RADd53-HA2::URA3 ptc2 ptc3::KANMX GAL-myc6-
CDC5::URA3 
this study 
US6267 MATa ho hml::ADE1 hmr::ADE1 ade1-110 leu2-3,112 lys5 
trp1::hisG ura3-52 ade3::GAL10::HO bar1 slk19::LEU2 
cdc15-2 arg4::KANMX 
this study 
US6350 MATa ho hml::ADE1 hmr::ADE1 ade1-110 leu2-3,112 lys5 
trp1::hisG ura3-52 ade3::GAL10::HO bar1 slk19::LEU2 
cdc15-2 DDC2-yeVenus::KANMX myc-CDC5::TRP1 
this study 
US6380 MATa ho hml::ADE1 hmr::ADE1 ade1-110 leu2-3,112 lys5 
trp1::hisG ura3-52 ade3::GAL10::HO cdc5::TRP1 MET3-
CDC5-LEU2 DDC2-yeCitrine::URA3 
this study 
US6381 MATa ho hml::ADE1 hmr::ADE1 ade1-110 leu2-3,112 lys5 
trp1::hisG ura3-52 ade3::GAL10::HO cdc5::TRP1 MET3-
CDC5-LEU2 DDC2-yeCitrine::URA3 
this study 
US6382 MATa ho hml::ADE1 hmr::ADE1 ade1-110 leu2-3,112 lys5 
trp1::hisG ura3-52 ade3::GAL10::HO bar1 slk19::LEU2 
cdc15-2 DDC2-yeCitrine::URA3 
this study 
US6391 MATa ho hml::ADE1 hmr::ADE1 ade1-110 leu2-3,112 lys5 
trp1::hisG ura3-52 ade3::GAL10::HO bar1 slk19::LEU2 
cdc15-2 arg4::KANMX GAL-myc6-CDC5::TRP1 
this study 
US6416 MATa ho hml::ADE1 hmr::ADE1 ade1-110 leu2-3,112 lys5 
trp1::hisG ura3-52 ade3::GAL10::HO bar1 slk19::LEU2 
cdc15-2 DDC2-yeCitrine::KANMX GAL-myc6-CDC5::URA3 
this study 
US6446 MATa ho hml::ADE1 hmr::ADE1 ade1-110 leu2-3,112 lys5 
trp1::hisG ura3-52 ade3::GAL10::HO bar1 slk19::LEU2 
cdc15-2 DDC1-yeCitrine::KANMX 
this study 
US6448 MATa ho hml::ADE1 hmr::ADE1 ade1-110 leu2-3,112 lys5 
trp1::hisG ura3-52 ade3::GAL10::HO bar1 slk19::LEU2 
cdc15-2 DDC1-yeCitrine::KANMX GAL-myc6-CDC5::URA3 
this study 
 
Table 5. Yeast strains used in this study. 
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2.2 Plasmids 
For cloning purposes and plasmid DNA amplification, E. coli XL1 Blue cells 
(Stratagene) were used as bacterial hosts. The E. coli cells were cultured in either 2X 
TY liquid medium (1.6% bacto- tryptone, 1% bacto- yeast extract, 0.5% NaCl) or on 
2X TY plates containing 2% bacto agar at 37oC. 100g/ml Ampicillin (Sigma) were 
added to the medium or plates for selection of cells carrying recombinant plasmids. 
 Name Description Source 
pUS149 pJGsst1-bar1:URA3 US Lab 
pUS1450 YIPlac204-slk19:LEU2 US Lab 
pUS1857 YIPlac211-5’ truncated Rad53-HA2 US Lab 
pUS2224 pUC19-cdc15-2-GFP-URA3  US Lab 
pUS2536 pBluescript II ptc2::hisG-klURA3-hisG this study 
pUS2451 YIPlac204-GAL-cmyc6-CDC5-TRP1 this study 
pUS2433 YIPlac211-GAL-cmyc6-CDC5 -URA3 this study 
pUS2583 pGEM-11Z(+) vector containing part of MATa locus. this study 
pUS2589 YIPlac204-5’UTR-cmyc6-CDC5(truncated)-TRP1 this study 
 
Table 6. List of plasmids used in this study. 
 
 
2.3 Yeast strains and culture conditions 
To synchronize cells in G1 phase, cycling yeast cells were diluted to an absorbance of 
0.5 at OD600, and yeast pheromone -factor was added at 1g/ml (for bar1) or 
5g/ml (for BAR1). After incubation for 2 hrs at 24oC, the cultures were filtered, 
washed and re-suspended in liquid medium. 
For cdc5 MET-CDC5 strains, cultures were grown and diluted in methionine 
free medium with 1g/ml -factor. After 1.5 hrs, methionine was added to final 
concentration of 20mM. Subsequently, after another 0.5 hr, cultures were filtered, 
washed and re-suspended into YEP medium supplemented with 20mM methionine 
and the desired carbon source. 
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2.4 Yeast transformation 
Yeast cultures were grown overnight. Cells were collected and spun down at 3500 
rpm for 2 minutes. Subsequently, the pellets were washed once with Li-TE buffer 
(0.1M lithium acetate, 10mM Tris-HCl pH 7.5, 1mM EDTA) and then resuspended in 
2ml of Li-TE buffer. The cells were incubated on a roller at room temperature for 1 hr. 
For each transformation, 10l of 1mg/ml salmon sperm DNA, linearized DNA of 
interest or plasmid DNA, 100l of cells in Li-TE buffer and 140l of 70% PEG 6000 
were mixed and incubated at 24oC for 3 hrs. This was followed by a heat shock 
(30mins) at 43oC. Finally, cells were spun down, resuspended in 80l sterile H20 and 
spread onto the appropriate selective plates. 
 
2.5 Yeast DNA extraction 
Yeast cells were pelleted, washed with ddH20 and resuspended in 0.2 ml of 
spheroplasting mix containing 80% SCE (1M Sorbitol, 0.1 M sodium citrate, 0.06 M 
EDTA, pH 7.0), 10% lyticase and 10% -mercaptoethanol. The mixture was 
incubated at 37oC with occasional shaking for 1 hr or more when required (cells were 
checked under microscope for complete digestion of cell). Upon complete lysis, 0.2ml 
SDS solution (2% SDS, 0.1M Tris-HCl, 0.05M EDTA) was added to the mixture and 
the mixture was heated at 65oC for 5mins. 0.2ml 5M KOAc was added and the 
mixture incubated on ice for 20mins. The mixture was centrifuged at 13000rpm for 
5mins. The supernatant was transferred to a fresh tube containing 0.2ml 5M NH4OAc 
and 1ml isopropanol and the DNA precipitated in dry ice for 5mins. The DNA pellets 
were collected by low speed centrifugation for 5mins, washed once in 70% ethanol, 
and dissolved in 50l TE or ddH20. 
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2.6 Southern blot analysis 
Chromosomal DNA was digested at 37oC (> 12 hrs) in a total volume of 100l. The 
restriction enzyme digest was set up as follows: 10l DNA, 10l 10X restriction 
buffer, 1l EcoR1, 1l 10mg/ml RNAse and 78l sterile water. The digested DNA 
was precipitated by addition of 10l 3M sodium acetate (pH 5.2), 1l 0.5M EDTA 
(pH 8) and 200l cold ethanol in dry ice for a minimum of 10mins. The samples were 
centrifuged at 13000rpm for 10mins. The supernatant was discarded and the pellets 
rinsed in 80% ethanol. The DNA pellet was dried and dissolved in 15l 1X gel 
loading buffer (6X gel loading buffer: 0.25% bromophenol blue, 0.25% xylene cyanol 
FF, 15% Ficoll [Type 400; Pharmacia] in water). The DNA samples were loaded onto 
1% agarose gels in 1X TBE (Tris-borate/ EDTA; 0.09M Tris-borate, 0.002M EDTA) 
running buffer. A few l of ethidium bromide (10mg/ml) was added to the gel to stain 
the DNA fragments. The DNA fragments were imaged using a UVIdoc gel 
documentation system (Uvitec, Cambridge). Subsequently, the gel was denatured with 
0.5N NaOH, 1.5M NaCl for 1 hr and neutralized with 1M TrisHCl (pH 7.4), 1.5M 
NaCl for 1 hr. Next, the gel was transferred to nylon membrane (Amersham Hybond 
N, GE Healthcare) according to Sambrook et al 1989 [185]. After the transfer, the 
membrane was prehybridized for a minimum of 1 hr (without radioactive probe) and 
hybridized overnight at 65oC with radioactive -32P dATP labeled probe (prepared 
using random priming kit from Roche Boehringer Mannheim and radioactive label 
from NEN). The hybridization mix contained 0.46 volumes sterile water, 0.0046 
volumes 10mg/ml denatured salmon sperm DNA and 0.56 volumes of Scp/ Sarc/ DS 
mix. To make Scp/ Sarc/ DS mix, 20 g Dextran sulphate was dissolved in 60 ml of 20 
X Scp (2M NaCl, 0.6M Na2HPO4, 0.02M EDTA, final pH 6.2), topped up to 101 ml 
with sterile water before addition of 7 ml of 30% SLS (sodium lauroyl sarcosine). The 
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mix was filtered. After hybridization, the blots were washed in 2 X SSC/ 0.1% SDS (2 
X 15mins at 65oC) and then in 0.1 X SSC/ 0.1% SDS (2 X 15 mins at 55oC). The blot 
was then exposed to film at -70oC for appropriate amount of time before the films 
were developed. Probe A was generated using PCR with oligos: OUS 1761 
(Probe_AF: Sequence 5' -ATG TCC TGA CTT CTT TTG ACG AGG-3’) and OUS 
1762 (Probe_AR: Sequence 5'-CCG CAT GGG CAG TTT ACC T-3’) [186]. 
 
2.7 Southern blot analysis with single-stranded probe 
2.5g agarose was melted in 250ml of 50mM NaCl, 1mM NaCl to make a 1% agarose 
gel. The gel was submerged in 50mM NaOH, 1mM EDTA (pH 8) and allowed to 
equilibrate for 30mins or more. Chromosomal DNA was digested at 37oC (> 12 hrs) 
in a total volume of 100l. The restriction enzyme digest was set up as follows: 10l 
DNA, 10l 10X restriction buffer, 1l Ssp1, 1l 10mg/ml RNAse and 78l sterile 
water. The digested DNA was precipitated by addition of 10
l 3M sodium acetate 
(pH 5.2), 1 
l 0.5M EDTA (pH 8) and 200
l cold ethanol in dry ice for a minimum of 
10 mins. The samples were centrifuged at 13000 rpm for 10mins. The supernatant 
was discarded and the pellets rinsed in 80% ethanol. The DNA pellet was dried and 
dissolved in 15
l 1X alkaline gel loading buffer (6X alkaline gel loading buffer: 
300mN NaOH, 6mM EDTA, 18% Ficoll, 0.15% bromocresol green, 0.25% xylene 
cyanol FF). The DNA samples were loaded onto 1% alkaline agarose gels and run at 
30V (4oC, 15 hrs) in freshly made alkaline electrophoresis buffer (50mN NaOH, 1 
mM EDTA pH 8). After the DNA had been loaded and after the dye had migrated out 
of the loading slot, glass plates were put onto the gel to prevent the dye from diffusing 
out of the agarose.  
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The gel was stained with ethidium bromide (0.5
g/ml) in 1X TAE (0.04M 
Tris-acetate, 0.001M EDTA pH 8) electrophoresis buffer (two washes of 2 hrs each). 
The gel was soaked in 0.25N HCl for 6 – 7mins, rinsed with water and immersed in 
denaturing solution (0.5N NaOH, 1.5M NaCl) for 30 mins with gentle agitation. The 
gel was rinsed briefly with water before being transferred onto nylon membrane 
(Amersham Hybond N, GE Healthcare). 
The blots were hybridized as described above but at 50oC and with -32P rCTP 
labeled probe (-32P rCTP at 10 
Ci/
l from NEN) prepared with Promega’s 
Riboprobe in vitro Transcription System kit and purified using ProbeQuant G50 
microcolumns (Amersham, GE Healthcare). After hybridization, the blots were 
washed in 2 X SSC/ 0.1% SDS (2 X 15mins at room temperature) and then in 0.1 X 
SSC/ 0.1% SDS (2 X 15mins at 50oC). The blot was then exposed to film at -70oC for 
appropriate amount of time before the films were developed. 
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2.8 Real-Time PCR (RT-PCR) 
Yeast DNAs were extracted as described in Section 2.5. To minimize interference 
from DNA secondary structure, the chromosomal DNAs were digested using StyI 
(10l 10X NEB buffer, 2l StyI enzyme, 1l RNase and 77l H20). StyI is used as its 
recognition site is commonly found in the yeast genome sequences. Thus, the 
restriction enzyme would cleave the chromosomes into shorter fragments, thereby 
reducing the tendency to form DNA secondary structure. Next, the digested samples 
were normalized to 10ng/l. RT-PCR reactions containing 10l 2x SYBR Green 
(Bio-Rad), 1l DNA (20ng/l), 0.5l forward primers (100M), 0.5l reverse primers 
(100M) and 8l H20 were prepared. The sequences of primers used are as follows:  
HOsite: (ous2059) 5’-CGGGTTTTTCTTTTAGTTTCAGCTTTCCGC-3’ and 
 (ous2060) 5’-ACCTCCGTCACGACCACACTCT-3’; 
Arg5,6:  (ous2481) 5’-GCGCAACAGCAAAGTGGCGG-3’and 
 (ous2582) 5’-TCATCGCCGCCGGTGAAGGT-3’ 
 
The RT-PCR cycle program is as follows: 
RT-PCR cycling: Step 1: 95.0 °C for 03:00.  
 Step 2: 95.0 °C for 00:10. 
Step 3: 57.0 °C for 00:30. 
Step 4: 72.0 °C for 00:40. 
Data collection 
Repeat step 2-4 
for 40x 
 
 Step 5: 72.0 °C for 10:00.  
Melting curve 
data collection: 
Step 6: 95.0 °C for 01:00.  
 Step 7: 55.0 °C for 01:00  
 Step 8: 55.0 °C-95.0 °C for 00:10. 
Increase set point temperature after 
cycle 2 by 0.5 °C 
 
 Step 9: 15.0 °C forever.  
. 
 
Data were analyzed by IQ5 optical system software version 2 (Bio-Rad). To 
ensure accuracy, each sample was run in triplicates and procedure repeated 3 times. 
The results were then combined and analyzed. 
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2.9 Protein extraction using TCA 
Frozen yeast samples were thawed, washed once and resuspended in ddH20. Next, the 
samples are normalized to absorbance of 2.0 at OD600 (1 ml final volume). To each 
normalized sample, 150l YEX lysis buffer (1.85 M NaOH, 7.5% -mercaptoethanol) 
was added. After 10 mins’ incubation on ice, 150l 50% TCA was added and the 
mixture again incubated on ice for 10mins. The protein pellets were collected by 
centrifugation at 4oC for 10mins at 13000rpm and resuspended in 50l of 1X gel 
loading buffer and 10l 1M Tris-HCl (pH 8.0). The samples were boiled for 5mins, 
and 8l were loaded onto SDS-PAGE gels for Western blot analysis. 
 
2.10 Western blot analysis 
Protein samples were resolved by sodium dodecyl sulphate polyacrylamide gel 
electrophoresis (SDS-PAGE) using 10% acrylamide:bis-acrylamide (29:1) gels. For 
analysis of Rad53, 12% acrylamide:bis-acrylamide (79:1) gels were used.  
S/N Antibodies Source 
1 Rabbit polyclonal anti-cmyc Santa Cruz Biotechnology, Inc 
2 Rabbit polyclonal anti-HA Sigma-Aldrich 
3 Mouse monoclonal anti-cmyc Santa Cruz Biotechnology, Inc 
4 Mouse monoclonal anti-HA Santa Cruz Biotechnology, Inc 
5 Rabbit polyclonal anti-G6PDH Roche Diagnostics 
6 Goat polyclonal anti-Rad53 Santa Cruz Biotechnology, Inc 
7 Rat monoclonal anti-Tubulin YOL1/34 Serotec 
 
Table 7. List of antibodies used in this study 
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2.11 Protein extraction using acid washed glass beads 
For immunoprecipitation, protein was extracted using acid washed glass beads. Cells 
were spun down and washed once with Stop Mix buffer (0.9%NaCl, 1mM NaN3, 
10mM EDTA, and 50mM NaF). Cell pellets were immediately frozen by liquid 
nitrogen, and stored in -20oC for later use. Cell pellets were later thawed on ice. 0.2 
ml of ice cold lysis buffer with protease inhibitors (1% Triton X-100, 1% sodium 
deoxycholate, 0.1% SDS, 50mM Tris- HCl pH 7.2, 1mM PMSF, 20g/ml leupeptin, 
40g/ml aprotinin, 0.1mM Na-orthovanadate, 15mM p-nitrophenylphosphate) and 
150-200l of acid-washed glass beads (Biospec) were added. The cells were lysed by 
vigorous vortexing at 4oC (IKA-Vibrax shaker). After centrifugation at 4oC for 15 
mins at 13000 rpm, the supernatant was transferred to a fresh Eppendorf tube, quick 
frozen in liquid nitrogen and stored at -80oC for later use. Protein concentration was 
determined by using the Bradford Protein Assay (Bio-Rad) according to 
manufacturer’s instructions. 
2.12 Co-immunoprecipitation 
Collected samples were lysed using the glass bead method as described above; the 
lysis buffer was modified: NP40 buffer (20mM Tris HCl pH 8, 150mM NaCl, 10% 
glycerol (Fresh), 1% Nonidet P-40 or NP-40, 2mM EDTA, 1mM DTT) supplemented 
with protease inhibitors (1mM PMSF, 20g/ml leupeptin, 40g/ml aprotinin, 0.1mM 
Na-orthovanadate, 15mM p-nitrophenylphosphate). Next, 1mg of cell lysate was 
transferred to an Eppendoff tube containing 40l of antibody-conjugated beads (Santa 
Cruz). The final volume was adjusted to 1ml with lysis buffer containing protease 
inhibitors so that the cell lysate can interact with the antibody-conjugated beads 
completely. This was followed by 3-4 hrs of incubation in a roller at 4oC. The beads 
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were then washed 4-6 times with lysis buffer. After removing all the remaining 
supernatant, 5l of 5× gel loading buffer was added to the beads. The samples were 
heat inactivated by boiling for 5mins and loaded for SDS- PAGE electrophoresis and 
subsequent Western blot analysis. 
 
2.13 Sample preparation for SILAC mass spectrometry 
Samples for mass spectrometry were prepared as described in [187, 188]. To prepare 
samples for SILAC [189], the yeast strains must be defective in endogenous lysine or 
arginine production, thus facilitating the incorporation of exogenous amino acids. 
Therefore, ARG4 and LYS1 were deleted. Control yeast strain, US6267 (control) was 
grown overnight in liquid labeling medium (6.7% Yeast nitrogen base, 30mg/L 
[13C6/15N4] L-arginine and 30mg/L [13C6/15N2] L-lysine, Cambridge Isotope 
Laboratories, and other normal amino acid mix), while the other strain, US6391, was 
grown in non-labeling medium (6.7% Yeast nitrogen base supplemented with 
complete normal amino acid mix including 30mg/L arginine and 30mg/L lysine). 
Both cultures were supplemented with the desired carbon source. Samples were 
collected and frozen in liquid nitrogen immediately. The samples were thawed on ice, 
and the proteins were extracted using the glass bead method (refer to Section 1.1). 5 
mg of crude extracts (both labeled and unlabelled) were subjected to 
immunoprecitation as described in Section 2.12, except that 50 l of beads were used. 
The beads from labeled and unlabelled samples were mixed just before the washing 
steps. Prior to boiling, the beads were resuspended in sample buffer (NuPAGE LDS 
Sample Buffer, Invitrogen). Finally, the protein samples were sent to our collaborator 
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(Dr Gunraratne from Walter Blackstock’ Lab) for subsequent 1D gel electrophoresis, 
in-gel trypsin digestion and mass spectrometric analysis.  
 
2.14 Immunofluorescent staining (IF) 
Yeast samples were immediately fixed with 3.7% formaldehyde, collected by 
centrifugation and, resuspended in 1ml KPF buffer (0.1M KH2PO4 pH6.4, 3.7% 
formaldehyde) and left at room temperature for 1-2 hrs. The cells were washed 3 
times with 0.1 M KH2PO4 pH 6.4, and once in 1ml sorb/phos/cit buffer (1.2 M 
sorbitol, 0.1M K2HPO4 pH5.9, 0.7% citric acid). To digest the cell wall, cells were 
resuspended in 0.2ml sorb/phos/cit buffer, 20l glusulase and 5l 10mg/ml lyticase, 
and incubated at 37oC for 15-90 mins. The digested cells were washed once with 
sorb/phos/cit buffer and re-suspended in 20l of the same buffer. 5l of cell 
suspension was applied to one well of a 30 -well slide previously coated with 0.1% 
polylysine (Sigma). The slide was immersed first in methanol at -20oC for 6 mins, and 
then acetone at -20oC for 30 secs. Next, the slide was air-dried and the samples 
incubated with primary antibody overnight at 4 oC. Samples were washed 3 times with 
PBS-BSA (1% BSA, 0.04M K2HPO4, 0.01M-KH2PO4, 0.15M-NaCl, 0.1% NaN3) and 
incubated with secondary antibodies for 2 hrs at 30 oC. The samples were washed 4 
times as before, Finally, mounting medium Vectashield (Vector Laboratories) 
containing DAPI (4’,6 diamidino-2-phenylindole ) was added to each well. Coverslips 
were added to protect the samples and the coverslips sealed in place with nail polish. 
For visualization of tubulin, rat monoclonal anti-tubulin YOL1/34 was the primary 
antibody (Serotec) and Alexa Fluor 594 goat anti- rat IgG (Invitrogen, Molecular 
Probes) the secondary antibody.  
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2.15 Microscopy 
To visualize signals from the YFP variant fusion proteins, cells collected at various 
time points were frozen immediately in dry ice without fixation and stored until 
further use. Cells were later thawed and mounted on slides with Vectashield 
containing DAPI (Molecular Probes). The images were captured using a Zeiss 
AxioImager upright motorized microscope with Plan Apochromat 100X objective 
equipped with EXFO 120W metal halide illuminator and attached to a Photometrics 
CoolSNAP HQ2 high sensitivity monochrome camera driven by the Metamorph 
software (Universal Imaging Corporation) or Zeiss Axiovert 200M Microscope 
connected to a Photometrics COOLSNAP HQ digital camera driven by Metamorph 
software. 
 
2.16 Flow cytometry analysis (FACS) 
Yeast samples were resuspended in 1ml 70% ethanol and incubated at room 
temperature for 1 hr or overnight at 4oC. After fixation, the samples were washed with 
0.2M Tris-HCl pH7.5, 20mM EDTA, and resuspended in 100
l 0.2M Tris-HCl pH7.5, 
20mM EDTA, 0.1% RNase A (1mg/ml), before incubating at 37oC for 4 hrs. The 
samples were washed 1X in PBS and incubated in 0.1ml PI solution (50mg/ml 
propidium iodide in PBS) at 4oC overnight. The samples were diluted by addition of 
900
l PBS and samples were sonicated for 5 secs. The DNA content was determined 
using the FACScan flow cytometer (Becton Dickinson Immunocytometry Systems, 
USA). The data was analyzed using WinMDI program. 
Chapter 2 Materials and Methods 
46 
2.17 Effects of TF oscillations on gene expression 
To obtain trends of target gene products mean level (XM and XP), oscillation amplitude 
(AM and AP) and phase-shift (M and P) as a function of each kinetic parameter in 
each model, first and second partial derivatives with respect to each parameter were 
derived. The directional trend and properties of possible stationary points were 
inferred from the signs of the first and second partial derivatives respectively. On the 
other hand, by equating the first and second partial derivatives to zero, possible 
stationary points and points of inflexion were identified and the conditions for their 
existence determined. 
 
2.18 Numerical simulations 
To obtain time-series trajectories of species’ concentrations in the model, the ODEs 
were integrated using a modified Rosenbrock formula of order 2 that is implemented 
in the MATLAB (The MathWorks, Natick, MA) platform (version 6.5, Release 13). 
Source codes are displayed in the Appendices. 
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3.1 Background 
Double strand beaks (DSB) are amongst the most detrimental DNA lesions which can 
pose a grave threat to a cell’s viability [190, 191]. The cell’s response to such 
damages and the subsequent repair of these lesions involve a close coordination 
between cell cycle machinery and the repair pathways. In the budding yeast, a DSB 
activates the DNA damage checkpoint which leads to a G2/M arrest; thus allowing 
the cell sufficient time to repair the damage. In yeast, DSBs are repaired 
predominantly by the homologous recombination repair pathway (HR) or, less 
frequently, by non-homologous end joining (NHEJ) [88-90]. In the event that cells are 
unable to repair the damage, the cells continue to arrest in G2/M for a longer period 
but they finally escape the DNA damage imposed cell cycle arrest and enter mitosis 
with damaged chromosomes (a process termed “adaptation”). Subsequent segregation 
of these damaged chromosomes subjects cells to further chromosomal aberrations. 
To understand the mechanism behind the adaptation phenomenon, we have 
adopted an experimental system [2] in which cells transiently express the HO 
endonuclease. The cells suffer one DSB at a defined chromosomal site and 
consequently arrest in G2/M. HO (homothallic) endonuclease is normally expressed 
by yeast cells during mating type switching. To initiate mating type switching, the HO 
endonuclease recognizes a specific site in the MAT locus and introduces a double 
strand break [192, 193]. The MAT locus, located on chromosome III, contains an 
active genetic-information-cassette (MATa and MAT) and two silent cassettes, 
HML (on the left) and HMRa (on the right). The DSB close to the active MATa (or ) 
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cassette initiates a gene conversion event during which the silent cassette of the 
opposite mating type is used as a donor template to ‘convert’ the active MAT cassette 
to the opposite mating type. Although the end-purpose of the gene-conversion event is 
to switch the mating type information, it can be considered as an event that utilizes 
homologous regions to repair the DSB. We use this innate cell-behavior to construct 
two basic strains (Figure 3) from which we derive many other strains for our study: (i) 
the ‘repairable’ (RP) contains a mutated MATa cassette (denoted as MATa-inc) on 
chromosome III (Chr III) but lacks both silent cassettes (HML and HMRa) [106]. In 
addition, it contains a copy of the MATa cassette on chromosome V (Chr V). While 
the MATa-inc cassette is resistant to HO endonuclease, it can be used as a 
homologous template to repair a DSB in the MATa copy. This strain also expresses 
HO endonuclease from the galactose-inducible GAL10 promoter, hence HO induction 
can be controlled. (ii) The ‘adaptable’ or ‘non-repairable’ strain (AD) is almost 
identical to the ‘repairable strain’; the differences being that the MATa cassette (Chr 
III) is not mutated and that it lacks a copy of MATa on Chromosome V. When a DSB 
is introduced at the active MATa cassette (Chr III), this strain is unable to repair the 
DSB using homologous recombination. Consequently, these cells will arrest in G2/M 
for an extended period and undergo adaptation i.e. enter mitosis with the DSB in 
chromosome III. 








Figure 3. Schematics of the Repairable (RP) and Adaptation (AD) strains. 
The experimental systems used in this study each contains a galactose-inducible HO 
endonuclease, and lacks both silent cassettes (HML and HMRa). In addition, the 
repairable (RP) strain contains a mutated MATa-inc cassette (at the endogenous site, 
ChrIII) which is non-cleavable by HO, and a copy of cleavable form of MATa cassette 
inserted at chromosome V (ChrV). Thus, if HO is expressed and generated a cut at 
ChrV, the RP strain is able to repair the DSB via homologous recombination (HR) 
using the template at ChrIII. On the other hand, the adaptable (AD) strain contains the 
normal MATa cassette at ChrIII which could be recognized and cut by HO. However, 
lacking a homologous template, the strain is unable to repair via HR. In addition, if 
the HO is persistently induced and cut at ChrIII, repair by non-homologous end 
joining through simple ligation will be prevented. Arrows (“” , “” ) refer to 
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What approach should one take to quantitatively ascertain the adaptive 
response in a cell population? In previous studies, the adaptive response has been 
monitored by the emergence of new buds and dephosphorylation of Rad53. However, 
in order to construct a new bud, a cell undergoing adaptation has to escape the G2/M 
arrest, traverse mitosis, complete mitotic exit, enter G1, and undergo START. These 
transitions require several components which may not be involved in checkpoint 
adaptation per se. Adaptation, therefore, has been monitored in terms of an event 
distant from G2/M. Moreover, the escape from G2/M arrest is not synchronous i.e. 
cells undergo bud emergence at different times and do not halt cell cycle progression 
after the bud has emerged. Thus, bud emergence as a marker for adaptation tends to 
underestimate the degree of adaptation in a cell population. The fact that the G2/M 
checkpoint causes DNA-damaged cells to arrest prior to chromosome segregation 
suggests (in a teleological sense) that the primary aim of this surveillance mechanism 
is to prevent segregation of damaged chromosomes. Indeed, in yeast, the DNA 
damage checkpoint inhibits chromosome segregation by preventing cohesin cleavage 
[194-196]. We reasoned that the ‘proportion of cells undergoing chromosome 
segregation’ (completion of anaphase) may serve as an apt parameter for monitoring 
adaptation. Hence, to prevent adapted cells from exiting mitosis, we introduced 
cdc15-2 and slk19 mutation into both repairable and adaptable strains. Efficient exit 
from mitosis requires two pathways, namely, MEN (mitotic exit network) and FEAR 
(fourteen early anaphase release) [49, 197]. While Cdc15 is an essential component of 
MEN, Slk19 is an effector of FEAR pathway [49]. Cells deficient in both Cdc15 and 
Slk19 functions are, therefore, unable to exit mitosis and arrest in telophase with a 
large bud, segregated chromosomes and a long spindle at 30ºC. Having responded to a 
DSB, both repairable and adaptable cells carrying cdc15 and slk19 mutations will be 
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expected to undergo chromosome segregation and accumulate in telophase. The 
proportion of these cells in a given population can thus be easily quantified. 
Since we are utilizing a different approach for quantifying cells’ behavior, we 
first characterized the recovery (in repairable strain) and adaptive responses (in non-
repairable strain) in these modified genetic backgrounds. In this chapter, we describe 
the results of this study. 
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3.2 Results 
3.2.1 The telophase trap using combined deficiencies of Cdc15 and 
Slk19 
For our experiments, it is imperative that cells escaping from G2/M arrest in telophase 
and do not exit mitosis. Mitotic exit requires proteolytic destruction of mitotic cyclins 
(Clb1 and Clb2 in budding yeast) catalyzed by a signaling pathway known as the 
mitotic exit network (MEN). Cdc15 kinase is an essential component of MEN. A 
mutant carrying temperature-sensitive allele of CDC15, namely cdc15-2, is unable to 
exit mitosis and arrests in telophase at 37°C. Therefore, cdc15-2 mutation can serve as 
a telophase trap. However, we have noticed that cells’ ability for adaptation is 
compromised at 37°C (data not shown). In our laboratory, an earlier attempt to 
identify mutations in genes, which would render MEN pathway completely inactive in 
combination with cdc15-2 allele at semi-permissive temperature (30°C), had yielded 
Slk19 (Hong Hwa Lim, personal communication). Subsequently, Slk19 was shown to 
be a component of the FEAR network [49], an auxiliary pathway required for efficient 
exit from mitosis, though not essential for it. Further characterization showed that 
cdc15-2 slk19 double mutant cells are unable to exit mitosis at 30°C and uniformly 
arrest in telophase with divided nuclei and long spindles, presumably due to 
inactivation of both the MEN and FEAR pathways. We found that the ability of non-
repairable (hence adaptable) cells to undergo adaptation at 30°C is comparable to that 
at 24°C (data not shown). Therefore, we used the combined deficiencies of Cdc15 and 
Slk19 at 30°C as a ‘telophase-trap’ in our experiments.  
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3.2.2 Recovery and adaptation in cells with telophase trap 
As briefly mentioned above, the RP strain carries GAL10 promoter-driven HO 
endonuclease gene, hml-MATa-inc-hmra on chromosome III, MATa on 
chromosome V and cdc15-2 slk19 mutations to allow cells to be trapped in telophase 
at 30ºC. MATa-inc on Chromosome III is mutated in this strain; hence it is resistant to 
HO-induced cleavage. Thus, a DSB is introduced only at the MATa cassette on 
chromosome V upon HO induction. The AD strain carries the same markers; it does 
not however contain an extra MATa copy and therefore cannot repair the DSB in 
MATa cassette by HR. 
To study the kinetics of cell cycle progression in response to a DSB in RP 
(US5881) and AD (US5880) strains, cells were synchronized in G1 by -factor 
treatment in YEP+raff and then released at 30ºC into YEP+raff+gal to induce HO 
expression (hence introducing a DSB). HO was expressed throughout this experiment. 
Samples were withdrawn at different time points and processed for 
immunofluorescence staining, Western blotting and real-time PCR (RT-PCR). By the 
4th hr after release, RP cells had accumulated at G2/M with a large bud, short spindle 
and an undivided nucleus due to activation of the DNA damage checkpoint (Figure 4). 
Unlike the AD strain, Rad53 hyper-phosphorylation is not detected after the release, 
probably due to efficient HR repair (but other studies have reported transient Rad53 
phosphorylation which disappears very rapidly [106]). RP cells begin to undergo 
anaphase at 4th hr with ~80% cells reaching telophase by 14 hrs, as indicated by the 
presence of divided nuclei and a long spindle. Progression into mitosis is 
accompanied by the disappearance of the hyper-phosphorylated forms of Rad53 
suggesting that the checkpoint is extinguished as cells initiate anaphase. AD cells also 
arrest at G2/M with a large bud, a short spindle and an undivided nucleus. As 
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expected, Rad53 is hyper-phosphorylated indicating that checkpoint is activated in 
response to DSB. However, these cells remain arrested in G2/M for ~8 hrs after which 
they begin to divide their nuclei at 10 hrs (about 10% cells in telophase as opposed to 
50% cells in RP strain at the same time point) (Figure 4C). The proportion of AD 
cells in telophase reaches almost 80% at 14 hrs.  
To ascertain if the DSB is still present in cells that have progressed to 
telophase, we used both Southern blot analysis and real-time polymerase chain 
reaction (RT-PCR). In the case of Southern blot analysis, a specific probe 
corresponding to the region containing the HO cleavage site was used to follow the 
fate of the DSB. As shown in Figure 5, HO-induced DSB in RP strain is indicated by 
the progressive disappearance of the 3kb fragment and concomitant appearance of 
two smaller (2.1 kb and 0.9 kb) fragments. Reappearance of the larger size fragment 
in RP cells, coincidental with increasing proportion of telophase cells suggests that 
the DSB is repaired. Disappearance of the 6.5 kb fragment and appearance of smaller-
size fragments are also observed in AD cells after induction of HO. However, the 6.5 
kb fragment never reappears even after a high proportion of cells have reached 
telophase (Figure 4C). This suggests that AD cells escape G2/M arrest and traverse to 
telophase without repairing the HO-induced double strand break. RT-PCR analysis 
(Figure 5C) using primers specific to HO-susceptible region further confirmed that 
while RP cells repair the DNA legion, DSB is still present in AD cells even though 
~80% cells have reached telophase (Figure 4C). 
5 μm






































Figure 4. Adaptation and recovery in cells with telophase trap.
AD (US5880) and RP (US5881) cells were synchronized at G1 with -factor in YEP+raff 
medium, and released into cell cycle in YEP+raff/gal medium at 30oC. Samples were 
collected every 2 hrs for 14 hrs. (A) Western blot analysis and (B) FACS profiles are shown.  
(C) The plot shows percentage of cells with divided nucleus at the indicated times. (D) The 
state of the spindle and nuclear division were monitored using anti-tubulin antibodies 
(Red) and DAPI (Blue).
24 hr14 hr12 hr10 hr8 hr6 hr4 hr2 hrαf







Probe A spans the HO site.
HPH MATaMATa
90 bp







MATa-inc                ChrIII
(donor sequence)
EcoR1          6.5 kb         EcoR1
MATa                      ChrIII
EcoR1          6.5 kb         EcoR1
2.6 kb        3.9 kb






































































Figure 5. Southern blot and RT-PCR analysis in AD and RP cells.
DNA from AD (US5880) and RP (US5881) cells were subjected to Southern Blot and 
RT-PCR analysis. 
(A) Southern blot hybridization of DNA samples obtained from AD and RP strains. Probe 
A, spanning the HO site, is used as the probe. The sizes of the DNA fragments are 
indicated on the right of the blot.
(B) Schematics of EcoRI sites at the MATa locus in RP and AD strains. For AD strain, a 6.5kb 
band indicates an intact HO site. If the HO site cleaved, 3.9kb and 2.6kb bands are 
released. For RP strain, in addition to the 3 kb band spanning the HO site, a 6.5kb is 
detected due to presence of  MATa-inc sequences. If HO site is cleaved, the 3 kb band 
yields 2.1 kb and 0.9 kb fragments. 
(C) Real-time PCR results. Chromosomal DNAs are digested with EcoRI, and subjected to 
Real-Time PCR reactions. A 166bp PCR fragment spanning the HOsite is amplified. Plots 
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3.2.3 Dramatic loss of viability in AD cells 
Since AD cells escape G2/M arrest and progress through mitosis without repairing the 
DNA lesion, they would be expected to lose viability as more chromosome 
aberrations are introduced during segregation. Hence we compared the loss of 
viability in RP (US5338) and AD (US5339) strains as they overcome G2/M arrest to 
progress through mitosis. The strains used in this study do not contain the telophase 
trap so as to allow colony formation. The RP and AD strains were synchronized in G1 
by -factor treatment in YEP+raff medium and then were allowed to resume cell 
cycle progression in YEP+raff+gal medium to induce HO expression. Cell samples 
were withdrawn after 2 hrs, plated on YEP+raff+gal plates and incubated for 72 hrs to 
allow colony formation. While >70% of RP cells formed colonies, ~0.1% of AD cells 
were able to so (Figure 6A), suggesting that AD (non-repairable) cells undergo a 
dramatic loss of viability. 
It was somewhat surprising that a few AD cells do eventually form colonies. 
Therefore, we examined the state of the HO-susceptible region by analyzing the DNA 
of 14 colonies obtained from both RP and AD strains (these strains were used in the 
experiment described in the preceding paragraph). The DNA was isolated and 
sequenced over the HO-cleavable region. As expected, the DSB in the HO-susceptible 
region had been repaired in all fourteen clones and the sequence was identical to the 
‘homologous region’ (on chromosome III, see Figure 5) used during HR repair. On 
the other hand, in the surviving AD colonies, the sequence in this region of all 
fourteen clones showed mutations or small deletions (Figure 6B). Because of these 
changes, this region is no longer susceptible to HO endonuclease. These results 
suggest that AD cells (which are unable to undergo repair by HR) lose their viability 
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dramatically when they escape G2/M arrest without repairing the DSB. The very 
small percentage of cells which are able to survive are those that have managed to 










AD + YEP raffinose/galactose RP + YEP raffinose/galactose
(i) AD AD (ii) RP
Cells Plated 50,000 100,000 500
Avg Survival 36 366
% Percentage 0.072% 0.078% 73.2%
Normalized% 0.098% 0.107% 85%
78
(A)
Figure 6. Viability of repairable (RP) and adaptable (AD) strains. 
G1 arrested cells from AD (US5339) and RP (US5338) strains were filtered and released into 
YEP+raff+gal medium at 24oC. After 4 hrs, triplicates of 50,000 and 100,000 of AD cells, and 
500 RP cells (quantified using a haemocytometer) were spread onto YEP+raff+gal plates. 
Subsequently, after 3 days of incubation at 24oC, colonies were counted. Next, DNA of the 
colonies (14 each from AD and RP) were extracted and sequenced. (A) shows the number of 
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3.2.4 Polo-like kinase Cdc5 is necessary for adaptation 
Toczyski et al [3] had conducted a genetic screen in an attempt to identify genes 
required for adaptive response in budding yeast. The strategy was to isolate mutants 
that fail to adapt and remain arrested in G2/M. This screen identified cdc5-ad, a 
mutation in Cdc5 which abolished the adaptive response, suggesting a role for Cdc5 
in the process of adaptation. However, it is not clear what role Cdc5 plays in 
adaptation. Cdc5 is an essential gene in budding yeast. Though not required for entry 
into or progression through mitosis, it is a critical effector of the mitotic exit network 
and plays an essential role in the final exit from mitosis [85, 198]. It is also involved 
in efficient cohesin cleavage during anaphase but this requirement is not absolute 
[117]. Thus, cells deficient in Cdc5 progress through the cell cycle fairly normally but 
arrest in telophase due to their failure to degrade mitotic cyclins. 
cdc5-ad allele is specifically defective in adaptation in that it retains its normal 
kinase activity and mitotic functions. To rule out any atypical allele-specific effects, 
we wished to characterize the adaptive response in cells completely deficient in Cdc5 
function. For this purpose, we deleted the CDC5 gene in a non-repairable strain, kept 
it alive by a copy of CDC5 driven by a methionine-repressible promoter (US5909). 
These cells are non-viable on methionine containing medium due to Cdc5 deficiency. 
Since Cdc5 deficiency also acts as a telophase trap, cdc15-2/slk19 was not 
introduced in these cells. AD (with cdc15-2/slk19 trap) and AD cdc5 cells were 
synchronized in G1 by  factor treatment in –met+raff medium and then released into 
YEP+raff+gal medium at 30ºC. As expected, AD cells begin to arrive at telophase 
after 10 hrs as indicated by the presence of a divided nucleus and a long mitotic 
spindle (>60% at 14thhr) as shown in Figure 7. Consistent with this, hyper-
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phosphorylated forms of Rad53 begin to disappear starting from 10 hrs, indicating the 
turning-off of the checkpoint (Figure 7A). AD cdc5 cells, on the other hand, remain 
arrested with a short spindle and an undivided nucleus (Figure 7C). In addition, 
Rad53 remains hyper-phosphorylated in these cells throughout the experiment, 
implying the existence of an active checkpoint in the absence of Cdc5 and the 
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Figure 7. Polo-like kinase CDC5 is essential for adaptation.
AD cells (US5880) were synchronized at G1 with -factor in YEP+raff medium, and released 
into cell cycle in YEP+raff/gal medium at 30oC; whereas AD cdc5Δ MET-CDC5 cells (US5909) 
were synchronized in methionine-free medium with raffinose, added with 20mM methion-
ine 30mins before being released into YEP+raff+gal+20mM methionine medium at 30oC. 
Results from (A) Western blots and (B) FACS analysis are presented.  (C) The plot shows the 
percentage of cells with divided nucleus at the indicated times. (D) The state of the spindle 
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3.2.5 Cdc5 polo kinase does not affect recovery in RP cells 
DNA damage checkpoint appears to be extinguished in both RP and AD strains 
(Figure 3) as they undergo recovery or adaptation, respectively, at least as estimated 
from the disappearance of hyper-phosphorylated Rad53. This implies that turning off 
of the checkpoint is a prerequisite for both recovery (damage repaired) and adaptation 
(no repair). In the preceding section, we have seen that in the absence of Cdc5, AD 
cells are unable to extinguish the checkpoint and fail to undergo adaptation (Figure 7), 
raising the possibility that Cdc5 is required for extinguishing the checkpoint. 
Therefore, we asked if Cdc5 is also required to turn off the checkpoint during the 
recovery process in RP cells.  
RP cells carrying cdc5 MET-CDC5 (with cdc15-2/slk19 trap) (US5866) 
were synchronized in G1 with -factor treatment in –met+raff medium and then 
released into YEP+raff+gal medium to induce HO and repress the expression of Cdc5. 
Cells were monitored for Rad53 phosphorylation and their ability to reach telophase. 
Interestingly, unlike the AD strain, Rad53 hyper-phosphorylation is not detected after 
the release (but other studies reported transient Rad53 phosphorylation which 
disappears very rapidly [106]) and cells accumulate in telophase with divided nuclei 
and a long mitotic spindle (Figure 8). This is rather surprising since RP cells would be 
expected to activate the damage checkpoint, arrest in G2/M and repair the single DSB. 
However, if Cdc5 is required for extinguishing the checkpoint, RP cells will be 
expected to remain arrested in G2/M, despite having repaired the DSB. One possible 
explanation is that the repair process via HR itself causes the checkpoint to be turned 
off when single-stranded DNA regions (that are critical for activating the checkpoint) 
disappear as repair process proceeds. Such a scenario, thus, ascribes the checkpoint-
extinction function to the repair process itself and precludes the requirement for Cdc5. 
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The ability of RP cells to reach telophase in the absence of Cdc5 also suggests that 
progression through mitosis (metaphase to anaphase transition) after cells escape from 
G2/M arrest (in the checkpoint context) does not require Cdc5 activity. 
 






































Figure 8. Recovery is unaffected in Cdc5 deficient cells.
AD cdc5Δ MET-CDC5 (US5868) and RP cdc5Δ MET-CDC5 (US5866) cells were synchronized 
at G1 with -factor in methionine-free medium with raffinose. 20mM methionine was 
added 30mins before cells were released into YEP + raff/gal + 20mM methionine medium 
at 30oC. Results for (A) Western blot analyses and (B) FACS profiles are shown. (C) The 
graph shows the percentage of cells exhibiting nuclear division over time. (D) The state of 
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3.3 Discussion 
We have used the terms ‘recovery’ and ‘adaptation’ in the sense employed by 
Hartwell and colleagues to describe cells’ escape from DNA damage-induced G2/M 
arrest [3]. However, we wish to sound a note of caution particularly with regard to 
usage of the term ‘adaptation’. The term ‘adaptation’ is very frequently used within 
the evolutionary context, where it is considered as an outcome of natural selection 
leaving the survivors better ‘fitted’ to their environment, hence better ‘adapted’. In the 
context of DNA damage, the use of the term ‘adaptation’ may, therefore, seem 
inappropriate. However, in the present scenario, ‘adaptation’ is meant as a process 
which allows cells to become ‘desensitized’ to the checkpoint-induced arrest (this is 
not necessarily accompanied with improved fitness) and to resume cell cycle 
progression. Desensitization has long been known in chemotactic and hormonal 
responses where a system is geared to respond to a change in concentration rather 
than the absolute concentration itself [199, 200]. However, it should be noted that 
checkpoint controls are designed to respond to absolute amount of damage, not the 
change in the extent of DNA damage.  
In this study, we have explored adaptation in a somewhat restricted sense in 
that we monitor, in most experiments, the cells’ ability to overcome the G2/M arrest 
and progress to metaphase and anaphase/telophase but not beyond. We reasoned this 
to be a better indicator (as opposed to budding) of adaptation because the DNA 
damage checkpoint’s central function is to prevent metaphase to anaphase transition 
and thus segregation of damaged chromosomes. Indeed, using this parameter to 
‘quantitate’ the adaptive response in a cell population can be difficult if cells 
overcome G2/M arrest in an asynchronous manner. However, this problem was 
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resolved by making use of the synthetic lethal interaction between cdc15-2 and slk19 
mutations at 30ºC which causes cells to arrest uniformly in telophase and can act as an 
efficient telophase trap.  
At a primary level, adaptation (desensitization) can be considered akin to 
slippages inherent to control systems such that the checkpoint regulation tends to 
dissipate after a prolonged arrest in G2/M. The fact that adaptive response in budding 
is almost completely abolished by a mutation in polo-like kinase Cdc5 (cdc5-ad) 
strongly suggests that it is a regulated process [3]. However, what role Cdc5 may play 
in adaptation pertaining to DNA damage is not known. cdc5-ad allele appears to be 
specifically defective in the adaptive response since this allele is not defective in its 
other cell cycle functions. To eliminate any allele specific effects, we have tested 
adaptation and recovery in cells completely deficient in Cdc5 function. We indeed 
find that in cdc5 cells, the adaptive response is largely abolished (Figure 7). The fact 
that Rad53 remains hyper-phosphorylated (Figure 7A) in these cells implies that 
turning-off of the checkpoint signaling is a pre-requisite for adaptation. However, RP 
cells carrying CDC5 deletion recover efficiently and accumulate in telophase (Figure 
8), suggesting that the absence of Cdc5 function does not affect the recovery process. 
This is rather surprising because during both ‘adaptation’ and ‘recovery’, the 
checkpoint is apparently extinguished (as monitored by dephosphorylation of Rad53) 
so that cells can initiate mitosis and proceed to telophase. Our results, thus, argue that 
while Cdc5 is required for checkpoint turn-off during adaptation, the mechanism for 
extinguishing the checkpoint during ‘recovery’ may be different and does not require 
Cdc5 function. We note that, unlike in AD strain, hyper-phosphorylation of Rad53 
after HO induction (Figure 4) is barely detectable in RP cells before they proceed to 
telophase, as if the checkpoint is activated only very transiently. In previous studies 
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[106], Rad53 phosphorylation has been detected in RP cells, but only transiently. 
How do RP cells extinguish the checkpoint independently of Cdc5?  
One possibility is that the repair response itself switches-off the checkpoint 
control. The single-stranded DNA generated by the repair machinery (MRX complex-
mediated resection of 5’end at the DSB), which is a prerequisite for the activation of 
DNA damage checkpoint, progressively disappears and is restored to double-stranded 
DNA as repair-reactions take root. This will eventually dislodge the upstream 
checkpoint effectors such as Mec1-Ddc2 complex which is recruited to the RPA-
bound single-stranded DNA to initiate the activation of checkpoint. Hence, the 
progression of repair processes and ‘turning-off of the checkpoint’ can be visualized 
as coupled events. This notion is consistent with the behavior of AD cells; without the 
capacity to repair the DSB by HR, they maintain the DNA-damage checkpoint in the 
activated state for prolonged periods of time and require a different mechanism 
(Cdc5-dependent) to extinguish it during adaptation. 
Cdc5 polo kinase-independent ‘recovery’ in budding also strongly suggests 
that initiation of mitosis or progression to telophase is not dependent on Cdc5. This is 
different from ‘recovery’ in mammalian cells. It has been known that initiation of 
mitosis in mammalian cells is regulated by redundant pathways. It has been shown 
that while Plk1 (polo like kinase 1) is not essential for mitotic entry in undamaged 
U2OS cells, the onset of mitosis in U2OS cells recovering from DNA damage 
becomes acutely dependent on Plk1 [112]. The Plk1 requirement appears to be 
because of its role in the degradation of the mitotic inhibitor Wee1 since inactivation 
of Wee1 abrogates the requirement of Plk1 for ‘recovery’ in DNA-damaged cells. 
This also suggests that the control circuitry regulating the onset of mitosis is possibly 
reset upon DNA damage in mammalian cells. Adaptation has also been studied in 
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U2OS cells exposed to ionizing radiation. The DNA damaged cells showed Chk1-
dependent arrest in G2, followed by Chk1 dephosphorylation and cells’ entry into 
mitosis [5]. The persistence of DNA damage in these cells was indicated by the 
presence of -H2AX foci. Interestingly, Plk1 is also implicated since depletion of 
Plk1 or overexpression of Chk1 delays the adaptation process. Chk2 is also 
phosphorylated (at Thr168 within SQ/TQ cluster) by ATM upon DNA damage [201]. 
Like Rad53 in S. cerevisiae, Chk2 Thr168 is dephosphorylated by PP2C type of 
phosphatase, namely Wip1 [202] in mammals. Wip1 also dephosphorylates Chk1 on 
Ser345 and Ser317 (phosphorylated by ATM) and is proposed to play an important 
role in the reversal of the DNA damage response [203]. Although Plk1 has been 
implicated in adaptation to replication checkpoint in both human cells [109-111] and 
Xenopus egg extracts [4], and in the ‘adaptation’ to DNA damage in mammalian cells 
[5], the role of Plk1 in the adaptation process is not clear. 
How does Cdc5 polo kinase extinguish the DNA damage checkpoint control 
during adaptive response in the budding yeast? This is the theme we explore in 
Chapter 4. 
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4.1 Background 
As described in the preceding sections, ‘adaptation’ is a desensitization process during 
which S. cerevisiae cells, if unable to repair a double strand break, escape from the 
checkpoint imposed G2/M arrest. During ‘recovery’, cells also escape G2/M arrest 
but they do so after having repaired the DNA lesion. At one level, ‘adaptation’ and 
‘recovery’ both can be broadly considered as involving two common steps: (i) 
turning-off of the checkpoint control and (ii) reactivation of the mitotic machinery. In 
Chapter 3, we have seen that during recovery, Cdc5 kinase is required neither for 
switching off the checkpoint nor for the onset of mitosis or for chromosome 
segregation. However, it is also clear that Cdc5 function is required for ‘adaptation’ 
(Figure 7). This could be either because cells defective in HR repair are unable to 
extinguish the checkpoint control in the absence of Cdc5 or they are unable to 
progress through mitosis without Cdc5 function. In budding yeast, Cdc5 is essential 
for mitotic exit. Moreover, the undamaged, Cdc5-deficient cells can traverse through 
mitosis and reach telophase quite efficiently (unlike mammalian cells where polo 
kinase Plk1 is required for the onset of mitosis). Therefore, it is likely that AD cells 
are unable to undergo ‘adaptation’ in the absence of Cdc5 because they fail to switch 
off the checkpoint and not because they are unable to initiate mitosis. What role does 
Cdc5 polo kinase play in extinguishing the DNA damage checkpoint? 
Polo-like kinase (Plx1 in Xenopus) has been implicated in the adaptive 
response in aphidicolin treated Xenopus egg extracts [4]. Aphidicolin blocks DNA 
replication and causes activation of the replication checkpoint (ATR-Chk1 axis) 
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which arrests egg extracts in interphase. Claspin, the checkpoint mediator protein, is 
necessary for this arrest because it mediates ATR-dependent activation of Chk1. It has 
been shown that during checkpoint response, Claspin itself gets phosphorylated on 
Thr906 (T906) which creates a Plx1 binding site [4]. Recruitment of Plx1 to this site 
leads to further phosphorylation of Claspin at Ser934 (S934). After a prolonged arrest 
in aphidicolin, these extracts undergo adaptation and initiate mitosis. This is 
accompanied by dissociation of Claspin from chromatin and inactivation of Chk1. 
Substitution of T906 or S394 by alanine abolishes the adaptive response. This 
suggests that turning-off of the replication checkpoint response is accomplished 
through Plx1-dependent phosphorylation of Claspin. 
Adaptation to DNA damage has been studied in human osteosarcoma cells 
(U2OS) [5]. When exposed to ionizing radiation, U2OS cells arrest in G2 in a Chk1 
dependent manner. However, after a prolonged arrest, they escape and enter mitosis. 
Depletion of Plk1 or overexpression of Chk1 can delay this process. In addition, the 
entry into mitosis is accompanied by Chk1 dephosphorylation. Chk1 may also be 
inactivated by proteolytic degradation in transformed human cells [205]. It has been 
proposed that ATR-mediated phosphorylation of Chk1 not only activates it but also 
primes it for proteolytic destruction [205]. Hence, switching off of the checkpoint 
response is also a prerequisite for adaptive response in human cells. However, what 
role does polo-like kinase play in extinguishing the DNA damage checkpoint 
response in human cells is not known. PP2A like phosphatases (PP4 and PP6) have 
been implicated in reversing Chk1 phosphorylation on Ser317 and Ser345 [203]. 
Chk2 is also activated by ATM/ATR mediated Thr168 phosphorylation in response to 
treatment with cisplatin or ionizing radiation [201]. Wip1 phosphatase has been 
shown to promote dephosphorylation of Thr168, thus antagonizing Chk2 activation 
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by ATM/ATR and this may be important in reversing the DNA damage response 
[202].  
Chk1 phosphorylation also plays a prominent role in imposing a G2 delay in 
DNA damage in fission yeast Schizosaccharomyces pombe. Activated Chk1 targets 
both Wee1 and Cdc25 to indirectly promote phosphorylation of Cdc2 (Cdk1) on the 
evolutionarily conserved tyrosine 15 (Tyr15) residue [206]. Dephosphorylation of 
Chk1 by PP1 phosphatase Dis2 allows DNA damaged cells to escape from G2 arrest 
since dis2 mutant remains arrested for a prolonged period upon DNA damage [207]. 
This correlates with the presence of persistent phosphorylation of Chk1 [206]. The 
theme of effector kinase inactivation extinguishing the DNA damage checkpoint also 
continues in the case of the budding yeast. Rad53 (yeast Chk2) is phosphorylated in 
response to DNA damage [208, 209]. During adaptive response, dephosphorylation of 
Rad53 correlates strongly with cells’ escape from G2/M arrest, suggesting that Rad53 
dephosphorylation is promoted by PP2C phosphatases Ptc2 and Ptc3 [107]. Another 
PP2A-like phosphatase, Pph3, also dephosphorylates activated Rad53 in cells 
subjected to MMS treatment [210]. However, switching off of replication checkpoint 
after hydroxyurea treatment appears to require a different set of phosphatases since 
Rad53 remains hyper-phosphorylated in pph3 ptc2 ptc3 triple mutant upon 
removal of hydroxyurea [211]. Thus, dephosphorylation of the checkpoint effector 
kinase is one of the main cellular strategies for dampening the checkpoint signaling 
allowing recovery or adaptation. 
A loss of function of a number of other proteins such as Ku complex subunits 
Yku70 and Yku80, RecA like protein Rad51, the Srs2 helicase and Sae2 impair the 
adaptive response in budding yeast [2, 68, 105, 106]. Deficiency of single stranded 
binding protein subunit Rfa1 and MRX complex subunit Mre11, on the other hand, 
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are conducive to adaptation. These proteins are known to be involved in the 
processing of DSB ends. Their presence or absence is, therefore, likely to promote or 
dampen checkpoint signaling and to eventually impinge on cells’ adaptive response. 
Casein Kinase II subunits Ckb1 and Ckb2 are also implicated in adaptation in that 
ckb1 and ckb2 mutants fail to undergo adaptation upon DNA damage. The exact 
mechanism of their involvement remains unclear. 
The foregoing discussion suggests that extinction of checkpoint signaling 
required for adaptation can be eliminated by interfering with the regulatory hierarchy 
at different points. It can be accomplished either by dephosphorylation of Rad53 or 
can occur somewhat upstream at the level of DNA processing of the DSB ends. But at 
what stage Cdc5 polo kinase acts in the adaptive response pathway remains unclear. 
We explore this issue in the following sections. 
 
4.2 Results 
4.2.1 Overexpression of Cdc5 accelerates adaptation 
We have seen in Chapter 3 that Cdc5 is essential for adaptation to DNA damage and 
for turning off of the checkpoint response. Without resorting to any preconceived 
assumptions of its role in adaptation, we asked if Cdc5 is a rate limiting factor in the 
adaptive response. Generally, the variation in the concentration or activity of a rate 
limiting factor determines the overall rate of the process. In the present context, an 
effector may be essential for adaptive response but, if not rate limiting, it may not be 
able to alter the kinetics of adaptation when its activity is spiked. Therefore, we tested 
if the kinetics of adaptation changes with altered physiological concentrations of Cdc5. 
AD cells (containing telophase trap) with (US5999) or without (US5880) one copy of 
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GAL-CDC5 integrated at its native locus were synchronized in G1 with -factor 
treatment in YEP+raff medium and then released into raffinose medium at 30ºC. After 
2 hrs, galactose was added to induce HO and Cdc5 expression. Since overexpression 
of Cdc5 dampens to some extent, cells’ capacity to bud, Cdc5 was induced 2 hrs after 
the release when most cells in the culture had budded. 
AD cells without GAL-CDC5 (US5880) remained arrested in G2/M with short 
spindles and undivided nuclei until 10 hrs with only ~10.2% of cells escaping the 
arrest as evidenced by the presence of divided nucleus (nuclei are stained with DAPI). 
The proportion of cells overcoming the G2/M arrest reached 68.1% by 14th hr (Figure 
9C). This is consistent with the Rad53 hyper-phosphorylation at 6th hr and its gradual 
disappearance by 12th hr. 15% of Cdc5-overexpressing AD cells (US5999) escaped 
G2/M by 8th hr, with ~69% cells reaching telophase by 10th hr (Figure 9C). The extent 
of Rad53 hyper-phosphorylation was much less compared to AD cells without Cdc5 
overexpression. Instead, there was a slight but distinct gel mobility shift starting from 
6th to 14th hr. The extent of shift was between Rad53 profile of undamaged cells at G1 
arrest, and Rad53 hyper-phosphorylation in AD cells at 4th to 6th hr. These results 
suggest that higher activity of Cdc5 causes adaptive response to initiate earlier in 
DNA damaged cells. It appears to do so by inactivating the checkpoint response. 
Acceleration of adaptation by overexpression of Cdc5 also implies that Cdc5 is 
perhaps a rate limiting factor in the adaptive response.  
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Figure 9. Overexpression of Cdc5 accelerates adaptation in normal cells.
AD (US5880) and AD GAL-CDC5 (US5999) cells were synchronized at G1 with -factor in 
YEP+raff medium, and released into the cell cycle in YEP+raff medium at 30oC with galac-
tose added 2 hrs later. Samples were collected every 2 hrs for 14 hrs. (A) Western blots 
analyses and (B) FACS profiles are shown (C) The graph shows the percentage of cells 
exhibiting nuclear division over time. (D) The state of the spindle and nuclear division are 
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4.2.2 Overexpression of Cdc5 rescues other adaptation defective 
mutants 
As mentioned earlier, cells lacking the function of a number of genes other than 
CDC5 (such as SAE2, PTC2/PTC3, CKB1, CKB2, YKU70 and YKU80) are known to 
be defective in mounting an adaptive response. Sae2 promotes the dissociation of 
MRX complex from DNA [68], whereas Ptc2 and Ptc3 are phosphatases belonging to 
PP2C family of phosphatases and are known to be responsible for dephosphorylation 
of Rad53 during adaptation [107]. Depletion of Ckb1 and Ckb2, subunits of Casein 
Kinase II (CKII), does not allow cells to adapt [3]. Yku70 and Yku80 are subunits of 
Ku-complex required for non-homologous end-joining (NHEJ). Since Cdc5 seems to 
be a rate-determining step in adaptive response, we asked if ectopic expression of 
Cdc5 kinase can overcome the adaptation defect in cells lacking these factors. 
 
4.2.2.1 Sae2 
In cells depleted of Sae2, MRX complex persists at the DSB site and leads to 
constitutive activation of the checkpoint. As a result, sae2 cells fail to adapt or 
undergo recovery [68]. If Cdc5 influences DNA damage response by affecting steps 
downstream of MRX complex, then overexpression of Cdc5 would cause sae2 cells 
to adapt. To test this, sae2, AD cells (US6106) with or without (US5998) GAL-
CDC5 cells were synchronized in G1 with -factor treatment and released into 
YEP+raff medium at 30ºC. After 2 hrs, galactose was added to induce both HO 
endonuclease and Cdc5. In sae2 cells without Cdc5 overexpression, Rad53 hyper-
phosphorylation was seen from 4th hr onwards, and persisted even at 24th hr (Figure 
10A). Immunofluorescence staining indicated that only 14.4% of these cells had 
adapted and arrested in telophase with long spindles and divided nuclei (Figure 10C). 
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Ectopic expression of Cdc5, however, allowed 34.9% of sae2 cells to escape G2/M 
arrest and reach telophase by 8th hr. This proportion increased to 56.7% by 14th hr 
(Figure 10C). Consistent with these observations, Rad53 was not hyper-
phosphorylated. These results suggest that Cdc5 overexpression suppresses adaptation 
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Figure 10. Overexpression of Cdc5  rescues adaptation defects in sae2Δ cells.
AD sae2Δ (US5998) and AD sae2Δ GAL-CDC5 (US6106) cells were synchronized in G1 with 
α-factor in YEP+raff medium and released in YEP+raff medium at 30oC with galactose 
added 2 hrs later. Results from various analyses are shown: (A) Western blot analysis, (B) 
FACS analysis, (C) percentage of cells with divided nucleus and (D) state of spindle using 
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4.2.2.2 Ptc2/Ptc3 
Cdc28 (Cdk1) is the main CDK that drives cell cycle progression in budding yeast. Its 
activity is regulated not only by its association with cyclins but also by 
phosphorylation events. Among these, phosphorylation of Thr169 residue, necessary 
for stabilization of Cdc28-cyclin interaction, is performed by Cdk-activating kinase 
(Cak1) [52, 212]. PP2C family kinase Ptc2 and Ptc3 were identified as phosphatases 
that reverse the phosphorylation of Thr169 [213]. Subsequently, Ptc2 and Ptc3 were 
implicated in switching-off the DNA damage response during adaptation by 
dephosphorylating Rad53 [107]. Consistent with this notion, ptc2 ptc3 double mutant 
cells are defective in the adaptive response [107]. 
To test, if ectopic expression of Cdc5 suppresses adaptation defect of ptc2 
ptc3 double mutant, a single copy of GAL10 promoter-driven CDC5 was integrated 
at the URA3 locus. AD ptc2 ptc3 cells with or without GAL-CDC5 (US6266, 
US6215) were synchronized in G1 and released into YEP+raff medium at 30ºC. After 
2 hrs, galactose was added to induced HO endonuclease and Cdc5 expression. Most 
AD ptc2 ptc3 cells remained arrested in G2/M with only ~5.4% with divided 
nucleus at 8th hr (Figure 11C). In addition, distinct Rad53 hyper-phosphorylation was 
seen from 6th hr until 24th hr in these cells. However, Cdc5 overexpression induced 
~51% of AD ptc2 ptc3 cells to progress to telophase at 10th hr (Figure 11C) with 
~80.5% cells at 14th hr. Consistent with this, a concomitant absence of Rad53 hyper-
phosphorylation was also seen. These observations suggest that Cdc5 is capable of 
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Figure 11. Overexpression of Cdc5 suppresses adaptation defects in ptc2Δ ptc3Δ cells.
AD ptc2Δ ptc3Δ (US6215) and AD ptc2Δ ptc3Δ GAL-CDC5 (US6266) cells were synchronized at 
G1 with -factor in YEP+raff medium, and released cell cycle in YEP+raff medium at 30oC 
with galactose added 2 hrs later. Results for (A) Western blot analyses and (B) FACS profiles 
are shown. (C) The graph shows the percentage of cells exhibiting nuclear division over time. 
(D) The state of the spindle and nuclear division were monitored using anti-tubulin anti-
bodies (Red) and DAPI (Blue).
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4.2.2.3 Ckb1 
Mutants lacking casein kinase 2 (CKII) subunits ckb1 or ckb2, are also known to 
be defective in adaptation [3]. It has been suggested that CKII kinase is needed for 
Ptc2/Ptc3 and Rad53 interaction [107]. However, ckb1 mutants displayed more 
severe defects in adaptation compared to ptc2 ptc3 cells, suggesting that CKII may 
additionally regulate adaptive response in a Ptc2-independent manner [214]. To 
determine if ectopic expression of Cdc5 can alleviate the adaptation defects of ckb1 
cells, AD ckb1 cells with and without GAL-CDC5 (US6072, US5885) were 
synchronized in G1 as before and then allowed to resume cell cycle progression in 
YEP+raff medium at 30ºC. After 2 hrs, galactose was added to induce both HO 
endonuclease and Cdc5, and cells were monitored for their capacity to undergo 
nuclear division. As expected, almost all AD ckb1 cells arrested in G2/M throughout 
the duration of the experiment (Figure 12B & C). However, AD ckb1 cells over-
expressing Cdc5 were able to escape G2/M arrest and traverse to telophase, starting 
from 27% at 8th hr to 53.8% at 14th hr (Figure 12C). Consistent with this, hyper-
phosphorylation of Rad53 was absent in AD ckb1 GAL-CDC5 cells. These results 
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Figure 12. Overexpression of Cdc5 rescues adaptation defects of ckb1Δ cells.
AD ckb1Δ (US5885) and AD ckb1Δ GAL-CDC5 (US6072) cells were synchronized at G1 with 
-factor in YEP+raff medium, and released cell cycle in YEP+raff medium at 30oC with galac-
tose added 2 hrs later. Results for (A) Western blot analyses and (B) FACS profiles are shown. 
(C) The graph shows the percentage of cells exhibiting nuclear division over time. (D) The 
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4.2.3 Resection of DNA at DSB is not affected by ectopic expression 
of Cdc5 
The experiments described in the preceding section suggest that ectopic expression of 
Cdc5 can extinguish the checkpoint independently of Ptc2, Ptc3 phosphatases or CKII. 
It is also clear that Rad53 is very transiently (or barely) hyper-phosphorylated in cells 
overexpressing Cdc5. One interpretation of these findings is that Cdc5 is capable of 
turning off the DNA damage checkpoint upstream of Rad53, perhaps the events 
associated at the very onset of DNA damage checkpoint. One of the early events after 
cells have experienced a DSB is the recruitment of MRX complex at the site of the 
lesion. The MRX complex and Exo1 are responsible for the resection of 5’ end 
generating a stretch of 3’-ended single-strand DNA (ssDNA) which is subsequently 
coated by single stranded DNA-binding protein RPA (a heterotrimer composed of 
Rfa1, 2, 3). RPA bound ssDNA also recruits Mec1-Ddc2 heterodimer which in turn 
activates the checkpoint control cascade. It is possible that Cdc5 overexpression 
interferes with the DNA resection thereby preventing robust activation of the 
checkpoint.  
To test this possibility, AD cells with or without GAL-CDC5 (US5828, 
US5880) were synchronized in G1 and allowed to resume cell cycle progression in 
YEP+raff medium. After 2 hrs, galactose was added to induce HO and Cdc5 
expression. DNAs, isolated from samples collected at various time points, were 
subjected to alkaline-gel electrophoresis. Southern blot analysis was performed using 
an appropriate strand-specific probe to detect the progression of DNA resection over 
time (refer to Section 2.7 for more details). As shown in Figure 13, no dramatic 
difference in the extent of ssDNA region is observed in cells with or without Cdc5 
Chapter 4 Polo-like kinase Cdc5 and Adaptation 
85 
overexpression. This indicates that Cdc5 activity does not interfere with DNA 
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Figure 13. DNA resection is unaffected in GAL-CDC5 or cdc5Δ strains.
G1 synchronized cells {RP (US5881), AD (US5880), AD cdc5Δ MET-CDC5 (US5909) and AD 
GAL-CDC5 (US5828)} were released into YEP+raff medium with galactose added 2 hrs later. 
Thereafter, samples were collected every 2 hrs for 18 hrs. 
(A) Ssp1-digested genomic DNAs, collected from the indicated times, were separated on 
alkaline agarose gels and probed using a radioactive single-strand riboprobe specific for 
MAT locus. For more details, please refer to Chapter 2 Materials and Methods. (B) Schematic 




Chapter 4 Polo-like kinase Cdc5 and Adaptation 
87 
4.2.4 High level of Cdc5 inhibits Ddc2 foci formation 
Recruitment of Mec1 kinase is considered to be the most upstream event in the 
activation of the DNA damage checkpoint pathway. Ddc2 is a Mec1-partner protein 
(analogous to ATRIP for ATR) and accumulates near the site of DNA damage 
together as a complex. Both Ddc2 deficient and mec1 mutant cells are found to be 
defective in DNA damage checkpoint activation. In the case of the latter, mec1 mutant 
cells fail to phosphorylate Rad9, Rad53 and Chk1 [77, 215]. Since Mec1 kinase 
activity is intact in Ddc2 deficient cells, this implies that Ddc2’s role in DNA damage 
response is to recruit Mec1 to the damaged DNA without which checkpoint signaling 
cannot be initiated. In the context of adaptation, it is possible that overexpression of 
Cdc5 in some way inhibits the recruitment of Ddc2 and Mec1 to the DNA or weakens 
the interaction between these proteins thereby preventing full activation of the 
checkpoint.  
To test if ectopic expression of Cdc5 affects formation of Ddc2 foci, AD cells 
with or without GAL-CDC5, but all containing endogenous DDC2 tagged with 
yeCitrine, were synchronized in G1 by -factor treatment and then released into 
YEP+raff medium at 30°C. After 2 hrs, galactose was added to induce expression of 
HO and Cdc5. In AD cells with (US6416) and without (US6382) GAL-CDC5 Ddc2- 
yeCitrine foci were clearly visible in ~38% cells within 3 hrs after HO induction. In 
AD cells, the percentage of cells with visible foci continued to increase and to peak at 
~76% by 5th hr (Figure 14A). In cells overexpressing Cdc5, 32.6% to 40.2% of cells 
displayed Ddc2-yeCitrine foci from 2.5 to 3.5 hrs. However, at the 4th hr, the 
proportion of cells with Ddc2-yeCitrine foci suddenly dropped to 18% and hovered at 
14.4%-22.2% for the next 2 hrs (Figure 14A). In addition, the intensity of the foci had 
also visibly decreased (Figure 14B), and long spindles started to appear (Figure 
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14C/D). Conversely, we found that Ddc2-yeCitrine foci persisted in cells depleted of 
Cdc5 (US6381) (Figure 15). These results imply that ectopic expression of Cdc5 
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Figure 14. Overexpression of Cdc5 inhibits formation of Ddc2 foci.
AD DDC2-yeCitrine (US6382) and AD GAL-CDC5 DDC2-yeCitrine (US6416) cells were 
synchronized at G1 with -factor in YEP+raff medium, and released in YEP+raff medium at 
30oC with galactose added 2 hrs later. Samples were collected every hr.  (A) Graph depict-
ing percentage of Ddc2-yeCitrine tagged cells (	: AD,  : AD GAL-CDC5) showing distinct 
Ddc2 foci. (B) Photomicrographs of AD and AD GAL-CDC5 cells with Ddc2 foci and nucleus 
stained with DAPI (Blue). (C) Graph depicting percentage of cells with divided nucleus 
over time. (D) Photomicrographs of AD and AD GAL-CDC5 cells with the mitotic spindle 
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Figure 15. Ddc2 foci formation in adaptable and cdc5Δ  strains.
AD (US6350) and AD cdc5Δ MET-CDC5 (US6381) with DDC2-yeCitrine cells were synchro-
nized at G1 with α-factor in YEP+raff medium, and released cell cycle in YEP+raff/gal 
medium at 30oC. (A) Western blot analyses and (B) FACS profile for AD cells. (C) The graph 
shows the percentage of cells exhibiting nuclear division and Ddc2 foci over the course of 
the experiment in AD cells. (D) The state of the spindle and nuclear division are shown 
using anti-tubulin (Red) staining and DAPI (Blue) in AD cells. For AD cdc5Δ MET-CDC5 cells 
(E) The graph shows the percentage of cells exhibiting nuclear division and Ddc2 foci 
over the course of the experiment. (F) FACS profile (G) The state of the spindle and 
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4.2.5 Cdc5 inhibits formation of Ddc2 foci assembled at the site of 
DNA damage 
It is clear from the results described in the previous section that Cdc5 prevents 
assembly of Ddc2 foci. To take the analysis further, we asked if Cdc5 polo kinase is 
capable of removing Ddc2 foci that have already been assembled at the site of DNA 
damage. To test this, we expressed Cdc5 only after Ddc2-yeCitrine foci have already 
been assembled on the DNA. AD cells (US6380) carrying cdc5 and MET-CDC5 
were arrested in G1 by -factor treatment in YEP+raff medium containing 20mM 
methionine to deplete Cdc5. These cells were allowed to resume cell cycle at 24oC in 
synthetic medium containing galactose (to induce HO expression) and methionine. 
Since cells take much longer to bud in synthetic medium, it took 10 hrs for >80% 
cells to arrest in G2/M with distinct Ddc2 foci. Cells were then washed and divided 
into two halves. One half was resuspended into synthetic medium containing 
methionine to continue repression of MET-CDC5, and the other half in medium 
without methionine for Cdc5 expression. 
In the absence of Cdc5, the percentage of cells with Ddc2-yeCitrine foci 
remained high throughout the experiment (84.7% to 98.1%). For the first 6 hrs in the 
synthetic medium, the Ddc2-yeCitrine foci could also be seen in ~90% of Cdc5-
expressing cells. However, the percentage of these cells dropped to 68.2% at 18 hrs to 
37.4% at 22 hrs (Figure 16A). The decrease in Ddc2 foci was consistent with cells’ 
progression into mitosis as indicated by presence of long spindles and divided nuclei 
(Figure 16D). At 18 hrs, long anaphase spindles began to appear in 5.4% of the Cdc5-
expressing cells. These observations imply that Cdc5 polo kinase is able to dislodge 
the Ddc2 foci assembled at the site of DNA damage.  
































































DIC               Anti-Tubulin                DAPI
Figure 16. Cdc5 can dislodge Ddc2 foci.
AD cdc5Δ MET-CDC5 (US6380) cells were synchronized at G1 with -factor in methionine-
free medium containing raffinose. 20mM methionine was added 30mins before releasing 
into +met medium (synthetic complete medium + raff/gal + 20mM methionine) at 24oC. 
After 10 hrs, the cell culture was divided into two halves. The cultre were filtered and 
washed and the cells resuspended in -met (methionine-free medium with raff/gal for + 
CDC5 sample) and +met (synthetic complete medium + 20mM methionine + raff/gal for - 
CDC5 sample) medium. Thereafter, samples were collected every 2 hrs for 12 hrs. 
(A) Graph (: - CDC5,  : + CDC5) depicting percentage of Ddc2-yeCitrine tagged cells 
showing distinct Ddc2 foci. (B) Photomicrographs of cells with Ddc2 foci and nucleus 
stained with DAPI (Blue). (C) Graph depicting percentage of cells with divided nucleus over 
time. (D) Photomicrographs of cells with spindle stained with anti-tubulin (Red) antibody 
and nucleus stained with DAPI (Blue).
Note: “+ CDC5” refers cells with active Cdc5; and “- CDC5” refers to cells depleted of Cdc5. 
Both were derived from the same strain (US6380).
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4.2.6 Cdc5 polo kinase and the checkpoint clamp  
In response to DNA damage, the checkpoint clamp complex (also known as 9-1-1 
complex, consisting of Ddc1-Rad17-Mec3 in S. cerevisiae, Rad9-Rad1-Hus1 in 
mammals) and Mec1-Ddc2 heterodimer (ATR/ATRIP in mammals) are recruited to 
RPA-coated ssDNA. Earlier studies in S. cerevisiae have shown that the two 
complexes are recruited independently [73, 74]. However, more recent reports suggest 
that 9-1-1 may also participate in recruiting Mec1-Ddc2 to double strand breaks [75, 
76]. Nevertheless, both complexes seem to be necessary for checkpoint activation 
[77], as activation of Mec1 may require 9-1-1 [78]. 
In the preceding section, we have discovered that overexpression of CDC5 
prevents the formation of Ddc2 foci. Therefore, we wish to ask if Cdc5 dampened the 
checkpoint signaling by interfering with the recruitment of 9-1-1 complex to DNA, 
and hence causing the delocalization of Ddc2. We monitored the 9-1-1 complex by 
tagging the endogenous DDC1 with yeCitrine; allowing us to visualize foci formation 
at the DSB. Therefore, AD cells expressing Ddc1-yeCitrine and with (US6448) or 
without (US6446) integrated GAL-CDC5 were synchronized in G1 and then released 
into raffinose medium at 30ºC. Galactose was added to induce HO and Cdc5 
expression after 2 hrs. Samples were collected and imaged every hour. The data 
revealed no significant difference in Ddc1 accumulation between cells with or without 
GAL-CDC5 (Figure 17); ~85% of Cdc5-overexpressing AD cells and ~73% of AD 
cells exhibited distinct Ddc1 foci by the 6th hr. These results show that the inactivation 
of checkpoint and delocalization of Ddc2 is not causally connected to 9-1-1 clamp. It 
suggests that either Mec1-Ddc2 or the upstream complex, RPA, is the target of Cdc5. 
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DIC                  Ddc1 foci                DAPI
A
D
Figure 17. Overexpression of Cdc5 does not affect the localization of Ddc1.
AD DDC1-yeCitrine (US6446) and AD GAL-CDC5 DDC1-yeCitrine (US6448) cells were synchro-
nized in G1 with -factor in YEP+raff medium, and released in YEP+raff medium at 30oC 
with galactose added 2 hrs later. Samples were collected every hr.  
(A) Plot of percentage of Ddc2-yeCitrine tagged cells (: AD, : AD GAL-CDC5) showing 
distinct Ddc1 foci at indicated times. 
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4.2.7 A search for Cdc5 substrate(s) in adaptive response pathway 
As described above,, we have observed that ectopic expression of Cdc5 polo kinase is 
capable of inactivating the checkpoint signaling. Our results suggest that Cdc5 may 
do so by specifically destabilizing the formation of Ddc2 foci, but not Ddc1 
(checkpoint clamp component) foci. However, it is possible that Cdc5 exerts its 
influence through other aspects of checkpoint signaling. 
During adaptation, Cdc5 may interact and form a (transient) complex with its 
substrates. In order to screen for candidate substrates of Cdc5, we employed a strategy 
that combines the labeling of cells with stable amino acid isotopes (SILAC) [189], co-
immunoprecipitation of Cdc5 together with its substrates during adaptation, and 
identification of these substrates through quantitative mass spectrometry [187]. 
SILAC is a metabolic labeling method that utilizes a cell’s machinery to incorporate 
exogenous heavy isotopes of amino acid residues into expressed proteins. This 
labeling strategy facilitates subsequent mass spectrometric analysis to differentiate 
between peptide signals from labeled or unlabeled source.  
To prepare cells for SILAC mass spectrometry, AD cells with or without 
GAL-cmyc6-CDC5 (US6391 and US6267) were grown overnight in labeled or 
unlabeled liquid medium, respectively (refer to Section 2.13 for more details), 
supplemented with raffinose. The next day, cells were diluted and synchronized in G1 
as described previously and then released into their respective medium at 30ºC. Two 
hrs later, galactose was added to induce HO and Cdc5. Cells were collected after 6 hrs 
for the preparation of cell extracts. Immunoprecipitates obtained using anti-cmyc 
antibodies were subsequently subjected to mass spectrometric analysis as described in 
Section 2.13. 
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In total, 1115 proteins were identified. Of these, 962 were detected in both 
samples. The remaining 153 proteins or ~13% were found only in control samples and 
this was probably due to the different physiological states of the samples, therefore, 
these were discarded.. Proteins involved in metabolic pathways, ribosomal biogenesis, 
heat shock response and other “house keeping” proteins were also removed from 
consideration. Since Cdc5 affects the recruitment of Ddc2 to the break site, it is more 
probable that Cdc5 mediates through a substrate that is involved in the DNA damage 
checkpoint response, and upstream of Ddc2 recruitment. Therefore, a total of 20 
proteins (out of ~80 candidate targets) relevant in the checkpoint context and based on 
their (possible) involvement in DNA damage response or interaction with Cdc5, was 
selected (Table 8). The most interesting candidate protein amongst them is the RPA 
complex, since all 3 subunits of RPA (Rfa1, Rfa2 and Rfa3) were identified with 
relatively high confidence (Table 9). The RPA complex is known to affect Ddc2 
recruitment. The mean sequence coverage (mean of the three RPA subunits) from 32 
peptides is ~36%, and the mean ratio is ~0.291 (a value smaller than 1 is better). Note 
that the normalized ratios are comparisons of protein ratio versus the medium ratio of 
all proteins. This method of normalization is often used in the analysis of whole 
proteome or transcriptome. It assumes that the majority of the proteins or transcripts 
are for housekeeping, and thus do not vary significantly. Since this is a mass 
spectrometry of Cdc5 immunoprecipates, the normalized ratio is not an insightful 
comparison. Subsequent scrutiny of Rfa1 protein sequence revealed a consensus Cdc5 
phosphorylation site (D/E-X-S/T-
-D, where 
 denotes a hydrophobic reside [216]) 
at Thr346 and 3 polo-box binding domains (S-[pS/pT]-P/X, where ‘p’ denotes the 
phosphorylated form and proline at +1 position confers a slight advantage but is not 
necessary [217]) (refer to Table 9). Although RPA is not a candidate substrate with 
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the lowest ratio, it is the only one with a direct role in the recruitment of Ddc2 [73, 
74]. These results raises the possibility that RPA could be targeted for 
phosphorylation by Cdc5 during adaptation. However, this scenario should be treated 
with caution since RPA does not uniquely stand out amongst the 20 candidates. 
Therefore, this possibilty must be corroborated with alternative assays. 
 



















1. Bmh1 3 61.8 0.20805 0.71313 24.0827 
2. Cdc14 1 2.4 0.20842 0.60846 18.82724 
3. Cdc28 2 8.1 0.61409 1.8504 20.75515 
4. Cka1 9 24.2 0.2816 0.90328 22.6826 
5. Ckb1 3 12.6 0.27099 1.0335 22.39375 
6. Glc7 9 33 0.26859 0.90673 23.2717 
7. H2A1 3 34.8 0.27462 0.83291 26.53022 
8. Pin4 9 17.5 0.20951 0.60685 23.78706 
9. Pph21 3 24.9 0.18887 0.66713 23.54887 
10. Pph22 3 22.8 0.29726 0.94269 22.87819 
11. Rad27 2 3.7 0.43609 1.3764 18.6826 
12. Rad6 1 9.8 0.18121 0.42045 21.00854 
13. Rfa1 24 46.7 0.29201 0.84808 25.87514 
14. Rfa2 5 22 0.28427 0.92853 23.59412 
15. Rfa3 3 41.8 0.29674 0.69292 22.84963 
16. Rfc5p 2 6.8 0.56268 1.9703 18.81694 
17. Smc1 4 3.1 0.53097 0.91059 21.08596 
18. Smc3 3 2.5 0.45512 0.65193 19.52816 
19. Tpd3 9 15.6 0.2738 0.89258 23.58646 
20. Yku80 1 1 0.01992 0.05068 24.79521 
 
Table 8. Cdc5 candidate substrates. 
Column 3 indicates the number of peptides identified corresponding to the protein in 
column 2. Column 4 is the percentage sequence coverage of the protein based on 
peptides identified in column 3. Column 5 is the ratio (H/L) of quantity of protein 
found in samples with heavy (H) or light (L) isotopes. Since the control sample was 
labeled with heavy, the ratio refers to the amount of protein found in the control 
sample divided by those found in GAL-CDC5 samples. Therefore, a lower ratio 
indicates a higher confidence in the proteins bound by Cdc5. Column 6 displays the 
ratio normalized with the median. Column 7 shows log2 of the signal intensity.  
 





1 2 - 4 SSV S[pS/pT]X 
2 117 - 119 STF S[pS/pT]X 
3 344 - 349 DITIVD [E/D]X[pS/pT][I/L/V/M]X[E/D]  
4 395 - 397 SST S[pS/pT]X 
 
Table 9. Possible Cdc5 phosphorylation and binding sites in Rfa1. 
Column 4 contains the consensus motifs: S[pS/pT]P/X for polo box binding domain 
[217], and [E/D]X[pS/pT][I/L/V/M]X[E/D] for Cdc5 phosphorylation site [216]. 
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4.3 Discussion 
It has been shown previously that Cdc5 is involved in the adaptive response in the 
budding yeast [3]. This conclusion was primarily gleaned from the behavior of the 
cdc5-ad allele in that cdc5-ad cells are largely defective in adaptation in response to 
DNA damage. Since cdc5-ad protein is normal with respect to other mitotic functions, 
it has been suggested that cdc5-ad may be a gain-of-function allele [108]. For some 
reason, cdc5-ad does not exhibit a strong phenotype in our experimental regimes (data 
not shown); therefore we have used cdc5 in our investigations described in Chapter 
3. Our results clearly show that cdc5 cells are completely defective in adaptation, 
implying that Cdc5 function is essential for adaptive response. In Chapter 4, we have 
taken a reverse approach to show that ectopic expression of Cdc5 accelerates 
adaptation. AD cells with high Cdc5 activity escape from the arrest and traverse to 
telophase in 8-10 hrs as compared to ‘normal’ AD cells (not over-expressing Cdc5) 
that take 12-14 hrs (Figure 9C). RT-PCR analysis (Figure 5) confirms that cells 
reaching telophase still contain unrepaired DSB, implying that Cdc5 overexpression 
does not cause escape from G2/M by increasing cells’ capacity to repair DSB, but by 
accelerating the adaptive response. We are aware that the experiments involving 
overexpression may, in some instances, lead to artefacts that are not valid at 
physiological concentrations of the relevant protein. However, our results show that 
ectopic expression of Cdc5 inhibits Ddc2 foci formation (Figure 14) but not the 
formation of Ddc1 foci (Figure 17). This specificity and our other observations give 
us a reasonable degree of confidence in our results. 
Cdc5 serves multiple functions in mitosis such as spindle assembly [218, 219], 
efficient cleavage of cohesin [117] and mitotic exit [85]. In mammalian cells, 
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recovery (after repair) from DNA damage checkpoint induced arrest has been shown 
to require polo-like kinase Plk1 [109-112]. Therefore, Cdc5’s contribution to 
adaptation via its mitotic function is a distinct possibility. Since cells undergoing 
recovery or adaptation need to traverse through mitosis we investigated this 
possibility by examining the recovery process in yeast. We find that RP (repairable) 
cells undergo recovery by inactivating the checkpoint, cleave cohesins, divide their 
nuclei and elongate their spindle in the absence of Cdc5 (Figure 8). These results 
strongly suggest that in the context of DNA damage, cells’ progression through 
mitosis during recovery does not require Cdc5 function. It is reasonable to expect, 
therefore, that mitotic progression during adaptation is also not dependent on Cdc5. 
Thus, we chose to look more closely at Cdc5’s role in the inactivation of the 
checkpoint signaling. 
Ectopic expression of Cdc5 is able to suppress the adaptation defect of sae2, 
ptc2 ptc3 and ckb1 mutants. Of these, Sae2 is required for disassociation of MRX 
complex from DNA damage sites [68]. Without Sae2, MRX complex remained bound 
to the damage site with persistent checkpoint activation. As a result, sae2 cells are 
unable to adapt or recover. Ptc2/Ptc3 phosphatases, on the other hand, are required for 
an event further downstream i.e. inactivation of Rad53 by dephosphorylation [107]. 
As inactivation of Rad53 by Ptc2/Ptc3 phosphatase is thought to involve CKII activity, 
it is not surprising that ckb1 is also defective in the adaptive response. The fact that 
Cdc5 overexpression corrects the adaptation defect of these mutants leads to the 
argument that Cdc5 is acting downstream of these effectors. However, our 
observation that Rad53 hyper-phosphorylation is seen very transiently in cells over-
expressing Cdc5 suggests that cells may not be able to mount a robust checkpoint 
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response in the presence of high Cdc5 activity. How, then, does Cdc5 dampen cells’ 
capacity to activate the DNA damage checkpoint? 
MRX complex and Exo1-mediated DNA resection of the 5’end is one of the 
initial events to happen in response to a double strand break and it is necessary for 
checkpoint activation. As we have seen, Cdc5 overexpression does not adversely 
affect 5’ end resection significantly (Figure 13), implying that Cdc5 does not 
participate in the adaptive response by influencing resection. It is known that loading 
of the checkpoint clamp (Rad17-Mec3-Ddc1 complex) and binding of Mec1-Ddc2 
complex to RPA-coated DNA are the most upstream events initiating the checkpoint 
signaling [75-78]. When expression of Cdc5 was induced concurrently with 
generation of a DSB, formation of Ddc2 foci was prevented. Conversely, in the 
absence of Cdc5, Ddc2 foci persisted (Figure 15), Rad53 remained hyper-
phosphorylated and cells were unable to undergo adaptation (Figure 7). These 
observations suggest that Cdc5 impedes recruitment of ‘Ddc2-Mec1’ complex to the 
DNA lesion. As a result, checkpoint signaling is not executed robustly and cells fail to 
arrest in G2/M. 
 What is the mechanism by which Cdc5 impede recruitment of Ddc2-Mec1 
complex? Since Cdc5-overexpression causes delocalization of Ddc2 during DNA 
damage, it is tempting to suggest that phosphorylation of Ddc2 by Cdc5 reduces its 
affinity for the RPA-coated ssDNA. It is also possible that Cdc5 does not inhibit Ddc2 
‘activity’ directly, but does so via a yet-to-be-identified factor X. However, such 
inhibitory schemes must take into account two additional observations: (i) adaptive 
response normally takes 10 hrs to initiate when Cdc5 is not over-expressed (ii) Cdc5 
is inhibited by activated Rad53 during DNA damage response. Three ‘bare-bone’ 
systems (Figure 18) containing functionally interacting effectors can be imagined 
Chapter 4 Polo-like kinase Cdc5 and Adaptation 
106 





Figure 18. Qualitative behaviors of networks are similar. 
Protein interaction networks of (A), (B) and (C) display similar qualitative behaviors, 
since (A) and (B) could be summarized to form the mutual inactivation network of 
Ddc2 and Cdc5 as shown in (C). (A) Cdc5 may inactivate the checkpoint through an 
unknown protein “X” or (B) directly inactivate Ddc2. The self amplifying double-
negative feedback loop of Cdc5 (B: Cdc5Ddc2Rad53Cdc5; C: 
Cdc5Ddc2Cdc5) could serve as a molecular clock to trigger adaptation after 
failed attempts to repair DNA damage during the prolonged cell cycle arrest. Dotted 
lines refer to indirect or unknown interactions; hammer heads “” refer to inhibition 
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During DNA damage (initial state), checkpoint signaling is initiated via 
recruitment of Ddc2-Mec1 complex to the site of DNA damage leading to Rad53 
activation. Activated Rad53 in turn inhibits the activity of Cdc5 [83, 126]. As our 
results show, Cdc5 continues to accumulate while cells are arrested in G2/M (Figure 
15A). Once the level of Cdc5 surpasses a critical threshold (present in a mutual 
inactivation network, see Figure 18), the system progressively switches into reverse 
gear such that Cdc5 begins to dampen the affinity of Ddc2-Mec1 complex for the 
RPA coated ssDNA. By deactivating the checkpoint protein Ddc2, more Cdc5 would 
be freed to participate in the deactivation, eventually setting up a self-amplifying 
positive feedback loop. Therefore, the prolonged period of G2/M arrest before 
adaptation could very well be the time needed for Cdc5 to reach and exceed the 
threshold level. Such a system can serve as a molecular clock which leads to 
adaptation in the absence of HR repair. These schemes also accommodate the 
requirement of CKII for adaptive response. CKII is a ubiquitous and constitutively 
active Ser/Thr protein kinase which can serve as a priming kinase for polo kinase, as 
Cdc5 binding sites have to be phosphorylated [217, 220]. According to the ‘priming 
model’, polo kinase substrate is first phosphorylated by CKII, thus creating a polo-
box binding domain. These sites in turn help to recruit polo kinase to the substrate for 
further phosphorylation. It is possible that Ddc2 is a substrate for both CKII and Cdc5. 
The schemes described above center around the functional relationship 
between Ddc2 and Cdc5. However, Ddc2 was not detected in Cdc5 
immunoprecipitates in our mass spectrometric analysis. Instead, RPA subunits Rfa1, 
Rfa2 and Rfa3 were detected (Table 8). Moreover, sequence analysis revealed a 
possible Cdc5 phosphorylation site (Table 9) in Rfa1. Although more experimental 
validation is needed, based on current data, it is possible that the switching-off of the 
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checkpoint by Cdc5 is mediated via trimeric RPA complex such that phosphorylation 
of RPA subunits by progressively accumulating Cdc5 reduces its affinity to ssDNA. 
This, in turn, will prevent recruitment of Ddc2-Mec1 complex (Figure 14). Our 
observation that ectopic expression of Cdc5 prevents Ddc2 foci formation but not 
Ddc1 foci would then suggest that while clamp loading is not affected by Cdc5, Ddc2 
recruitment is. This is consistent with the previous reports that the clamp-loading does 
not require extensive DNA resection [221] i.e. extensive RPA-coated ssDNA. This 
model also explains why checkpoint remains permanently inactivated in the 
subsequent generation of adapted cells even though they inherit a double strand break. 
In conclusion, our results are most consistent with a scheme (Figure 19) in 
which progressive accumulation of Cdc5 polo kinase during G2/M arrest allows 
phosphorylation of RPA complex, thereby disrupting its interaction with Mec1-Ddc2 
heterodimer. This eventually results in the inactivation of the checkpoint signaling 









Figure 19. A proposed scheme for Cdc5-mediated inactivation of the DNA 
damage checkpoint.  
During active DNA Damage checkpoint, Cdc5 is inhibited by Rad53. However, as the 
former continues to accumulate during G2/M arrest, once the critical threshold is 
exceeded, the mutual inactivation interaction (as shown in Figure 18) of Cdc5 and 
Rad53 further amplifies the activity of Cdc5. The active Cdc5 is able to trigger the 
dissociation of Ddc2 from RPA, probably via direct phosphorylation of RPA on RPA-
Ddc2 interaction sites. As a result, heterodimer Mec1-Ddc2 could no longer activate 
the downstream checkpoint cascades. 
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Chapter 5 Regulation of Gene Expression by 
Oscillatory Transcription Factors 
 
5.1 Background 
Oscillatory gene expression is quite widespread in cells of various types. Reported 
observations indicate this oscillatory behavior is not random but highly regulated. 
This suggests that oscillatory transcriptions are essential for normal functioning of a 
cell. This is notion is reinforced by the data from animal models and in vitro studies 
where oscillatory gene expression dynamics are either altered or eliminated.. 
Circadian oscillations are required for functional electrical responses to light in the 
mouse retina [222] and somite segmentation oscillations are required for proper 
differentiation of neuronal cells [8]. Distinct differences exist between the p53 
oscillation profiles of normal and cancer-prone Bloom’s syndrome patients [19]. Cells 
manifesting p53 oscillations may possess a lowered death threshold upon DNA 
damage [20]. Differential expression of target genes has also been reported for 
different NF-B oscillation profiles [13, 15]. The transcription factor (TF) oscillations 
allow the cell to discern and respond appropriately to diverse stimuli. Genome-wide 
oscillations of transcription in yeast and in metabolic cycles have also been suggested 
to facilitate temporal compartmentalization and coordination of biological processes 
[223-225]. 
A prerequisite to understanding mechanisms underlying oscillatory 
transcription-induced biological responses is to elucidate how oscillatory TFs induces 
oscillatory dynamics to specific gene expressions and its ensuing effects. Prior studies 
have focused on investigating mechanisms that induce TF oscillations and not their 
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effects on gene expressions. Due to the diversity of oscillatory TFs, it is desirable to 
determine in general terms their molecular properties and their target genes that shape 
the response to TF oscillations.  
In this chapter, general and analytically tractable gene expression models are 
constructed, solved and analyzed. Such mathematical models would avert the need to 
make inference from numerical simulations which requires the usage of specific 




5.2.1 Formulation of gene expression models 
A kinetic model is a mathematical representation of biological processes involving the 
concentrations of various biochemical components as functions of time. ODEs 
(ordinary differential equations) are commonly used in modeling of various forms of 
dynamical systems, mostly due to the availability of several mathematical theories 
that facilitate subsequent analytical and numerical solutions [226].  
 
Figure 20. Schematics of gene expression process. 
The gene expression process consists of transcription (vM), translation (vP) and self-
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In general, gene expression consists mainly of 3 species (transcription factor, 
mRNA and protein) and 4 processes: transcription (vM), translation (vP), degradation 
of mRNA (xM) and protein (xP), as shown in Figure 20. To formulate a kinetic model, 
an equation is assigned to each species to account for changes in its concentration 
with time in the form of an ODE. 
dt
dS = Rate of formation – Rate of removal or degradation   Eqn(1) 
 
The left-hand side (LHS) denotes rate of change of the concentration of a 
species “S”, which equals to its rate of formation minus its rate of removal on the 
right-hand side (RHS). The equations for the mRNA (M) and protein (P) in the model 
are listed in Equation 2. 





          Eqn(2) 
 
The TF oscillation profile is approximated by a sinusoidal function, which is 






2sin       Eqn(3) 
where XTF is mean level of TF intracellular concentration  
ATF is oscillation amplitude of TF intracellular concentration (< XTF) 
PTF is TF oscillation period 
 tTF  is the TF intracellular concentration with respect to time, and 
  .00 tTF  
 
To model transcription (vM), two expressions generally encapsulate the 
kinetics of gene expression regulation by a TF. In the first, the rate of transcript 
production follows mass action kinetics - an empirical law stating that transcriptional 
rates are proportional to TF intracellular concentration, denoted as Model M 
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henceforth. Therefore, the expression is given by   nMM tTFkv  , where kM is 
the rate constant of transcription, n is the stoichiometry,  is the time delay for 
transcription. 
 
The second model includes the binding co-operativity of a TF to its gene 
promoters, which is commonly captured by the Hill function [229-231], denoted as 











, where kM 
and jM are parameters that denote the maximal rate of production and the dissociation 
constant respectively, n is the Hill coefficient, and  is the time delay for product 
transcripts X that is dependent on concentration of transcription factors TF. Studies 
have suggested that the concentration of gene transcripts normally follows that of a 
sigmoidal curve (S shape) as represented by a Hill function [232-234]. 
In both models, self degradation reactions (xM and xP) are assumed to have 
first-order kinetics as expressed by Sdx MM  , where dM is the rate constant of 
degradation and S represents the species undergoing the reaction. The ODEs 
describing the kinetics of target gene transcription in Models M and H are given in 
Eqn(4) and (5) respectively. 





MM     Eqn(4) 
where M is intracellular concentration of mRNA 
 kM is rate constant of mRNA transcription 
 M is transcriptional time-delay 
 n is TF stoichiometry 
 dM is mRNA self-degradation rate 
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   Eqn(5) 
where M, kM, M, dM are as defined in Equation 1 
 jM is TF dissociation constant from its gene promoter 
n is TF binding co-operativity to its gene promoter (binding co-operativity is 
negative if n < 1 and is positive if n > 1; n = 1 indicates no binding co-
operativity. ) 
 
Finally, the ODE describing the kinetics of protein production for both models is 




PPP         Eqn(6) 
 
where P is intracellular concentration of protein 
 kP is rate of protein translation 
 P is translational time-delay 
 dP is protein self-degradation rate 
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5.2.2 Solutions of gene expression models 
5.2.2.1 Solving model M 









PPP        Eqn(6) 
 
Integrating Equation (4) with respect to t (details are given in Appendices) yields  
     tdtdnMtdM MMM eCdtetTFektM    1  
 
substituting Equation (3) yields 
















2sin    Eqn(7) 
 
Since Equation (7) is intractable, 
















2sin2sin ,  Eqn(8) 
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Put Equation (7) into Equation (6) and integrate with respect to t yields 
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As t # $,  
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Note: analytical solution is exact for n = 1. 
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  Eqn(14) 
 
Put Equation (12) into Equation (6) and integrate with respect to t yields 
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 (from Equations 4 and 5 respectively) are approximated as a 
sinusoidal wave with a mean level ignoring other higher terms, as given in Equations 
8 and 13 respectively. Thereafter, the resultant equations are solved using integration 
by parts, giving rise to Equations 11 and 15. For elegance, we encapsulate the mean 
and amplitude of  tM  into MX  / MA , and  tP  into PX  / PA  respectively.  
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5.2.3 Estimation of trends 
In the last section, the approximated analytical solutions for M and P are obtained. For 




















    Eqn(14) 
where XM / XP is mean level of mRNA/protein intracellular concentration  
AM / AP is oscillation amplitude of mRNA/protein intracellular concentration 
PM / PP is mRNA/protein oscillation period 
M / P is mRNA/protein phase-shift 
 
and each term in the equations is given below: 
For Model M: 
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  Eqn(15) 
 
For Model H: 
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Eqn(17) 
To elucidate the effects of TF oscillations, it is of interest to determine gene 
expression response resulting from various biologically plausible parameters, 
including the mean level of target gene products (XM and XP), oscillation amplitude 
(AM and AP) and phase-shift (M and P). Using standard differentiation, analytical 
solutions to each concerned parameter are obtained. Based on the equations, dynamic 
trends of gene expression are estimated (see Materials and Methods). Given those 
trends, we can determine if there is an association of the target protein mean level (XP) 
or oscillating amplitude (AP) with regards to the parameter. For instance, the trend of 
XP vs. XTF indicates that XP generally increases with XTF, thus a positive “+” 
association is assigned. Finally, the directionality of each trend is computed and 
tabulated in Table 10, wherein “*” denotes either non-monotonic or non-intuitive 
trends that will be explained in more detail in the next section (for more 
comprehensive and detailed trends, see Appendices).  
In order to ascertain the accuracy of the solutions, Model H is simulated in 
MATLAB (see Materials and Methods). For the simulation, a total of 12,960 
combinations of parameter values are selected based on biologically plausible range. 
Subsequently, results from the approximated solutions and simulations are analyzed 
and compared in Figure 21. As expected, the relative percentage error increases as 
non-linearity intensifies [for instance, compare the curves of n = 1 (red) vs. n = 8 
(gray)]. Nevertheless, more than 80% of the 12,960 values have less than 10% relative 
error (black curves). Most importantly, all the qualitative trends predicted by the 
approximated analytical solutions (Table 10) agree with computer-simulated trends. 
This validates the accuracy of the approximated analytical solutions of the models. 






TF oscillation parameters 
XTF  
(TF mean level) + * 
ATF  






(TF dissociation constant – Model H) – * 
n  
(TF co-operativity / stoichiometry) * * 
kM / kP  
(transcription / translation rate) + + 
dM / dP  
(mRNA / protein self-degradation rate) – – 
 
Table 10. Directionality of target protein trends as a function of Models M and H 
parameters 
The directionality of target protein mean level (XP) and oscillation amplitude (AP) as 
the magnitude of each parameter in column 1 is increased are tabulated; “+” indicates 
that the trend is positively associated with the parameter, i.e., the target protein trend 
increases as the parameter value is increased. “–” indicates negative association 
whereas “*” means that the trend is either non-monotonic or non-intuitive (see main 
text for details). Shaded in black denotes ‘no association’. 
 























































































































Figure 21. Quantitative comparisons between approximated analytical solutions 
and simulation results 
Numerical values of target gene transcript and protein mean level (XM and XP), 
oscillation amplitude (AM and AP) and period (PM and PP) obtained from the 
approximated analytical solutions (Equation 14) and computer simulations are 
compared for Model H. The absolute difference between the two values is expressed 
as a percentage error relative to the simulated value, represented at the horizontal axis 
of the plots. In each plot, the vertical axis indicates the percentage of the total number 
of approximated analytical solutions with difference less than the percentage relative 
error on the horizontal axis. A total of 12,960 approximated analytical solutions, 
based on 12,960 unique sets of parameter values, are compared with computer 
simulations. These sets of parameter values are generated by permutations among 
different biologically plausible parameter values spanning over a wide range.  
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The specific parameter values used in the permutations to generate 12,960 unique sets 
of parameter values are as follows: 
1. TF oscillation parameters 
a. XTF  = [0.0001, 0.001, 0.01, 0.1, 1, 10] M 
b. A*TF  = [0.1, 0.5, 0.9] 
c. PTF  = [2*60, 12*60, 24*60] min 
2. Parameters 
a. jM  = [0.01, 0.05, 0.1, 0.5, 1, 5, 10] M 
b. n  = [1, 2, 4, 8] 
c. kM  = [0.001, 0.005, 0.01, 0.05, 0.1, 0.5, 1] Mmin-1 
d. kP  = [0.001, 0.01, 0.1, 1] min-1 
e. dM and dP = [0.001, 0.005, 0.01, 0.05, 0.1, 0.5, 1] min-1 
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5.2.4 Oscillatory vs. non-oscillatory TF induction of gene expression 
Figure 22 depicts the trends of target protein mean level (XP) as a function of ATF and 
n under an oscillatory TF and a non-oscillatory TF. The consequences of TF 
oscillations on gene expression can thus be discerned by comparing the trends 
induced by an oscillatory (black) and a non-oscillatory (gray) TF. 
The trends of XP as a function of TF oscillation amplitude (ATF) for both 
models are interesting and non-intuitive (Figure 22A). In Model M, while an 
oscillatory monomeric TF does not have any effect on XP, an oscillatory polymeric TF 
(n > 1) always induce higher level of protein expression than its non-oscillatory 
counterpart. In contrast, in Model H, when there is no TF binding co-operativity to the 
gene promoter (n=1), an oscillatory TF always induced less protein than a non-
oscillatory TF. However, for positive binding co-operativity (n > 1), complex trends 
are obtained. For instance, at n=2, an oscillatory TF always induces more protein than 
a non-oscillatory TF when either TF mean level (XTF) or TF binding affinity to gene 
promoter is low (i.e. high jM), or vice versa when either XTF is high or jM is low. 
Between these two boundaries, the TF oscillation amplitude dictates the trend – at 
small ATF, an oscillatory TF induces less protein than a non-oscillatory TF. However, 
as ATF is increased, the trend is reversed. In principle, a cell could exploit the above 
complex trends generated by an oscillatory TF to induce differential gene expressions 
that could not be achieved by a non-oscillatory TF.  
 





Figure 22. Comparison of gene expression induced by an oscillatory and a non-
oscillatory TF. 
Trends of XP (protein mean level) as a function of (A) ATF (TF oscillation amplitude) 
and (B) n (M: TF stoichiometry; H: TF binding affinity to gene promoter) of Models 
M and H are depicted. Trends generated by a non-oscillatory TF are shown as gray (if 
applicable). both the oscillatory and non-oscillatory TFs have equal mean level, i.e., 
XTF. C is given as kMkP / (dMdP).  
n > 1 
XP
XP




n = 2, 3, 
XP
XP





XP vs. ATFModel HModel M








XTF – ATF < jtM < XTF + ATF
XTF – ATF > jtMC
½




XTF + ATF < 1 
C
XP XTF – ATF > 1
XTF  ATF < 1  or  XTF + ATF > 1 









Chapter 5 Regulation of Gene Expression by Oscillatory Transcription Factors 
126 
Given that n is a key parameter conferring complexity of the trends above, the 
trends of XP as a function of n are no less non-intuitive (Figure 22B). Two general 
trends are observed as n is increased under oscillatory and non-oscillatory TF for both 
models: XP increases if XTF is relatively high but decreases if XTF is relatively low. 
However, if XTF is intermediate, oscillatory TF produces additional XP trends as n is 
increased. Specifically, a parabolic trend is observed for Model M whereas four trends 
are possible for Model H (Figure 22B). 
Remarkably, the expression fold-difference between a protein induced by an 
oscillatory TF and its non-oscillatory counterpart is significant. As an illustration, two 
arbitrary sets of biologically plausible kinetic parameters are chosen for Model H 
computer simulation. Using the first set, an oscillatory TF always expressed more 
protein than the non-oscillatory TF (for n > 2) while the reverse is observed using the 
second set. As shown in Figure 23A, the fold difference gets even more considerable 
as n is increased for both sets (for Model M simulation results, see Figure 23B).  
 




Figure 23. Fold difference between proteins expressed by an oscillatory to a non-
oscillatory TF. 
(A) For Model H, fold difference between proteins expressed by an oscillatory to a 
non-oscillatory TF at different TF binding co-operativity, n are obtained from 
computer simulations. Parameter values used to generate the representative plot on the 
left are: XTF = 0.015 M, A*TF = 0.9, PTF = 2 hrs, kM = 0.01 M/min, jM = 0.05 M, kP 
= 0.01 min-1 and dM = dP = 0.01 min-1. Parameter values used to generate the 
representative plot on the right are identical to the left plot except XTF = 0.65 M and 
jM = 0.5 M.  
(B) For Model M simulations, fold difference at different TF stoichiometry are 
obtained. Parameter values used to generate the plot are: XTF = 0.0001 M, A*TF = 0.9, 
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Specifically for gene whose expression dynamics resemble Hill kinetics 
(Model H), TF oscillations offer a mechanism for differential expression of target 
genes. As an illustration, consider three genes G1, G2 and G3 regulated by an 
oscillatory TF with positive binding co-operativity say n = 4. For simplicity, the 
model parameter values of each gene are identical except TF dissociation constant 
from gene promoter (jM). Values of jM are chosen so that the trend of XP (protein mean 
level) vs. ATF (TF oscillation amplitude) is distinct for each gene, as shown in Figure 
24 (see inset). For each gene, the amount of proteins expressed by a non-oscillatory 
(gray) and oscillatory (black) TF are compared (Figure 24A). In the presence of TF 
oscillations, G1 is down-regulated by 30%, G2 is unaffected and G3 is up-regulated 
by 2.5 folds, relative to their respective level induced by a non-oscillatory TF. On the 
other hand, TF mean level could also influence the XP vs. ATF trend. Indeed, other 
patterns of differential gene expressions are observed by altering the TF mean level, 
as depicted in Figure 24B and Figure 24C. In contrast, in the absence of TF 
oscillations, none of the differential regulation of gene expression can be achieved. 
However, if the transcription kinetics follows Model M, differential gene expression 
by oscillatory TF is not possible since an oscillatory polymeric TF always induces 
more proteins than its non-oscillatory counterpart. 








































































































































































































































Figure 24. Differential gene expression. 
Time-courses of the protein levels of three representative target genes (G1, G2 and G3) 
induced by a non-oscillatory (gray) and oscillatory (black) TF via computer 
simulations of Model H. G1, G2 and G3 differ by their TF dissociation constants (jM) 
whose values are 0.3, 0.53 and 1 M, respectively. (A) XTF = 0.5 M (B) XTF = 0.94 
M (C) XTF = 0.28 M. The remaining parameter values are set to be: ATF* = 0.9, PTF 
= 90 min, n = 4, kM = 0.1 M/min, kP = 0.01 min-1 and dM = dP = 0.01 min-1. Inset: 
trend of XP vs. ATF of each target gene; trends generated from a non-oscillatory and 
oscillatory TF are depicted in gray and black, respectively; the broken vertical line 
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5.3 Discussion 
Oscillating transcription factors (TFs) are observed in myriad biological processes, 
including circadian cycle, cell cycle and yeast glucose metabolism etc (see Table 1). 
Notably, insights obtained from studies on NF-B and p53 showed different 
oscillating dynamics leading to differential gene expression [13], and distinct p53 
profiles correlating with specific phenotypic response [19]. However, the underlying 
mechanism is.not well understood 
In this chapter, we have formulated two mathematical models which could 
generally represent the response of gene expression with oscillating TFs. To explore 
the effects of oscillating TFs, we decided to include transcription, translation and 
degradation processes only. Other forms of regulation such as repressor and DNA 
enhancers are not considered as we wish to explore the effects emanating from a basic 
gene expression process. Moreover, it may dilute the significance of each individual 
molecular property in later analysis.  
We decided to solve the model analytically since the solutions could provide 
more insights than simulations alone. Furthermore, this approach averts the need to 
employ specific model parameter values, but yet can reveal all plausible responses. In 
addition, it facilitates a subsequent study (which is still in progress) designed to 
investigate the propagation of oscillation amplitudes in (prevalent) TF cascades, 
which would require consideration of time-associated factors such as TF periodicity 
and transcriptional/translational time-delays etc. The choice of using ODEs is 
attractive since it facilitates derivation of analytical solutions, which would be 
challenging, if not, impossible for stochastic approaches.  
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In general, the rate of transcription follows either mass action kinetics (model 
M) or Hill type function (model H). The mass action kinetics is an empirical ‘law’ 
generally followed by a chemical species in a biochemical reaction. On the other hand, 
studies have shown that gene transcription could follow a sigmoidal curve function 
[232-234], especially when the system exhibits binding co-operativity. For instance, 
TFs are often composed of multiple subunits. A single subunit usually can activate 
transcription, while full activation requires all subunits. In addition, a sinusoidal wave 
is used to represent the shape of oscillating TFs to facilitate subsequent manipulation 
which is a common approach [227, 228]. In order to derive tractable solutions, the 
transcriptional response is approximated to be a sinusoidal wave. Numerical 
simulations are conducted to show that the error between our approximation and 
simulation is marginal (Figure 21). We reasoned that the difference would be 
insignificant especially when the primary interest is to determine the qualitative 
response. By analyzing the solutions with differentiation, the trends of gene 
expression response are estimated due to changes from individual system parameters, 
and tabulated a summary of their associations (Table 10). 
The estimated trends yield interesting yet non-intuitive results. For a 
polymeric TF (n > 1) that follows mass action kinetics (model M), for the same mean 
concentration of TF molecules (XTF), oscillating TFs tend to express more proteins 
than non-oscillating counterparts. On the other hand, for TFs with Hill type kinetics 
(model H) and positive co-operativity (n > 1), the amount of proteins expressed by 
oscillating TFs could differ from non-varying TFs. Furthermore, such TFs displayed 
non-monotonic trends dependent on its oscillating amplitude and dissociation constant. 
These features could be exploited to differentially regulate specific genes. As shown 
in Figure 24A, suppose a system with non-varying TFs could express three genes, 
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namely G1, G2 and G3. By oscillating, G1 is down-regulated, G3 is up-regulated 
while expression of G2 is unchanged.  
What could be the reason underlying the effect of oscillatory TF on its target 
gene expression? Recall that for TFs with positive cooperativity, the transcription rate 
function (used for converting TF concentration to transcription rate) is a sigmoidal (S 
shape) curve which can be approximately divided into three regions of operation: for 
low TF concentration, the transcription rate increases gradually; for medium TF 
concentration, the transcription rate gradient is steep; for high TF concentration, the 
gradient is gradual as it approaches saturation. Suppose that the mean level of a TF is 
between low and medium concentration. If the TF is non-oscillating, based on the 
transcription rate function, the mean TF concentration would be converted to a 
constant transcription rate. However, if the TF is oscillating, the crest cycles will be 
operating in the steep gradient region, and the trough cycles will be in the gradual 
gradient region. Since in the steep gradient region, the TF concentration will be 
converted to a higher transcription rate relative to the gradual gradient region, the nett 
effect will be a higher mean TF transcription rate than the non-oscillating TF. 
Therefore, oscillatory TFs would express a higher mean protein levels. On the other 
hand, if the mean concentration of an oscillating TF is between medium and high, the 
crest cycles will be in the gradual region, and the trough cycles in the steep region. As 
a result, the nett mean TF transcription rate will be lower than that of a constant TF. 
Binding affinity (1/jM) affects the concentration of TF to be bound at a gene promoter. 
Therefore, different genes (with different binding affinity to its promoter) would 
respond differently when TFs oscillates (see inset in Figure 24A). 
Possible consequences of TF oscillations on regulation of cellular processes 
can be envisaged using p53 as an example. Because p53 target genes impinge on 
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various key biological functions (such as cell cycle arrest, DNA damage repair and 
apoptosis see Table 4), it is beneficial or even obligatory to selectively up-regulate 
genes involved in specific functions in response to prevailing cellular condition. 
Assuming that there is no feedback mechanism in a TF system, say p53, without 
oscillations, however, augmenting the levels of the TF would lead to non-selective up-
regulation of all target genes. In particular, p53 has a larger dissociation constant for 
binding promoters associated with apoptotic genes than with cell cycle arrest genes 
[235]; this means that p53 induces less apoptotic transcripts compared to cell cycle 
arrest transcripts. In the same manner as illustrated in Figure 24A, by exhibiting 
oscillations, p53 could selectively up-regulate apoptotic genes (analogous to G3) but 
not other genes (analogous to G1 and G2) upon irreparable DNA damage, and thereby 
tip the cell towards death [20]. The TF dissociation constant of G3 promoter is largest 
among G1, G2 and G3.  
Taken together, these analyses and results revealed an interesting ability of an 
oscillatory gene expression process to elicit differential gene expression. This ability 
appears to be intrinsic to the process, but mostly restricted to Hill type TFs with 
appropriate molecular properties. Since molecular properties such as reaction rates do 
not vary, thus by oscillating, the TFs alone could selectively up-regulate or down-
regulate different genes. If not by oscillation, differential gene expression probably 
requires additional form of regulation involving other entities, e.g. residue specific 
phosphorylation of TFs requires certain kinases, or other forms of transcriptional 
control such as chromatin modification or transcriptional repression etc. We speculate 
that this feature might be exploited in the p53 system since the normal level of p53 is 
constant. Upon DNA damage, it starts to oscillate and concurrently, respond by either 
inducing pro-apoptotic or DNA repair genes. Nevertheless, this study suggests that 
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switching between constant and oscillating levels could provide TFs another layer of 
specificity over its target genes. 
Given that multiple target genes, which impinge on myriad cellular processes, 
are common among the reported oscillatory TFs reported (Table 2/4), oscillatory TF 
mediated differential gene expression could be a general mechanism to specifically 
regulate cellular processes.
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Chapter 6 Perspective and future directions 
 
6.1 Role of Cdc5 in Adaptation 
Detection of DNA damage, checkpoint activation, onset of repair processes, turning-
off of checkpoint signaling after the offending lesion has been repaired and recovery 
from cell cycle arrest are all parts of the greater cellular scheme that maintain the 
integrity of the genetic heritage of a cell during cell division. Checkpoint-induced cell 
cycle arrest is an important part of this system which would provide cells sufficient 
time for the repair machinery to complete its task before chromosome-segregation 
apparatus gets activated. In the event that repair machinery fails to repair the damage, 
cells maintain G2/M arrest for a prolonged period but not indefinitely; eventually they 
switch to “get on with life” mode and progress through mitosis with the unrepaired 
DNA lesion. This diversion is called adaptation. First described in budding yeast [1-3], 
adaptation has also been shown to occur in Xenopus [4] and human cells [5] in 
response to replication stress and DNA damage, respectively. 
At one level, both recovery (mitosis after repair) and adaptation (mitosis 
without repair) can be considered as processes that bring cells from a ‘high alert state’ 
(damage-checkpoint-repair) to the ‘ground state’ so that cell cycle progression can 
resume. Both recovery and adaptation require switching-off of the checkpoint control 
so that inhibition on mitotic progression can be lifted; however the outcomes of the 
two processes are very different. While cells undergoing recovery have repaired the 
DNA damage and undergo subsequent divisions with a very high survival rate, cells 
undergoing adaptation progress through mitosis with unrepaired DNA lesions and 
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have a very low rate of survival. How checkpoint signaling is turned off during 
recovery and adaptation has been under investigation for a few years now.  
In the case of recovery, the answer may lie in the manner in which DNA 
damage checkpoint is activated. Generation of single stranded DNA by resection of 
5’end of a double strand break via action of MRX complex and ExoI is necessary for 
the activation of the checkpoint. The ssDNA thus created is bound by RPA and helps 
in the recruitment of Ddc2-Mec1 complex. This is followed by the recruitment of 
Rad9 and phosphorylation of Chk1 and Rad53. It is easy to envision that with the 
completion of the repair process, ssDNA would disappear and consequently, the 
upstream checkpoint signaling would progressively cease. The effectors, already in 
the active state, can be inactivated by corresponding inhibitors to bring the entire 
system to the ground state and to relieve the inhibition on mitosis. One example of 
such reversal is the inactivation of active-Rad53 by Ptc2/Ptc3-mediated 
dephosphorylation [107]. Thus, repair-driven turning-off of the upstream checkpoint-
signaling may not require additional regulation. 
Extinguishing checkpoint control during adaptation poses a different problem. 
Since the DNA lesion is constantly present in cells that are unable to repair it, the 
conditions for checkpoint activation, are, in principle, always present for sustained 
signaling. In such a scenario, cells have to either become ‘desensitized/resistant’ to 
the checkpoint signaling or use an alternative way of extinguishing the checkpoint 
control. In this study, we have attempted to investigate the mechanism by which cells 
switch-off checkpoint signaling during adaptation. A number of genes have been 
reported previously to be necessary for adaptive response in budding yeast, namely, 
YKU70, YKU80, PTC2, PTC3, SAE2, TID1, CKB1, CKB2 and CDC5 polo kinase. Of 
these Sae2, Tid1, Ptc2 and Ptc3 are required for both recovery and adaptation [107]. 
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Some of the previous studies used dephosphorylation of Rad53 as an indicator of 
cessation of checkpoint control [2] and found that the Ptc2/Ptc3 phosphatases mediate 
adaptation by inactivating Rad53 via dephosphorylation [107]. In the present study, 
we have specifically focused on the role of Cdc5. 
The use of the telophase trap provided us with a means to quantify the 
adaptive response as well as to study the temporal dynamics of the adaptive response. 
Since cdc5-ad mutation does not show a strong defect in the adaptive response in our 
experimental set up (data not shown), we have resorted to using cdc5 cells. This 
allowed us to uncover that Cdc5 function is not required for recovery but is essential 
for adaptive response. That CDC5-deficient RP cells proceed to dephosphorylate 
Rad53 during recovery, suggested that requirement of Cdc5 in adaptive response is 
not, directly or indirectly, for Rad53 dephosphorylation. Our finding that ectopic 
expression of Cdc5 accelerates adaptive process provided us an opportunity to scan 
for ‘sub-events’ that correspondingly accelerated due to Cdc5 overexpression. The 
following observations were important in linking Cdc5 to Ddc2 foci formation: (i) 
overexpression of Cdc5 accelerated both adaptation and disappearance of Ddc2 foci 
(ii) Ddc2 foci persisted throughout the course of the experiment in the absence of 
Cdc5 (no adaptation) (iii) overexpression of Cdc5 can diminish the number of 
already-formed Ddc2 foci. The fact that ectopic expression of Cdc5 does not perturb 
Ddc1 (checkpoint clamp component) foci, suggests that the effect on Ddc2 foci is 
specific and most likely not a spurious effect of Cdc5 overexpression. It has been 
shown previously [74] that Ddc2 foci, but not Ddc1, disappear during normal adaptive 
response. However, their accelerated disappearance due to Cdc5 over-activity implies 
that this effect is functionally (directly or indirectly) associated with Cdc5 activity.  
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We also find that ectopic expression of Cdc5 is able to suppress the adaptation 
defect of sae2, ptc2 ptc3, and ckb1 mutants. We have argued in Chapter 4 that 
this suppression suggests Cdc5 to be the rate determining factor in the adaptive 
response. However, it has been reported that overexpression of Ptc2 can suppress the 
adaptation defect of cdc5-ad mutant [107]. Even though in this report [107], cells’ 
capacity to rebud was taken as the criterion for suppression, unlike our study where 
transition through anaphase was the main criterion, our own conclusion about Cdc5 
being a rate limiting factor should be taken with caution. Nevertheless, taken together 
with our other observations, Cdc5 appears to be acting upstream of other facilitators 
of adaptive response. 
How does Cdc5 polo kinase interfere with Ddc2 foci formation or recruitment 
of Ddc2-Mec1complex to the DNA damage site? One possibility is that Ddc2 is a 
direct substrate of Cdc5 and this phosphorylation of Ddc2 either reduces its affinity 
for Mec1 or binding to RPA-coated ssDNA. However, examination of Ddc2 amino 
acid sequence did not reveal any Cdc5 phosphorylation site, tentatively suggesting 
that Ddc2 may not be a direct substrate of Cdc5 polo kinase. Our mass-spectrometric 
analysis indicated RPA subunits Rfa1, Rfa2 and Rfa3 as proteins present in the Cdc5 
immunoprecipitates. Of these, Rfa1 does indeed contain a consensus Cdc5 
phosphorylation site. It is therefore possible that Cdc5 phosphorylates RPA and 
compromises its affinity to bind the ssDNA. This, in turn, can affect the recruitment 
of Ddc2-Mec1 complex to the site of DNA damage, thereby dampening the 
checkpoint signaling. 
It is known that Rad53, activated in response to DNA damage, inhibits the 
activity of Cdc5 polo kinase ([83, 126] and our unpublished observations). Since 
Cdc5 is an essential component of the mitotic exit network (MEN), this observation is 
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interpreted as checkpoint control’s attempt to prevent mitotic exit. In the present 
context, we suggest that Cdc5 plays an important role in turning off the checkpoint 
signaling during adaptive response. This notion demands that Rad53 inhibition of 
Cdc5 progressively erodes during G2/M arrest to allow sufficient accumulation of 
Cdc5 protein to initiate adaptation. It is possible that progressive erosion of Rad53-
imposed inhibition over time releases sufficient amount of Cdc5 to initiate a positive-
feedback loop such that increasing activity of Cdc5 causes increasing dampening of 
the checkpoint control and, eventually, an escape from G2/M arrest. What, then, 
causes the progressive erosion of Rad53-imposed Cdc5 inhibition during prolonged 
G2/M arrest? This could be accomplished by either a slow degradation of active 
Rad53 or a slow but continuous action of Ptc2, Ptc3 phosphatases during the extended 
G2/M arrest. Further investigations are clearly required to resolve this issue. 
The role of Ptc2, Ptc3 and CKII in adaptive response can be explained in 
terms of their involvement in Rad53 inactivation. As mentioned above, Ptc2 and Ptc3 
are known to dephosphorylate the active Rad53. CKII phosphorylates Ptc2 and 
increases its interaction with Rad53 [107]. Similarly, the adaptation defect of sae2 
can be explained in terms of sustained presence of MRX complex at the unrepaired 
DSB, which results in sustained checkpoint signaling. However, what possible roles 
Yku70 and Yku80 might play in adaptation is not clear at the moment. Double strand 
breaks in budding yeast are predominantly repaired by HR repair system [88-90]. By 
some estimates 70% of the DSB repairs are carried out by HR while ~30% are 
repaired by nonhomologous end joining (NHEJ) pathway. The involvement of Ku 
complex subunits may not occur through DSB repair during prolonged arrest because 
adapted cells go through mitosis with unrepaired DNA lesion. It has been suggested 
that the adaptation defect in yku70 cells is due to increased 5’-3’ resection of the 
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unrepaired DSB since Mre11 deficiency suppresses the adaptation defect of yku70 
mutant. However, an understanding of the exact role of Ku complex in adaptive 
response will require further work. 
What advantage could the adaptive response possibly provide to a unicellular 
organism like budding yeast? As discussed earlier, it might offer cells an opportunity 
to repair DNA damage in the subsequent cell cycle, thereby increasing their chances 
of survival. However, this is at the risk of genomic instability which may also affect 
subsequent generations. It can also be argued that some of the DNA lesions may be 
repaired by error prone repair system which will alter the genetic information but may 
also help to increase the genetic diversity in small measures. In mammalian cells, 
entry into mitosis with unrepaired DNA lesions during adaptive response may 
enhance the chances of defective cells to undergo apoptosis thereby reducing the 
number of defective cells in a tissue.  
 
Future Directions 
Much remains to be done in order to achieve a full understanding of the mechanism 
underlying the adaptive response. Our mass spectrometric analysis together with other 
results suggests that Cdc5 polo kinase’s participation in adaptation may occur through 
trimeric RPA complex. In order to test this hypothesis, it is imperative to investigate 
the following:  
(i) Can any of the RPA subunits serve as a substrate for Cdc5 in vitro? 
(ii) Is phosphorylation status of RPA subunits altered during adaptive response? 
(iii) Is ectopic expression of Cdc5 accompanied by increased phosphorylation 
of RPA subunits? 
Chapter 6 Perspective and future directions 
141 
(iv) Identification of the Cdc5 phosphorylation sites in RPA subunits. 
(v) Does Cdc5 phosphorylated RPA subunits exhibit low affinity for ssDNA? 
(vi) Do mutations in Cdc5 phosphorylation sites in RPA subunits lead to 
predicted behavior? 
The double-negative feedback loop leading to increased activity of Cdc5 is an 
essential feature of the scheme we have proposed for amplification of the Cdc5-
imposed suppression of the checkpoint signaling. Therefore it will be important to test 
if there is progressive erosion of Rad53 activity and concomitant increase in Cdc5 
activity during the prolonged G2/M arrest. It will serve well to explore if the 
progressive erosion of Rad53 activity is due to specific factors or due to the innate 
fluctuation built into the checkpoint control network. During DNA damage, 
checkpoint activation is accompanied by post-translational modification of proteins 
not directly downstream of Mec1-Ddc2 such as modifications of histones or proteins 
involved in resection reactions. It might be productive to investigate the status of 
these proteins during adaptive response and their importance in determining the 
dynamics of adaptation. 
6.2 Oscillating Transcription Factors 
Studies have revealed diverse biological processes with oscillating TFs: in circadian 
clock for normal physiological functions [222], in somite segmentation during 
developmental stage [8], in p53 tumor suppression [20], as p53 displayed different 
oscillation profiles in tissues from normal and cancer patients [19] and for proper 
metabolism and coordination of biological processes as reported in yeast [223-225]. 
Together, these studies indicate that oscillating gene expressions are regulated 
biological processes. 
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Prior studies have reported that NF-B display distinct oscillatory dynamics 
upon stimulation by different ligands, such as TNF or LPS (see Table 4). Similarly, 
p53 displayed oscillatory expression after DNA damage induction. As a consequence 
of NF-B and p53 oscillations, different genes are expressed [13, 20, 171]. It is 
suggested that these oscillations are caused by feedback loops in the system [20, 130, 
236-238]. However, the mechanism underlying the causal relationship of oscillatory 
TFs and differential gene-expression response is not well understood. 
Most transcript productions follow the mass action or Hill kinetics; therefore 
results from our models should encompass behaviors from most TFs. In both models, 
the analyses showed non-intuitive results. Surprisingly, protein production from 
oscillatory TFs could differ from non-varying TFs, even if the mean number of TF 
molecules over a certain period is the same. Especially in model M, oscillatory TFs 
often exhibit higher efficiency in protein productions. On the other hand, model H 
displayed more non-monotonic response trends. These trends are dependent mainly 
on: (i) binding co-operativity (n), (ii) dissociation constant (jM) and (iii) oscillation 
amplitude (ATF). Whether a TF demonstrates positive binding co-operativity or not is 
mostly intrinsic depending on the system; for example, number of subunits in a TF or 
binding sites on promoters. While dissociation constant, which indicates binding 
affinity inversely, of a TF to its promoters could vary, e.g. by phosphorylation of TFs, 
these post-translational modifications often requires other entities, for instance 
phosphorylation of p53 (Ser46) requires p53DINP1 (p53-dependent damage-inducible 
nuclear protein 1) as a co-factor [239, 240] so as to express an apoptotic gene 
p53AIP1 (p53-regulated apoptosis-inducing protein-1). Thus, by oscillating, i.e. 
varying its ATF, TFs alone could have different effects on its target genes, subjected to 
other properties (i) and (ii). This is another layer of dynamic and specific control for 
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TFs that can alter the gene expression response due to input changes. Together, the 
analyses presented here reveal interesting features that may be inherent in the 
dynamics of gene-expression process. 
 
Future Directions 
A mathematical model is an abstract representation of the biological system. It is 
often built according to the questions at hand, and is often not intended to be an in 
silico cell. Hence, assumptions are mostly made to facilitate the analysis. The 
following paragraphs aim to extend the study, making it more applicable to a wider 
range of TFs. 
The basic gene expression process that is modeled here could represent most 
protein production. To be applicable to more TFs, the analyses and results should be 
extended to include other forms of gene regulation, including gene repressors, and co-
activators etc. It would be interesting to understand how the additional layer of 
regulation shapes the response-trends or whether the addition of co-activators/-co-
repressors can render the trend of TF response in model M non-monotonic. In this 
study, the input TF signal is represented by a sinusoidal function. It would be 
insightful to examine the trends of response due to different form of TF signals, such 
as damped or sustained oscillations, and sharp pulses. However, it should be noted 
that addition of more details often results in an increased complexity for the system, 
rendering analytical solutions intractable. Nevertheless, it is a possible extension for 
this work. 
We have employed kinetic differential equations for this investigation. It is a 
deterministic approach which assumes a large quantity of each reactant in the process, 
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thus they can be modeled as continuous entities. On the other hand, when modeling 
biochemical entities, discrete or random fluctuations that might affect reaction-
response can be accounted for [241]. These effects may become significant as the 
levels of reactants in a system become smaller. To be applicable to TFs with low 
abundunce, the gene expression model should be subjected to stochastic analysis. 
Since the model is manageable, the process can be simulated using the Gillespie 
algorithm [242]. Therefore, it would be interesting to determine if similar behaviors 
and trends could be predicted in the stochastic simulation. 
Although the analyses revealed a possible mechanism for differential gene 
expression, as exhibited by NF-B or p53, it is not known whether a biological cell 
can utilize such a mechanism. Therefore, an experimental validation is essential. One 
possible approach is to construct a synthetic oscillating TF, such as those reported 
previously [243, 244], and compare the quantities of gene products with those from 
non-varying TF. The alternative method is to make use of endogenous TFs such as 
NF-B or p53, and measure the expression of its downstream target gene before and 
after oscillation. Such experiments would definitely help us gain better understanding 
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XTF – ATF > jtMC
½C
XTF + ATF < jtM
XP












XTF + ATF < 1
C
XP XTF – ATF > 1















Increasing XTF or decreasing jM
n = 3, 4
XP
XP
XTF XTF XTF XTF
Increasing XTF or decreasing jM
n = 1
C XP / XP
Figure S1A.  Trends of target protein mean level as a function of parameters in 
Models M and H 
For each plot, the vertical axis represents the protein mean level that is either induced by 
an oscillatory TF (denoted as XP) or a non-oscillatory TF (denoted as XP); the level of a 
non-oscillatory TF is set to be equal to the mean level of the oscillatory TF.  Where 
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applicable, XP trends are shown in gray.  The horizontal axis represents the varied 
parameter as indicated in column 1.  Blue curves signify possible trends under the same 







Identical to Model H













n = 2n = 1
ATF
C
n = 3 , 4
C
ATF











































































XTF  ATF < jM < XTF + ATF










XTF + ATF < 1




Figure S1B.  Trends of target protein amplitude and normalized amplitude as a 
function of parameters in Models M and H
For each plot, the vertical axis represents the protein oscillation amplitude (AP) or 
normalized oscillation amplitude (A*P).  The horizontal axis represents the varied 
parameter as indicated in column 1.  Blue curves signify possible trends under the same 
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condition.  C is given as 





 unless otherwise stated where wTF is TF 
oscillation frequency defined as 2/PTF.
7.2 Solution of Model M and H 
7.2.1 Model H: Transcription is modeled with Hill-type kinetics 
      00: --- PMM tPtMtTFIC 






























































































































































































































































Note: XTF  ATF. XTF signifies the mean of the oscillation; ATF signifies the amplitude of the oscillation; PTF
signifies the period of the oscillation. 















































































To solve the integral analytically, we need to approximate the denominator to a tractable form. Since the 
aim is to study the amplitude of oscillations, the approximated form needs to retain the same amplitude, 
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7.2.2 Model M: Transcription is modeled with Mass Action kinetics 
Solve M(t) 
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proven in earlier section that: 























































































































































































































































































































































































































































7.3 Model M: Estimation of Trends 
A. Oscillation mean of target gene 
    





















































Effect of TF oscillation period, (PTF = 2/wTF)
Same trend as Hill-type case. 
Effect of stoichiometry of TF, n
        






































When n = 0, XM = k1 / dM.










1 – ATF < XTF < 1 + ATF :  











X  < 0. 
































  Note: TFTFTF AAA -- 111
2 .
XTF < 1 – ATF 
k1 / dM
XM





























































When n = 0, XM = k1 / dM.   




X M , XM   as n  .




X M , XM  0 as n  .
Effect of TF oscillation amplitude, ATF
    









































































































































n = 1 
XM
XM





























Effect of TF oscillation mean, XTF
    









































When .0,0 ## MTF XX

































Effect of rates of transcription (k1) and translation (k2)
Same trend as Hill-type case. 
Effect of degradation rates of mRNA (dM) and protein (dP)
Same trend as Hill-type case. 
B. Oscillation amplitude of target gene 
    











































Effect of TF oscillation period, (PTF = 2/wTF)
Same trend as Hill-type case. 
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XTF < 1  ATF









XTF < 0.5 
Effect of stoichiometry of TF, n
        














































A > 0. 







A < 0. 
As n  , AM  0.








































4 > 0.  
1 – ATF < XTF < 1 + ATF : As n  , AM  .
















Effect of TF oscillation amplitude, ATF
    
















































When ATF = 0, AM = 0.


























n = 1 
n = 2 
n = 4 
ATF 
ATF < 0.5 
n = 1 
n = 2 
n = 4 
ATF
ATF > 0.5 









Effect of TF oscillation mean, XTF
    





























































When XTF  , AM  .

































































Effect of rates of transcription (k1) and translation (k2)
Same trend as Hill-type case. 
Effect of degradation rates of mRNA (dM) and protein (dP)
Same trend as Hill-type case. 
C. Normalized oscillation amplitude of target gene 
   
   
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n > 1 
n = 1 
Note: as    
   
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Effect of TF oscillation period, (PTF = 2/wTF)
Same trend as Hill-type case. 
Effect of stoichiometry of TF, n
      
    
           

































































When n = 0, A*AM = 0.










Effect of TF oscillation amplitude, ATF
 
    
       

































































































A  as ATF  XTF. No valid non-trivial point of inflexion exists. 







4 = 0 as ATF  XTF. No other valid non-trivial point of inflexion exists. 
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Effect of TF oscillation mean, XTF
 
    
       







































































When XTF  , A*M  0.







4 > 0. 







4 < 0 as XTF  ATF.







4 = 0 as XTF  ATF.
Effect of rates of transcription (k1) and translation (k2)
Same trend as Hill-type case. 
Effect of degradation rates of mRNA (dM) and protein (dP)
Same trend as Hill-type case. 
D. Oscillation period of target gene 





























 n > 2 
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Same trend as Hill-type case. 
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7.4 Model H : Estimation of Trends 

























Effect of T.A. oscillation period, (Pa = 2/wa)
NA. 
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Note: when j1 = 0, Xm = Xm = k1/k4, Xp = Xp = (k2/k5)Xm; as j1  $, Xm, Xp, Xm, Xp  0. 
(independent on T.A. oscillations!)












4  > 0. 

















































































Matlab: 2 points of inflexion are observed.















































































































4  increases from a negative to a 
positive value. Note: for the purpose of illustration, graphs of Xm and Xm are shown as identical 
curves. While the trends are qualitatively similar, their respective non-stationary points of inflexion 





















































Effect of binding cooperativity between T.F. and DNA enhancer site, n
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AX aa  have opposite signs, i.e., Xa  Aa < j1 < Xa + Aa.









4 < 0. Note: when j1 = Xa  Aa, as n  $, Xm  0.75(k1/k4);
when j1 < Xa  Aa, as n  $, Xm  k1/k4.
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X  < 0 if   TFTFTFTF AXAXj ,1 .
Note:    TFTFTFTFTFTFTFTF AXAXAXAX --  is always true. 









4 > 0. Note: when j1 = Xa + Aa, as n  $, Xm  0.25(k1/k4);


















j1 = Xa + Aa





j1 < Xa  Aa













  TFTFTFTFtM AXAXj -













































































































































































j1 < Xa: n
X m
4





4  < 0; as n  $, Xm  k1/k4.
j1 = Xa: n
X m
4





4  = 0; as n  $, Xm  0.5(k1/k4).
j1 > Xa: n
X m
4





4  > 0; as n  $, Xm  0.
Effect of T.A. oscillation amplitude, Aa





       
  
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4  = 0, i.e., 
      2 3      04 1121111122   naanaannanaanaanaa AXAXjjAAXAXAX .
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4 < 0). 



































4 < 0. 
n = 2: turning points are Aa = 0 and solutions of 
     032 22122122214  aaaaa XjXjAXjA . For a valid solution (i.e., 0  Aa < Xa), j12 
< 3Xa2 which gives   22114
122
1 2 aaa XjXXjA   (minimum); Aa = 0 is a 
maximum point. However, if j12 5 3Xa2, only one turning point exists at Aa = 0
(minimum). 
























4  > 0. 


















































































































































Hurwitz determinants: {1, + (j13 > 2XTF3) / – (j13 < 2XTF3), 0} and {1, 0}. 









X  < 0. Thus, ATF = 0 is a maximum point. 















































































































































































 < 0 if j13 < 
16XTF3.
n = 4: turning points are Aa = 0 and solutions of 
        0523653721127 1041681228141464414264148210  aaaaaaaaaaaaaa XjXjXAjjXXAjXXAjXAXA
. The maximum possible number of real and positive values of Aa that satisfy the latter 
expression is determined using Routh-Hurwitz determinants (refer to Supplemental 
Data). The maximum number of positive turning points is bifurcated at j14 = 5/3Xa4, i.e., 
four turning points if j14 < 5/3Xa4 and three turning points if j14 > 5/3Xa4. However, 
because of the complexity of the algebraic expression, the condition Aa < Xa can be 
checked only when numerical values of Xa and j1 are supplied. Nevertheless, the results 















































































































































































































4  > 0. 





























XM can intersect XM at 2 to 3 positive non-trivial points given by 
  010654 62412441426  TFTFTFTFTFTFTF XXjAXjAXA ; 2 positive roots if j14 > 1/3XTF4
whereas 3 positive roots if j14 < 1/3XTF4. However, the validity of these points can only 

















 < 0 if j14 < 80/3Xa4.
Maple: did not obtain > 1 valid turning points; at most 1 valid turning point is obtained. 
Matlab: at most 1 valid turning point is observed.
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  
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 ; as Xa  $, Xm  k1/k4 (note: independent on T.A. 
oscillation!)
 







































































As Xa  0, Xm  0; as Xa  $, Xm  k1/k4.














4 < 0 for n  1. 





































































































































4  decreases from a positive to 
a negative value. Note: for the purpose of illustration, graphs of Xm and Xm are shown as identical 
curves. While the trends are qualitatively similar, their respective non-stationary points of 




































































































Effect of rates of transcription (k1) and translation (k2)
Effect of degradation rates of mRNA (k4) and protein (k5)
B. Oscillation amplitude of target gene 
k1
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A  < 0. 















A  > 0 (minimum point). 















A  = 0 (stationary point of inflexion). 





















































































































































































8, 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8,  ,,, .
jI
AM
  TFTFTFTF AXAX 
n = 1 
n = 2 
n = 4 
n = 8 
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Note: when j1 = 0, Am, Ap = 0; as j1 $, Am, Ap 0. 
Effect of binding cooperativity between T.F. and DNA enhancer site, n









Note:    










































































































































































































































































































































































AX aa , i.e., Xa  



























AX aa , however, 




























AX aa  have same signs, i.e., j1 < Xa   Aa or j1 > Xa + Aa.
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. Discuss the biological implication that Am as n  $ depends on 
wa… 





X  > 0. Since Am is also zero at n 
= 0, Am cannot have a minimum value to satisfy the condition, Am 5 0.





       
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       






























































































































 Xa  Aa < j1 < Xa + Aa





Hence Am increase monotonically with Aa, i.e., maximum value of Am occurs as Aa  Xa.




































(trivial non-stationary point of inflexion).  








A  for Aa > 0.















4  can be negative, positive or zero for 0 < Aa < Xa. Thus, multiple non-stationary 




















2466  jXjXjXmjXjXXmjXXmX aaaaaaaaaaaa
. A maximum number of three non-trivial non-stationary points of inflexion could exist. 























4  can be negative, positive or zero for 0 < Aa < Xa. Thus, multiple non-



















0  cmcmcmcmcmc aaaaa   where c1 to c8 are 
functions of ji and Xa. A maximum number of eight non-trivial non-stationary points of 


























Example: one trivial non-stationary 




Example: one trivial and one non-












































TFXAnMXAnM XjifAA TFTFTFTF 2|| 11,, -, ## ; TFTFTFTF XAnMXAnM AA ## - || 1,,  when 
otherwise. 
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Example: one trivial and two non-stationary points of inflexion 
(denoted by crosses). 
j14 5 80/3 Xa4












n = 1 
n = 2 
n > 2 




n = 1 
n = 2 


















n = 1 
n > 2 





























































































A . Although 1 to 3 positive turning points, only 1 or 3 





















































Maple: did not obtain > 1 valid turning points; only 1 valid turning point is obtained. 






























































































































Effect of rates of transcription (k1) and translation (k2)















































Ajk 11 ) is maximum at k4 = 0. There is a non-stationary point of inflexion 
at k4 = 2










































Ak2 ) is maximum at k5 = 0. There is a non-stationary point of inflexion at 
k5 = 2












C. Normalized oscillation amplitude of target gene 
 
   






























































































































4 . Therefore, the effect of Pa on mm is qualitatively similar to the effect 













4  < 0. 






































































































. Therefore, the effect of Pa on mp is qualitatively similar to the effect 















 < 0. 











Effect of T.A. binding affinity to DNA enhancer site, j1
      
      
                 2 3






































































































When j1 = 0, mm = 0; as j1  $, mm  
   
























































































k . A non-
stationary point of inflexion occurs at 
 














































Two non-stationary points of inflexion at ji = 0 and 
 













































k . Two non-stationary points of inflexion at ji = 0
and 
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Since    
   
   
































mm , mm,n > mm,n-1 as j1  $.
Effect of stoichiometry of T.A. or binding cooperativity between T.F. and DNA enhancer 
site, n
When n = 0, mm = 0.
Note:
   
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n = 1 
n = 2 
n = 4 
























mX aa , i.e., 




4  can be zero, positive or negative when j1 < Xa(1 ma) or j1 > Xa(1 + ma).


















. Discuss the 
biological implication that mm as n  $ depends on wa…









4  can be zero, positive or negative. As n  $, mm  
0. Since mm is also zero at n = 0, mm cannot have a minimum value to satisfy the 
condition, mm 5 0.
j1 > Xa(1 + ma): n
mm
4































 Xa(1  ma) < j1  Xa(1 + ma)
j1 = Xa(1  ma)
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Effect of T.A. oscillation amplitude, ATF
      
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4 > 0. 


































4 = 0 as Aa  Xa.
Effect of T.A. oscillation mean, Xa
      
      
 
      
       
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 0.  







4  > 0. 



































n = 2 n > 2 
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4 = 0 as As Xa  Aa. Thus, a point of inflexion must exist. 
Effect of rates of transcription (k1) and translation (k2)
Both mm and mp are independent of k1 and k2.





























































. (discuss that it is very interesting that 








































































When k5 = 0, mp = 0; as k5  $, mp  mm. (discuss that it is very interesting that a high 
degradation rate promotes mp but not vice-versa as anticipated!!!) 







The oscillation periods of the target gene mRNA and protein level were compared with 
the oscillatory T.A. period. In agreement with the analytical solution, the oscillation 
periods of the target gene mRNA and protein levels are identical to the oscillation period 
of the T.A. for all simulation runs. 





















































































































































































































4   can be positive, zero or 
negative. 





0 . As wa  $, m  01. (discuss that the resultant time-delay is 
always longer than the transcriptional time-delay by 1/k4, i.e., the self-degradation rate of 
































4   increases  























































































































































































































































































be positive, zero or negative. 











00 . As wa  $, p  01 + 02. (discuss that the 
resultant time-delay is always longer than the transcriptional and translational time-delay 
by 1/k4 & 1/k5, i.e., the self-degradation rate of mRNA & protein influences its time-
delay!!!) Thus,
Effect of degradation rates of transcriptional time-delay (01) and translational time-delay 
(02)
























4   increases  















































0  . As k4  $, m  01. (similar to the effect of wa, the 







































































00 . (similar to the effect of wa, the resultant time-delay is always 
longer than the transcriptional and translational time-delay by 1/wa)




































































































00 . (similar to the effect of wa, the resultant time-delay is always 


























7.5 Simulation source codes 
Dynamics_A1_constant_validate.m.txt 
k1 = 0.1*1000*60;      % [0.001, 1]*1000*60 nM/hr = {0.001, 0.01, 0.1, 1}*1000*60 <insignificant effect> 
j1 = 0.53*1000;          % [0.01, 10]*1000 nM = {0.01, 0.1, 1, 10}*1000 --> 
k2 = 0.01*60;           % [0.001, 1]*60 /hr = {0.001, 0.01, 0.1, 1}*60 
dM = 0.01*60;           % [0.001, 1]*60 /hr = {0.001, 0.01, 0.1, 1}*60 -->; large effect on time to steady state 
(large dM => fast; small dM => slow) 
dP = 0.01*60;           % [0.001, 1]*60 /hr = {0.001, 0.01, 0.1, 1}*60 
n = 4;                % {1, 2, 4, 8} <-- 





%Setting the Initial Concentrations and Timing Vectors 
% y(1) = T.F. 
% y(2) = mRNA 
% y(3) = Protein 
% y(4) = time 
y0 = zeros(4, 1); 
options = odeset('RelTol', 1e-6, 'AbsTol', [1e-6 1e-6 1e-6 1e-6]); 
y0(1) = X1; 
t = [0 15]; 
[T, Y] = ode23s(@Model_A1_constant_validate, t, y0, options); 
figure(1); 
subplot(2,1,1) 
plot(T, Y(:,1), 'b-'); 
legend('T.F.');  
subplot(2,1,2) 







k1 = 0.01*1000*60;      % [0.001, 1]*1000*60 nM/hr = {0.001, 0.01, 0.1, 1}*1000*60 <insignificant 
effect> 
j1 = 0.01*1000;          % [0.01, 10]*1000 nM = {0.01, 0.1, 1, 10}*1000 --> 
k2 = 0.01*60;           % [0.001, 1]*60 /hr = {0.001, 0.01, 0.1, 1}*60 
dM = 0.01*60;           % [0.001, 1]*60 /hr = {0.001, 0.01, 0.1, 1}*60 -->; large effect on time to steady state 
(large dM => fast; small dM => slow) 
dP = 0.01*60;           % [0.001, 1]*60 /hr = {0.001, 0.01, 0.1, 1}*60 
n = 1;                % {1, 2, 4, 8} <-- 





%Setting the Initial Concentrations and Timing Vectors 
% y(1) = T.F. 
% y(2) = mRNA 
% y(3) = Protein 
% y(4) = time 
y0 = zeros(4, 1); 
options = odeset('RelTol', 1e-6, 'AbsTol', [1e-6 1e-6 1e-6 1e-6]); 
y0(1) = X1; 
t = [0 10]; 
[T, Y] = ode23s(@Model_A3_constant_validate, t, y0, options); 
figure(1); 
subplot(2,1,1) 
plot(T, Y(:,1), 'b-'); 
legend('T.F.');  
subplot(2,1,2) 
plot(T, Y(:,2), 'r-', T, Y(:,3), 'k-'); 
xlabel('Time'); 
ylabel('Concentration'); 








k1 = 0.1*1000*60;      % [0.001, 1]*1000*60 nM/hr = {0.001, 0.01, 0.1, 1}*1000*60 <insignificant effect> 
j1 = 0.53*1000;          % [0.01, 10]*1000 nM = {0.01, 0.1, 1, 10}*1000 --> 
k2 = 0.01*60;           % [0.001, 1]*60 /hr = {0.001, 0.01, 0.1, 1}*60 
dM = 0.01*60;           % [0.001, 1]*60 /hr = {0.001, 0.01, 0.1, 1}*60 -->; large effect on time to steady state 
(large dM => fast; small dM => slow) 
dP = 0.01*60;           % [0.001, 1]*60 /hr = {0.001, 0.01, 0.1, 1}*60 
n = 4;                % {1, 2, 4, 8} <-- 





% y(1) = T.F. 
% y(2) = mRNA 
% y(3) = Protein 
% y(4) = time 
% v1 = k1*(T.F.)^n / (j1^n + (T.F.)^n) 
% v2 = k2*[mRNA] 
% v4 = dM*[mRNA] 
% v5 = dP*[Protein] 
% d[T.F.]/dt = A1*w1*cos(w1*t), T.F.(0) = X1, [T.F.] = X1 + A1*sin(w1*t) 
% d[mRNA]/dt = v1 - v4 
% d[Protein]/dt = v2 - v5 
Func = zeros(4, 1); 
Func(1) = A1*w1*cos(w1*t); 
Func(2) = k1*y(1)^n / (j1^n + y(1)^n) - dM*y(2); 
Func(3) = k2*y(2) - dP*y(3); 








k1 = 0.01*1000*60;      % [0.001, 1]*1000*60 nM/hr = {0.001, 0.01, 0.1, 1}*1000*60 <insignificant 
effect> 
j1 = 0.01*1000;          % [0.01, 10]*1000 nM = {0.01, 0.1, 1, 10}*1000 --> 
k2 = 0.01*60;           % [0.001, 1]*60 /hr = {0.001, 0.01, 0.1, 1}*60 
dM = 0.01*60;           % [0.001, 1]*60 /hr = {0.001, 0.01, 0.1, 1}*60 -->; large effect on time to steady state 
(large dM => fast; small dM => slow) 
dP = 0.01*60;           % [0.001, 1]*60 /hr = {0.001, 0.01, 0.1, 1}*60 
n = 1;                % {1, 2, 4, 8} <-- 





% y(1) = T.F. 
% y(2) = mRNA 
% y(3) = Protein 
% y(4) = time 
% v1 = k1*(T.F.)^n / (j1^n + (T.F.)^n) 
% v2 = k2*[mRNA] 
% v4 = dM*[mRNA] 
% v5 = dP*[Protein] 
% d[T.F.]/dt = A1*w1*cos(w1*t), T.F.(0) = X1, [T.F.] = X1 + A1*sin(w1*t) 
% d[mRNA]/dt = v1 - v4 
% d[Protein]/dt = v2 - v5 
Func = zeros(4, 1); 
Func(1) = A1*w1*cos(w1*t); 
Func(2) = k1*y(1)^n - dM*y(2); 
Func(3) = k2*y(2) - dP*y(3); 
Func(4) = 1; 
